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Resumo 
A plasticidade sináptica descreve um processo no qual a força da interacção entre neurónios, 
ou sinapses, é alterada. Por definição, é um termo funcional que se refere ao aumento ou 
decréscimo na eficácia sináptica, sendo acompanhado por alterações estruturais nas sinapses. A 
potenciação sináptica de longa duração (LTP) é a forma mais estudada de plasticidade sináptica 
e tem sido amplamente reconhecido que as alterações sinápticas responsáveis por certas formas 
de aprendizagem e memória podem ser semelhantes aquelas em que a expressão da LTP se 
baseia. 
Algumas das modificações estruturais, bioquímicas e funcionais nas sinapses associadas à 
plasticidade sináptica dependem do transporte e da tradução de RNAs mensageiros (mRNAs) 
localizados nas dendrites, em resposta à actividade sináptica, com a concomitante alteração 
local do proteoma. É cada vez mais evidente que a síntese de proteínas nas dendrites 
desempenha um papel crucial em diversas formas de plasticidade sináptica, incluindo na 
potenciação de longa duração mediada pelo BDNF (factor neurotrófico derivado do cérebro). 
Os transcritos dendríticos são transportados ao longo dos microtúbulos, numa forma em que a 
tradução está bloqueada, como componentes de complexos ribonucleoproteicos mensageiros 
(mRNPs). Para serem transportados, os mRNAs necessitam de conter na sua sequência um 
elemento cis-acting que é reconhecido por proteínas que ligam RNA e que, juntamente com 
outros factores, formam um complexo funcional que se liga a proteínas motoras para o 
transporte. Quando chegam ao seu destino, normalmente em sinapses ou na imediação de 
sinapses activadas, o bloqueio da tradução é libertado e os mRNAs são traduzidos após 
activação neuronal. Entre os constituintes moleculares que compõem os mRNPs em neurónios 
estão vários membros da família de proteínas hnRNP (ribonucleoproteinas nucleares 
heterogéneas). A proteína hnRNP A2/B1 é um dos mais bem descritos factores trans-acting 
envolvidos no transporte de mRNAs ao longo das dendrites em neurónios, contudo não se sabe 
se este é um processo constitutivo ou regulado. A hnRNP K também está presente em mRNPs 
em neurónios mas a sua função, e se desempenha algum papel no metabolismo de mRNAs nas 
dendrites, ainda está por determinar. 
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Neste trabalho mostramos que tanto a hnRNP A2/B1 como a hnRNP K se acumulam nas 
dendrites e nas sinapses após actividade sináptica em neurónios do hipocampo em cultura. 
Verificou-se também que o endereçamento de hnRNP A2/B1 para a sinapse em resposta à 
actividade neuronal depende de BDNF. De acordo com estes resultados, a estimulação de 
neurónios do hipocampo com BDNF também aumentou os níveis de hnRNP K e hnRNP A2/B1 
nas dendrites e nas sinapses. 
Estudos anteriores realizados no nosso laboratório identificaram diversos transcritos 
associados com a hnRNP K em neurónios do hipocampo, incluindo mRNAs que codificam 
proteínas importantes para a plasticidade sináptica como GluA1, GluN1, BDNF e CaMKIIẞ. De 
seguida verificou-se também que a neurotrofina BDNF induz a libertação desses transcritos de 
mRNPs que contêm hnRNP K em neurónios do hipocampo. Neste trabalho mostrámos que o 
BDNF também promove a dissociação dos mRNAs associados à hnRNP K localmente na 
sinapse. Estes resultados sugerem um papel fundamental da hnRNP K na tradução local de 
várias proteínas que contribuem para a fase tardia da LTP. De acordo com estas evidências 
experimentais, demonstrámos que os mRNAs associados à hnRNP K são regulados 
diferencialmente durante a potenciação de longa duração (LTP) induzida pela estimulação de 
alta frequência nas sinapses da via perforante - giro dentado em ratos vivos anestesiados. 
Demonstrámos também que esta forma de potenciação sináptica requer a activação dos 
receptores TrkB. Apesar de os resultados obtidos indicarem que o BDNF induz a libertação dos 
transcritos associados a mRNPs contendo a hnRNP K, não é possível excluir a contribuição de 
outras ribonucleoproteínas que co-imunoprecipitaram com a hnRNP K num estudo de proteómica 
efectuado. 
No seu conjunto, os resultados obtidos apoiam o modelo que propõe uma função para a 
hnRNP A2/B1 na entrega de transcritos em regiões específicas das dendrites e sugerem que 
este é um processo regulado pela actividade sináptica e pelo BDNF. Demonstrámos também que 
a acumulação de hnRNP A2/B1 na sinapse após actividade sináptica depende de BDNF. A 
hnRNP K é outra hnRNP que parece desempenhar um papel crucial na regulação do 
metabolismo do mRNA localmente nas dendrites. Os nossos resultados demonstram que a 
interacção entre a hnRNP K e os mRNAs a ela associados é regulada pela actividade sináptica e 
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pelo BDNF, tanto in vitro como in vivo, o que sugere a hnRNP K como um importante regulador 
da função neuronal, em particular em fenómenos de plasticidade sináptica induzidos pelo BDNF. 
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Abstract 
Synaptic plasticity describes the process by which connections between neurons, or synapses, 
change in strength. By definition, it is a functional term referring to an increase or decrease in 
synaptic efficacy, which is accompanied by structural changes at synapses. Long-term 
potentiation (LTP) is the most studied form of synaptic plasticity and it has been widely 
recognized that synaptic changes that underpin certain forms of learning and memory may be 
similar to those involved in the expression of LTP. 
Some of the structural, biochemical and functional modifications at the synapse associated 
with synaptic plasticity require activity-dependent transport and translation of dendritic-localized 
mRNAs, with concomitant alterations in the synaptic proteome. It is becoming evident that 
dendritic protein synthesis has a crucial role in several forms of synaptic plasticity, including brain-
derived neurotrophic factor (BDNF)-mediated LTP. Dendritic transcripts required for local protein 
synthesis are transported in a repressed state along the microtubule cytoskeleton as components 
of large messenger ribonucleoprotein complexes (mRNPs). In order to be transported, dendritic 
mRNAs must contain a cis-acting element in their sequence that is recognized by specific RNA 
binding proteins that, together with other factors, form a functional mRNP granule that engage 
with motor proteins for the transport. When they reach their destination, usually in, or in the 
vicinity of activated synapses, the translational-block is relieved and the mRNAs are translated 
upon neuronal activation. Among the molecular components of neuronal mRNPs, there are 
several members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family of proteins. 
hnRNP A2/B1 is one of the best described trans-acting factor involved in the transport of 
dendritic-localized mRNAs in neurons, but whether this is a constitutive or a regulated process is 
unknown. hnRNP K is another member of the hnRNP family of proteins present in neuronal 
mRNPs, but the function of hnRNP K in neurons, and whether this protein plays a role in dendritic 
mRNA metabolism, remains to be determined. 
Here we show that both hnRNP A2/B1 and hnRNP K accumulate in dendrites and at the 
synapse following neuronal activation in hippocampal neurons. Importantly, the activity-dependent 
delivery of hnRNP A2/B1 into synaptic sites requires BDNF. In addition, we observed that this 
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neurotrophin also upregulates the dendritic and synaptic levels of hnRNP K and hnRNP A2/B1 in 
primary cultures of hippocampal neurons. 
Previous studies from our laboratory identified several transcripts associated with hnRNP K in 
cultured hippocampal neurons, including mRNAs coding for proteins with roles in synaptic 
plasticity such as GluA1, GluN1, BDNF and CaMKIIẞ. In addition, we demonstrated that the 
neurotrophin BDNF induces the release of these transcripts from the hnRNP K-containing mRNPs 
in hippocampal neurons. Herein we show that BDNF also promotes the dissociation of hnRNP K-
bound mRNAs locally at the synapse. These results suggest a key role for hnRNP K in the local 
translation of several proteins that contribute to the late phase of LTP. Accordingly, we 
demonstrate that hnRNP K-associated mRNAs are differentially regulated during high-frequency 
stimulation (HFS)-induced LTP in the perforant path - dentate gyrus synapse in live anesthetized 
rats. Importantly, we show that this form of synaptic potentiation requires TrkB (tropomyosin-
related kinase B) signaling. Although our results indicate that BDNF induces the release of the 
transcripts bound to mRNPs containing hnRNP K, at this time point it is not possible to rule out 
the contribution of other RNA-binding proteins that were found to co-immunoprecipitate with 
hnRNP K in a proteomic screen. 
Altogether, our data support the evidence available pointing to a prominent role of hnRNP 
A2/B1 in the delivery of transcripts into dendritic domains and suggest that this process is 
regulated by synaptic activity and by the neurotrophin BDNF. Furthermore, we show that BDNF is 
required for the activity-induced synaptic delivery of hnRNP A2/B1. We also show that hnRNP K 
is another hnRNP that is likely to have a major role in the regulation of local mRNA metabolism in 
dendrites. Our results show that hnRNP K and hnRNP K-associated mRNAs are regulated by 
synaptic activity and BDNF, both in vitro and in vivo, and suggest hnRNP K as an important 
regulator of neuronal function, in particular in BDNF-induced plasticity events. 
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Introduction 
An adult human brain is thought to have more than 100 billion neurons, being these cells 
considered the core information processing structure in the central nervous system. Neurons are 
different from most other cells in the body in that they are polarized and have distinct 
morphological regions, each with specific functions. The connection between neurons is called 
synapse. Neurons connect to each other to form neuronal networks, and most of the actions 
mediating information storage are thought to take place at synapses. Thus, it is evident that 
synaptic alterations are critically involved in several fundamental physiological processes. On the 
other hand, several disease-related phenomena also implicate synaptic dysfunction.  
There are two distinct types of synaptic connections, chemical and electric synapses. The 
typical chemical synapse in the nervous system requires the following steps: the synthesis of a 
neurotransmitter molecule in the presynaptic cell and its storage in secretory vesicles, the activity-
dependent fusion of the neurotransmitter-containing vesicles with the plasma membrane, with the 
concomitant release of the neurotransmitter from the presynaptic terminal, the diffusion of these 
molecules across the synaptic cleft (space between the pre- and postsynaptic neurons), the 
activation of specific receptors localized in the postsynaptic cell eliciting a biochemical/electric 
response, and finally a mechanism for termination of the action of the released neurotransmitter. 
In the vertebrate central nervous system (CNS), the predominant mode of excitatory transmission 
is mediated by the neurotransmitter glutamate and the ionotropic glutamate receptors (Traynelis 
et al., 2010). Upon activation, ionotropic receptors open a channel which is more or less 
permeable to Na+ and K+ ions, and some receptors are also Ca2+-permeable. While α-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors support fast excitatory 
transmission, N-methyl-D-aspartate (NMDA) receptors have been classically viewed as 
coincidence detectors for the induction of long-term plasticity expressed as changes in AMPA 
receptors-mediated transmission (Malenka and Nicoll, 1993). 
Synaptic plasticity describes the process by which synapses change in strength. By definition, 
it is a functional term referring to an increase or decrease in synaptic efficacy, which is 
accompanied by structural changes at synapses. Plasticity at synapses can be mediated at the 
presynaptic level, by changing the release of neurotransmitter molecules, or postsynaptically by 
changing the number, type, or properties of neurotransmitter receptors and their coupling to the 
intracellular signaling machinery. Long-term potentiation (LTP) is the main form of synaptic 
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plasticity, reflecting the activity of synaptic information storage processes, and has been identified 
as the prime candidate to be the cellular correlate of learning and memory (Lynch, 2004; 
Malenka, 2003a).  
The neurotrophin brain-derived neurotrophic factor (BDNF) has been shown to play a key role 
in LTP and learning (Minichiello, 2009). This neurotrophin was shown, for instance, to regulate the 
induction and maintenance of a stable LTP (Minichiello, 2009), to regulate neurotransmitter 
release, to modulate postsynaptic glutamate receptors, to regulate protein synthesis and 
transcription (Carvalho et al., 2008), to play a role in the delivery and translation of dendritic-
localized mRNAs (Leal et al., 2013; Santos et al., 2010) and to modulate structural plasticity in 
dendritic spines (Waterhouse and Xu, 2009). In this chapter we discuss the role of BDNF in LTP, 
highlighting the modulatory actions induced by this neurotrophin on dendritic protein synthesis. 
 
1.1. Hippocampal formation and the trisynaptic circuit 
The hippocampal formation is a large functional unit of the brain that belongs to the limbic 
system and plays important roles in the consolidation of short- and long-term memory and spacial 
navigation. One of the most captivating features of the hippocampus is its neuroanatomy. The 
peculiar organization of its main cell layers coupled to the highly organized laminar distribution 
(most axons are oriented parallel to each other and develop nearly transversally to the 
hippocampus axis) of many of its inputs has encouraged the use of the hippocampus as a model 
system for modern neurobiology (Amaral and Lavenex, 2007; Whitter, 2011). The hippocampal 
formation comprises three cytoarchitechtonically distinct regions: the dentate gyrus (DG), the 
subiculum and the hippocampus proper (Cornu Ammonis, CA). The CA is subdivided into the 
CA1, CA2 and CA3 regions (Fig. 1.1). Other regions of the hippocampal formation include the 
presubiculum, parasubiculum, and entorhinal cortex (Amaral and Lavenex, 2007; Whitter, 2011).  
One of the unique features of the hippocampal formation is that many of its connections are 
unidireccional (Fig. 1.1). The entorhinal cortex provides most of the input to the dentate gyrus via 
fibers named the perforant path. The perforant pathway can be divided into two parts based on 
the origin and pattern of termination of its fibers. The lateral perforant path, which originates in the 
lateral entorhinal area and terminates in the most superficial third of the molecular layer, and the 
medial perforant path, originating in the medial entorhinal area and terminating in the middle third 
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of the molecular layer (Fig. 1.1) (Amaral and Lavenex, 2007; Whitter, 2011). Since the entorhinal 
cortex is the major source of cortical sensory information and the dentate gyrus the major receiver 
of entorhinal cortex projections, the dentate gyrus represents the first step in the processing of 
information that may lead to the formation of a memory (Amaral et al., 2007). The dentate gyrus 
does not project back to the entorhinal cortex. The dentate granule cells, the major cell type in the 
dentate gyrus, project their axons (Mossy fibers) into the CA3 region in the hippocampus. Again, 
the CA3 cells do not project back; they are instead the major input into the CA1 region (Shaffer 
collaterals). The CA1 projections are to some extent more elaborated however; the CA1 cells 
constitute the major excitatory input into the subiculum region although they also project into the 
entorhinal cortex (Amaral and Lavenex, 2007; Whitter, 2011). Because of its “relatively” simple 
organization and architecture the hippocampus is the ideal place to study synaptic transmission in 
the mammalian brain. 
 
 
Figure 1.1 - The rodent hippocampus and the trisynaptic circuitry. The main input into the hippocampus 
comes from the entorhinal cortex (EC) and is named perforant path. The lateral perforant path (LPP) 
terminates in the most superficial third of the molecular layer whereas the medial perforant path (MPP) 
terminates in the middle third of the molecular layer. The granule cells of the dentate gyrus project to the 
CA3 region of the hippocampus via Mossy fiber projections. Pyramidal neurons in the CA3 region of the 
hippocampus project to CA1 via Schaffer collaterals. Pyramidal cells in CA1 project to the subiculum. Both 
CA1 and the subiculum project back to the deep layers of the entorhinal cortex. The entorhinal cortex also 
projects to the CA1 region through another pathway called temporoammonic pathway [Adapted from (Deng 
et al., 2010)]. 
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1.2. Neurons: the functional units of the central nervous system 
The idea that neurons constitute the functional units of the CNS arose after the extensive work 
on the structure of the nervous system performed by Santiago Ramón y Cajal in the late 19th and 
early 20th centuries. He postulated the neuron theory which has changed all the neuroscientific 
disciplines since then. He demonstrated that the relation between nerve cells was not of continuity 
but rather of contiguity (Lopez-Munoz et al., 2006) and that signal propagation is mediated by 
contacts at the level of certain apparatus (Lopez-Munoz et al., 2006). The concept of synapse 
emerged but from a semantic point of view. It was only several years later that the name synapse 
was adopted. We now know that the typical chemical synapse in the nervous system involves the 
activity-dependent release of a neurotransmitter molecule from the presynaptic cell that will act 
onto specific receptors localized in the postsynaptic cell. 
In the vertebrate CNS, the predominant mode of excitatory transmission is mediated by the 
neurotransmitter glutamate and by ionotropic glutamate receptors (Traynelis et al., 2010). The 
dendritic spines constitute the primary recipient for the excitatory input and provide the 
biochemical compartments that locally control the signaling mechanisms at individual synapses 
(Bourne and Harris, 2008). Long-term changes in the efficacy of these synapses are coupled to 
changes in spine structure and morphology (Bourne and Harris, 2008). There is a considerable 
diversity in spine size and shape, and the following morphologies are typically found: stubby-, 
thin-, mushroom-shaped (Fig 1.2) (Bourne and Harris, 2008; Racz and Weinberg, 2013) and 
branched spines (Bourne and Harris, 2008). In contrast, inhibitory synapses are symmetric and 
typically located in the dendritic shaft (Bourne and Harris, 2011; Megias et al., 2001).  
In the postsynaptic cell of an excitatory synapse there is a highly dense and specialized region 
attached to the postsynaptic membrane called postsynaptic density (PSD) that is composed by 
receptors, anchoring and scaffold proteins, as well as signaling molecules. Glutamatergic 
synapses mediate virtually all excitatory transmission in mammalian brains. Glutamate released 
from the presynaptic terminals activates several types of glutamate-gated ion channels on 
postsynaptic membranes, including AMPA and NMDA receptors (AMPAR; NMDAR) (Traynelis et 
al., 2010).  
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Figure 1.2 - Morphology of dendritic spines as observed by electron microscopy. (A) 3D 
reconstruction of serial thin sections from the stratum radiatum of the rat CA1 region. In the same dendritic 
shaft (d) it is possible to observe thin- (t), stubby- (s) and mushroom-shaped (m) spines. Excitatory synaptic 
contacts are colorized in red and symetric (presumably inhibitory) synapses in the dendritic shaft in blue. (B) 
Micrograph showing a typical mushroom-shaped spine from the rat hippocampus. Note the postsynaptic 
density (PSD) and the spine head (sp) with filamentous material that represent the actin cytoskeleton. The 
arrow indicates the synaptic cleft and at the top it is visible the presynaptic terminal with synaptic vesicles. 
Scale bars: 200 nm. From (Racz and Weinberg, 2013). 
 
AMPAR are composed by several combinations of four subunits (GluA1-GluA4), and only 
AMPAR that lack GluA2 are permeable to Ca2+ (Cull-Candy et al., 2006). In contrast, all NMDAR 
are permeable to Ca2+ and are tetrameric complexes composed by two essential GluN1 subunits 
(8 isoforms) and by two GluN2 (from A-D) or GluN3 (A and B) subunits (Sanz-Clemente et al., 
2013). In addition to glutamate, NMDAR require membrane depolarization to display a high 
opening probability,  because of a voltage-dependent Mg2+ block. During bouts of synaptic activity 
AMPAR-mediated membrane depolarization of the postsynaptic membrane facilitates the the 
activation of NMDAR, which in turn initiate Ca2+ signaling pathways that modulate the presence of 
AMPAR at the membrane (Derkach et al., 2007; Kessels and Malinow, 2009; Malinow and 
Malenka, 2002; Rao and Finkbeiner, 2007; Scannevin and Huganir, 2000). Changes in the 
surface expression of AMPAR affect the synaptic strength, being LTP and long-term depression 
(LTD) two of the best described phenomena in which these changes are observed (Malenka and 
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Bear, 2004). Stability of LTP and LTD over time require synthesis of new gene products. The 
synaptic signals that culminate in gene transcription are tought to originate in the NMDAR-
dependent activation of second messenger pathways (West et al., 2002). Thus, in a classical view 
of long-term changes in synaptic plasticity, the NMDA receptors have a regulatory role whereas 
AMPA receptors are the effectors. 
 
1.3. Basic mechanisms of Long-Term Potentiation (LTP) 
The concept of synaptic plasticity was postulated by Hebb in 1949 when he suggested that the 
experience can modify synapses favoring some neuronal pathways within a circuit and weakening 
others (Hebb, 1949). Since then, an enormous effort was made to understand the mechanisms 
that contribute to synaptic strengthening. 
The first full description of LTP was published in 1973 by Bliss and Lomo (Bliss and Lomo, 
1973). They reported that trains of high-frequency stimulation to the rabbit perforant path induced 
a sustained increase in efficiency of synaptic transmission in the granule cells of the dentate 
gyrus. This report, and others which followed during the 1970s, confirmed the Hebbian nature of 
this form of synaptic plasticity, and it was immediately recognized that the synaptic changes that 
occur during LTP may be similar and correlate with those that occur during certain forms of 
learning and memory. The LTP is characterized by three basic properties: i) the cooperativity, 
which describes the existence of an intensity threshold for induction; ii) LTP is associative in the 
sense that a weak input can be potentiated by other separated but convergent input; iii) finally, 
LTP is input-specific meaning that potentiation is not shared to other pathways distinct from the 
potentiated synapse (Bliss and Collingridge, 1993).  
Since its discovery, LTP has been studied in detail in several brain regions and much is known 
about the molecular mechanisms underlying this form of plasticity. LTP in the hippocampus is the 
most studied form of synaptic plasticity and is typically divided into at least three distinct and 
sequential phases: short-term potentiation, early LTP (E-LTP), and late LTP (L-LTP). Short-term 
potentiation and E-LTP are transient and involve the modification of preexisting proteins, whereas 
L-LTP requires changes in gene expression and de novo protein synthesis, and lasts for hours, or 
even days (Kandel, 2001; Sweatt, 1999). 
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It is now well established that the postsynaptic influx of Ca2+ mediated by the activation of 
NMDA receptors is necessary and sufficient for the induction of E-LTP (Bliss and Collingridge, 
1993). The opening of NMDA receptors requires glutamate binding and membrane depolarization 
which relieves the Mg2+ block. Activation of NMDA receptors allow the entry of Ca2+ into the cell 
and this rise in the intracellular Ca2+ concentration activates several enzymes that mediate E-LTP 
induction, including Ca2+/calmodulin-dependent protein kinase II (CaMKII) and protein kinase C 
(PKC) (Sweatt, 1999). The sustained activation of these enzymes is also crucial for the 
maintenance of E-LTP [reviewed in (Bliss and Collingridge, 1993; Lynch, 2004)]. During the 
maintenance of E-LTP, the longer-term effects on synaptic strength are achieved due to 
generation of persistently active forms of PKC and CaMKII that become autonomously active and 
phosphorylate downstream targets that underlie E-LTP maintenance, such as AMPA receptors, 
resulting in an increase in their trafficking and insertion into the postsynaptic membrane, with a 
consequent upregulation in receptor activity (Derkach et al., 2007; Lin et al., 2009; Malenka, 
2003a, b; Shepherd and Huganir, 2007). In addition, the increase in the surface expression of 
NMDA receptors was also observed upon E-LTP induction (Grosshans et al., 2002).  
The E-LTP is transient and is followed by the L-LTP which is believed to depend on dendritic 
protein synthesis (Sutton and Schuman, 2006) and transcription activity [reviewed in (Adams and 
Dudek, 2005; Lynch, 2004)] (Fig. 1.3). Several signaling molecules such as PKA, CaMKIV and 
extracellular signal-regulated protein kinase (ERK) are involved in the activation of key 
transcription factors, including cyclic-AMP-responsive element-binding protein (CREB) and the 
ternary complex factor (TCF) Elk-1 [reviewed in (Adams and Dudek, 2005; Lynch, 2004; Platenik 
et al., 2000)], which will lead to an increase in the synthesis of proteins that mediate changes in 
the structure and/or function of the synapses, presumably required for the maintenance of L- LTP. 
In addition, the maintenance of L-LTP is also thought to require structural changes in dendritic 
spines. In particular, the actin-mediated enlargement of spine head and increase in spine number 
is believed to support the long-term changes in synaptic efficacy (Fukazawa et al., 2003; Krucker 
et al., 2000). 
Several studies now indicate that neurotrophins, in particular brain-derived neurotrophic factor 
(BDNF), are potent regulators of hippocampal LTP [for a review see (Bramham and Messaoudi, 
2005; Lu et al., 2008; Minichiello, 2009)]. BDNF is one of the downstream genes induced by L-
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LTP and the protein has been shown to be a crucial player in the induction and maintenance of 
LTP, as discussed in the next sections. 
 
 
Figure 1.3 - LTP in the Shaffer collateral-CA1 synapses and the dependence on transcription of its 
late phase. (A) Illustration of a coronal slice of the rodent hippocampus. A stimulating electrode placed in 
the stratum radiatum (pyramidal cell dendrites) activates the fibers of the Schaffer collateral-commissural 
pathway that forms synapses on CA1 pyramidal cells. Synaptic responses can be recorded extracellularly 
with a recording electrode, also placed in the stratum radiatum. Inset: extracellular responses before and 
after the induction of long-term potentiation (LTP). CA3 and CA1, CA3 and CA1 hippocampal region; MF, 
Mossy fibers; PP, Perforant path; SC Shaffer collaterals. (B) LTP induced with high-frequency stimulation 
(arrow) often lasts more than 8 h in a slice preparation (blue dots). If dendrites are severed from their cell 
bodies, LTP decays to baseline level within 4 h (green dots). From (Adams and Dudek, 2005). 
 
1.4. Dendritic protein synthesis and dendritic transcripts 
The hypothesis of local protein synthesis at neuronal sites distant from the soma was raised 
after the work of Steward and Levy, who showed that polyribosomes can accumulate at the base 
of the dendritic spines forming a rosette-like structure (Steward and Levy, 1982), suggesting that 
they were bound to mRNA and involved in protein synthesis. This observation lead to the search 
for the mRNAs present in dendrites, and to the study of the mechanisms involved in their 
transport and how local protein synthesis is regulated at the synapse. 
In highly polarized cells such as neurons, the transport of mRNAs coupled with local 
translation provides an important mechanism for spatial and temporal control of protein synthesis. 
Dendritic-localized mRNAs are usually packaged into large messenger ribonucleoprotein 
complexes (mRNPs) that engage with motor proteins for the microtubule-dependent transport 
along dendrites. In order to be transported, the transcripts must contain a cis-acting element (also 
called zipcode or localization element) in their sequence, typically present in the 3’-untranslated 
region (UTR), which is recognized by the proper RNA-binding proteins (RBPs) present in mRNPs 
together with other factors (Fig. 1.4). These transcripts are generally kept in a dormant state 
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during the transport and are then translated upon stimulation at or near activated synapses 
(Bramham and Wells, 2007). Several mRNAs were found to localize in dendritic processes under 
different physiological conditions. One of the major challenges of identifying dendritic mRNAs is 
the concentration of mRNAs in dendrites which is several times lower when compared with cell 
body-localized mRNAs, making somatic contamination a real issue. 
 
 
Figure 1.4 - Dendritic mRNA transport in mammalian neurons. Bottom panel- Schematic representation 
of a mRNA. The cap structure in the 5’-end, the poly(A) tail in the 3’-end, the 5’UTR, the ORF, the 3’UTR 
containing a localization element (LE), and the associated RBPs are represented. Top paneI- Simulation of 
mRNA motility in neurons. mRNA tracks represent mRNA movement as a function of time, coded from 
purple/blue to red. (f) Neuronal mRNAs largely depend on microtubule-based transport for localization into 
dendrites. (g) mRNAs are seen to be docked at specific domains at or near activated synapses. Adapted 
from (Eliscovich et al., 2013). 
 
The dendritic transcriptome is not yet fully characterized. The first estimations predicted that 
approximately 400 dendritic mRNAs could be present in the dendrites of cultured rat hippocampal 
neurons (Eberwine et al., 2001). A similar number of transcripts was identified in two other 
studies: i) in neurites of hippocampal neurons, using microarray analysis and a culture system 
that allows mechanical separation of axons and dendrites (129 mRNAs) (Poon et al., 2006); ii)  in 
the stratum radiatum (dendritic lamina) from the rat hippocampal CA1 region (156 mRNAs)  
(Zhong et al., 2006). A different approach used consisted in the identification of conserved 
sequence elements in the transcripts that may explain their cellular localization and intracellular 
transport specificity (Lein et al., 2007). This strategy also predicted a low number of dendritic 
mRNAs (59 transcripts). A much higher number of transcripts was recently identified using deep 
RNA sequencing in microdissected synaptic neuropil (stratum radiatum and lacunosum 
moleculare) segments from the CA1 region of the adult rat hippocampus (Cajigas et al., 2012). 
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Since the neuropil tissue is comprised of dendrites, axons, glial cells, interneurons and blood 
vessels, the data obtained for the full neuropil transcriptome was filtered and 2550 mRNAs were 
attributed to dendrites and/or axons (Cajigas et al., 2012). 
 
1.5. The neurotrophin family and its receptors 
Nerve growth factor (NGF) was the first member of the neurotrophin family to be discovered in 
the early 50’s as a target-derived protein that promotes the growth and survival of sympathetic 
and sensory neurons during development (Cohen et al., 1954). The establishment of the 
neurotrophin family came when in the early 80’s brain-derived neurotrophic factor (BDNF) was 
purified from pig brain, and showed similar neurotrophic actions in sensory neurons (Barde et al., 
1982). Two more neurotrophins were discovered since then, neurotrophin 3 (NT3) and 
neurotrophin 4 (NT4) (Lewin and Barde, 1996). 
A major advance in our understanding of neurotrophins came when it was suggested that 
neurotrophins can be released in response to neuronal activity (Thoenen, 1991). This inspired 
future investigation addressing the roles of the neurotrophins in plasticity-related events. It is now 
well established that neurotrophins have pleiotropic functions in the nervous system, including 
roles in the control of neuronal survival and differentiation, in synaptogenesis and as mediators of 
activity-dependent synaptic plasticity (Park and Poo, 2013). 
The physiological responses to neurotrophins are mediated by the activation of two distinct 
classes of membrane-bound receptors. Neurotrophins bind to p75NTR receptors and to one of the 
three tropomyosin-related kinase (Trk) receptors. NGF binds to TrkA, BDNF and NT4 bind to TrkB 
and NT3 binds to TrkC (Chao, 2003; Reichardt, 2006). In contrast with Trk receptors, activation of 
p75NTR does not display the same specificity. p75NTR binds both the mature and the uncleaved 
forms (pro-neurotrophins) of neurotrophins (Lee et al., 2001; Teng et al., 2005). 
 
1.5.1. BDNF synthesis and secretion 
The subcellular localization and the nature of the secreted BDNF protein is still very unclear, in 
part due to the very low levels of endogenous BDNF. Like many other secreted proteins, BDNF is 
initially synthetized in the endoplasmic reticulum as a precursor protein, pre-pro-BDNF, which is 
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then converted into pro-BDNF by removal of the signal peptide. Pro-BDNF is then cleaved to 
generate the mature form of this neurotrophin, but whether this occurs before the neurotrophin is 
released remains controversial (see below). BDNF produced in the cell body is targeted to 
vesicles of the regulated secretory pathway before being transported to postsynaptic dendrites in 
secretory granules (Adachi et al., 2005; Hartmann et al., 2001; Kohara et al., 2001; Matsuda et 
al., 2009). Alternatively, the neurotrophin may be delivered to presynaptic terminals in large dense 
core vesicles through anterograde transport (Adachi et al., 2005; Dieni et al., 2012; Kohara et al., 
2001; Matsuda et al., 2009). BDNF stands out among all neurotrophins in the activity-dependent 
regulation of its expression and secretion [reviewed in (Lessmann and Brigadski, 2009)]. Upon 
high-frequency stimulation, BDNF is secreted in response to the influx of Ca2+ through NMDA 
receptors and/or voltage-gated Ca2+ channels (Aicardi et al., 2004; Balkowiec and Katz, 2002; 
Gartner and Staiger, 2002; Hartmann et al., 2001). Synaptic stimulation may also induce the 
release of the dendritic pool of BDNF by activating N-type Ca2+ channels and the release of Ca2+ 
from intracellular stores (Balkowiec and Katz, 2002). 
Several lines of evidence suggest BDNF is released mainly in the precursor form (pro-BDNF), 
and the molecule is further processed into the mature form extracellularly, via the action of 
mettaloproteinases and the extracellular plasmin (Pang et al., 2004; Woo et al., 2005). A recent 
study using a BDNF hemagglutinin knock-in mice showed the presence of a significant amount of 
endogenous pro-BDNF during the perinatal period in mice, and both BDNF and pro-BDNF were 
found to be secreted in hippocampal cultures (Yang et al., 2009). In contrast, another study 
demonstrated that pro-BDNF is rapidly converted intracellularly into mature BDNF being the later 
stored and released by excitatory input (Matsumoto et al., 2008). Accordingly, a recent study 
showed the presence of BDNF and its cleaved pro-peptide in large dense core vesicles located at 
the presynaptic terminals of excitatory neurons (Dieni et al., 2012). These findings suggest that, 
although the cleavage of pro-BDNF may occur in secretory granules, both forms of the 
neurotrophin may be released from the presynaptic terminals. 
As mentioned above, several studies performed in primary cultures demonstrated that BDNF 
may be stored and released from both axonal and dendritic compartments [reviewed in 
(Lessmann and Brigadski, 2009)]. However, a recent study using a pH-sensitive fluorescent 
tagged BDNF showed that axonal secretion requires much higher levels of neuronal spiking than 
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dendritic secretion (Matsuda et al., 2009), supporting the model proposing that dendritic-BDNF 
release represents the predominant form of activity-dependent BDNF secretion in these neurons. 
A large number of findings suggest that BDNF mRNA is transported to dendrites to allow the local 
synthesis of the protein [reviewed in (Leal et al., 2013)]. The release of this pool of BDNF from 
dendrites with concomitant activation of dendritic TrkB receptors (Baj et al., 2011) further 
indicates that BDNF can be released from dendritic processes. Given that the majority of the 
studies investigating the release of BDNF were performed in cultured neurons, future studies 
should address the nature and the source of secreted BDNF in vivo, and explore the physiological 
relevance of those findings. 
 
1.5.2. TrkB localization and signaling pathways 
TrkB receptors have been found in nerve terminals, axons and dendritic spines of 
glutamatergic pyramidal and granule cells in the hippocampus (Drake et al., 1999), and in 
dendritic spines of cerebrocortical neurons (Aoki et al., 2000). Another study demonstrated that 
TrkB receptors are present at glutamatergic nerve terminals in the hippocampus and evenly 
distributed between the presynaptic active zone and the postsynaptic density (Pereira et al., 
2006). 
The binding of neurotrophins to TrkB receptors induces ligand-receptor dimerization and 
autophosphorylation of tyrosine residues in the intracellular kinase domain of the receptor. This 
leads in turn to the phosphorylation of tyrosine residues in the intracellular juxtamembrane 
domain as well as in the carboxyl terminus of the receptor, which act as docking sites for adaptor 
molecules (Fig. 1.5). Phosphorylation of these two tyrosine residues, located outside the kinase 
activation domain of the Trk receptors, mediates the interaction with Shc (Src homology 2-
containing protein) and phospholipase Cγ (PLCγ), respectively (Reichardt, 2006). Another 
adaptor molecule, fibroblast growth factor receptor substrate 2 (FRS2), competes with Shc 
adaptor molecules for the binding to Trk receptors (Kouhara et al., 1997; Meakin et al., 1999). 
Additional adaptor proteins containing pleckstrin homology and SH2 domains, such as SH2B and 
SH2B2, bind the phosphotyrosine residues on the catalytic domain of Trk receptors and can 
activate Trk signaling (Qian et al., 1998). 
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Due to the high homology of the intracellular domains, the signaling cascades are highly 
conserved among Trk receptors (Atwal et al., 2000). The three main intracellular signaling 
cascades activated by TrkB receptors are the Ras-mitogen activated protein kinase (MAPK) 
pathway, the phosphatidylinositol 3-kinase (PI3-K)-Akt pathway and the PLCγ-Ca2+ pathway 
(Kaplan and Miller, 2000). 
 
 
 
Figure 1.5 - Major signaling cascades activated by TrkB receptors. Binding of BDNF to TrkB receptors 
induces the dimerization and transphosphorylation of the receptors on tyrosine residues localized in the 
intracellular kinase domain. This increases the tyrosine kinase activity of the receptors and leads to the 
phosphorylation of other tyrosine residues that recruit several adaptor and signaling molecules such as Shc, 
FRS2 and PLCγ (more details in the text). TrkB signaling activates three major signaling pathways: the Ras-
MAPK, the PI3-kinase and the PLCγ pathways. The activation of these pathways is coupled to several 
physiological actions that control neuronal survival, differentiation and synaptic plasticity. From (Minichiello, 
2009). 
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1.5.2.1. ERK/MAPK pathway 
The recruitment and phosphorylation of Shc adaptors results in the binding of growth factor 
receptor-bound protein 2 (GRB2) and son of sevenless (SOS), with the consequent activation of 
the Ras-MAPK pathway (Reichardt, 2006). FRS2 is also phosphorylated and can recruit GRB2 
providing an Shc-independent mechanism for the activation of Ras through the GRB2-SOS 
complex (Hadari et al., 1998; Kouhara et al., 1997; Wright et al., 1997). FRS2 may also recruit 
additional signaling proteins such as CRK, the tyrosine kinase Src and a protein phosphatase, Src 
homology phosphatase 2 (SHP2), which are thought to mediate sustained activation of the MAPK 
pathway upon neurotrophin binding (Reichardt, 2006). The activation of this pathway leads, for 
instance, to the activation of CREB which activates the transcription of essential pro-survival 
genes [reviewed in (Reichardt, 2006)]. 
 
1.5.2.2. PI3-kinase pathway 
Several adaptor proteins mediate the association and activation of PI3-K by TrkB receptors. 
GRB2-associated binder-1 (GAB1), insulin-receptor substrate 1 (IRS1) and IRS2 bind to the 
activated TrkB receptors through GRB2 to activate the PI3-K pathway (Holgado-Madruga et al., 
1997; Yamada et al., 1997). Activation of PI3-K generates 3-phosphoinositides that activate 3-
phosphoinositide-dependent protein kinase 1 (PDK1) which in turn, together with the 3-
phosphoinositides, activate protein kinase Akt (Crowder and Freeman, 1998). Among the targets 
of Akt is SHP2 which enhances MAPK signaling (Liu and Rohrschneider, 2002). The PI3-kinase 
pathway has several targets that promote axon growth and pathfinding as well as neuronal 
differentiation [reviewed in (Reichardt, 2006)]. 
 
1.5.2.3. PLCγ pathway 
Phosphorylation of the TrkB receptor on tyrosine 816 recruits PLCγ1 which is phosphorylated 
by the active receptor (Kaplan and Miller, 2000). Activated PLCγ1 hydrolyses 
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) to generate inositol-1,4,5-trisphosphate 
(Ins(1,4,5)P3) and diacylglycerol (DAG). Ins(1,4,5)P3 promotes the release of Ca2+ from internal 
stores, which results in the activation of Ca2+-dependent enzymes such as Ca2+/calmodulin-
dependent protein kinases. Signaling through this pathway controls the expression and/or activity 
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of many proteins, including ion channels and transcription factors, and plays an important role in 
TrkB-mediated long-term synaptic potentiation (Minichiello et al., 2002). 
 
1.5.3. Activation of p75NTR by pro-neurotrophins 
Several lines of evidence show that the activation of p75NTR by pro-neurotrophins induces 
physiological responses distinct from those initiated by TrkB receptors. Activation of the complex 
of p75NTR-sortilin by pro-BDNF induces neuronal apoptosis (Teng et al., 2005). In addition, several 
studies demonstrated that the binding of pro-BDNF to p75NTR is required for LTD induction at 
CA3-CA1 synapses (Pang et al., 2004; Woo et al., 2005). However, a distinct study using 
conditional Bdnf-knockout mice showed that LTD induction was normal in these synapses, 
suggesting that neither the mature BDNF nor the pro-BDNF is involved in LTD (Matsumoto et al., 
2008).  
p75NTR is a member of the tumour necrosis factor receptor superfamily with a cytoplasmic 
region that contains a “death” domain similar to those present in other members of this family (He 
and Garcia, 2004). Although the receptor does not have catalytic activity, several signaling 
pathways are activated following neurotrophin binding to p75NTR. These are mediated through the 
binding of adaptor proteins, including TRAF6, neurotrophin-interacting factor (NRIF), melanoma-
associated antigen (MAGE), RhoGDI, among others (Reichardt, 2006). Activation of p75NTR may 
activate the Jun kinase signaling cascade (Reichardt, 2006). Neurotrophin binding to p75NTR also 
promotes the activation of NF-κB, thereby inducing NF-κB-dependent neuronal survival 
(Hamanoue et al., 1999). Activation of p75NTR by neurotrophins also controls Rho family GTPase 
activity and neurite outgrowth (Yamashita et al., 1999). Interestingly, it was suggested that Trk 
receptor function may be regulated by the presence of p75NTR. For example, activation of p75NTR 
suppresses the ubiquitination of TrkB and thereby delaying receptor internalization and 
degradation (Makkerh et al., 2005). 
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1.6. BDNF and regulation of mRNA transport along dendrites  
1.6.1. Cis-acting elements and mRNA transport into dendrites 
The evidence discussed in the section 1.4 demonstrate that dendritic mRNA targeting is not a 
feature of a small subset of mRNAs as initially thought and confirms the enormous potential of 
localized translation in synaptic regulation. Among the dendritic mRNAs identified there are 
several transcripts encoding proteins with synaptic roles such as ionotropic and metabotropic 
receptors, scaffolding proteins, adhesion molecules, signaling molecules, and components of the 
translational machinery (Cajigas et al., 2012). The use of high-resolution RNA in situ hybridization 
revealed the mRNA for CaMKIIα (Ca2+/calmodulin-dependent protein kinase II, α subunit) as the 
most abundant in the neuropil region. The dendritic trafficking of this transcript and the role of 
local translated CaMKIIα in synaptic plasticity events has been widely studied (Mayford et al., 
1996; Miller et al., 2002; Ouyang et al., 1999). Other relatively abundant mRNAs in the neuropil 
region included the transcripts encoding for Shank1, PSD95 (postsynaptic density protein 95), 
Dendrin and MAP (microtubule-associated protein) 1A (Cajigas et al., 2012), all of them 
previously reported as dendritic mRNAs (Bockers et al., 2004; Herb et al., 1997; Muddashetty et 
al., 2007; Tucker et al., 1989).  
The selectivity of dendritic mRNA transport results from a complex and orchestrated series of 
events and is determined by the presence of cis-acting RNA elements which are recognized by 
trans-acting RNA-binding proteins. These ribonucleoprotein complexes may combine with other 
factors to form a functional complex which is transported along the microtubule cytoskeleton to its 
final destination (Doyle and Kiebler, 2011; Martin and Ephrussi, 2009). The cis-acting elements on 
the mRNAs (also called zipcodes or localization elements) can vary in length and in spatial 
arrangement and, with few exceptions, are contained in the 3’UTR (Andreassi and Riccio, 2009). 
Nevertheless, the presence of localization elements in the 5’UTR and in the coding sequence has 
also been reported (Chiaruttini et al., 2009; Pal et al., 2003). One of the shortest, well described, 
zipcodes was found in myelin basic protein (MBP) mRNA and is only 11-nucleotide long (Munro 
et al., 1999). This localization element was identified after mutational analysis of a 21-nucleotide 
cis-acting element previously identified in MBP mRNA (Ainger et al., 1997). The later is called 
hnRNP A2 response element (A2RE) because it is recognized by hnRNP A2/B1, a trans-acting 
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factor responsible for MBP mRNA trafficking in oligodendrocytes (Ainger et al., 1997; Munro et al., 
1999) The A2RE-dependent targeting of mRNAs is also involved in the dendritic delivery of Arc, 
CaMKIIα, and Neurogranin mRNAs, which appear to cluster in the same hnRNP A2/B1-containing 
granules in hippocampal neurons (Gao et al., 2008). Moreover, hnRNP A2/B1 was also shown to 
be necessary for the delivery of the noncoding BC1 RNA and PKMζ mRNA to distal dendritic 
domains (Muslimov et al., 2006; Muslimov et al., 2011). Surprisingly, the interaction of the latter 
RNAs with hnRNP A2/B1 depends on a non-canonical purine*purine interaction within BC1 and 
PKMζ zipcodes, suggesting the existence of a spatial code mediating the targeting of these 
transcripts to dendrites by hnRNP A2/B1 (Muslimov et al., 2011). In a recent study, the guanine 
(G)-quadruplex structures present in the 3’UTRs of CaMKIIα and PSD95 mRNAs were shown to 
direct these transcripts into dendrites (Subramanian et al., 2011). Taken together, these results 
demonstrate that the RNA structure adopted by the zipcodes may be essential for the localization 
of the transcripts in the cell. Interestingly, several other well established dendritic mRNAs possess 
G-quadruplex structures in their 3’UTR (Subramanian et al., 2011), which may indicate the 
presence of a common signature for the recognition of the cis-acting elements by the proper 
RNA-binding proteins. In fact, given the number of localized mRNAs, it is plausible to think that 
several localization elements could share structural characteristics that allow the recruitment of 
the appropriate transport apparatus.  
The identification of localization elements within dendritic mRNAs can sometimes generate 
conflicting results. An early study identified a 94-nucleotide element in the 3’UTR of CaMKIIα 
mRNA that was sufficient for the delivery of the transcript into dendrites (Mori et al., 2000). 
However, additional studies showed that CaMKIIα mRNA containing this element but lacking most 
of the 3’UTR fail to be targeted to dendrites in vivo (Miller et al., 2002). Furthermore, another 
localization element was identified in the middle of the 3’UTR of CaMKIIα transcript (Blichenberg 
et al., 2001), and the CaMKIIα transcript also contains an hnRNP A2 response element (A2RE) 
(Gao et al., 2008). Taken together, these findings suggest that the dendritic localization of 
CaMKIIα mRNA depends on diverse cis-acting elements. Similarly, two different localization 
elements were described for the Arc mRNA (Gao et al., 2008; Kobayashi et al., 2005) but 
surprisingly little is known about the mechanism of Arc mRNA transport into dendrites. In 
hippocampal neurons the Arc transcripts are transported along dendrites in hnRNP A2/B1-
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containing granules (Gao et al., 2008) and a cis-acting element on the 3’UTR of the Arc mRNA 
showed a moderate ability to target these transcripts to dendrites (Kobayashi et al., 2005). 
However, it is currently unknown whether hnRNP A2/B1 is required for Arc mRNA trafficking 
along dendrites in vivo and the identity of the trans-acting factors that recognize the localization 
element present in the Arc transcripts described by Kobayashi and coworkers also remains to be 
determined.  
Another well described dendritic mRNA is the β-actin transcript. β-actin mRNA contains a cis-
acting element 54-nucleotide long in the 3’UTR, which is recognized by ZBP1 (zipcode-binding 
protein 1) and is essential for the localization of the transcript in the cytoplasm of cultured chick 
embryo fibroblasts (Kislauskis et al., 1994; Ross et al., 1997) and in neurites and growth cones of 
cultured chick forebrain neurons (Zhang et al., 2001). The complex ZBP1-β-actin mRNA 
accumulates in dendritic spines upon synaptic activity (Tiruchinapalli et al., 2003). In developing 
neurons the localization of ZBP1-β-actin mRNA in growth cones, which is coupled to localized β-
actin translation, critically regulates growth cone navigation by mediating responses to external 
cues (Lin and Holt, 2007). In addition to the role in the localization of β-actin mRNA, ZBP1 also 
represses its translation (Huttelmaier et al., 2005). This is abrogated through Src-dependent 
phosphorylation of ZBP1, which results in the release of β-actin mRNA from ZBP1-containing 
granules and local translation of β-actin (Huttelmaier et al., 2005). Recent findings implicated the 
RNA-binding protein Src-associated in mitosis of 68 kDa (Sam68) in the metabolism of β-actin 
mRNA in dendrites (Klein et al., 2013). The authors showed that knockdown of Sam68 or blocking 
the interaction of Sam68 with β-actin mRNA decreases the levels of β-actin transcript in dendrites 
and results in fewer dendritic spines (Klein et al., 2013). In addition, absence of Sam68 results in 
a decreased number of functional synapses in vivo and reduces the amount of β-actin mRNA in 
synaptic polysomal fractions (Klein et al., 2013), suggesting that Sam68 may also be involved in 
the translational control of β-actin locally at the synapse. 
A role for BDNF in the regulation of mRNA localization in dendrites has been suggested by 
several studies. Intrahippocampal infusion of BDNF resulted in the accumulation of Arc transcripts 
in dendrites and triggered long-term potentiation (BDNF-LTP) at medial perforant path-granule 
cell synapses in vivo (Messaoudi et al., 2007; Ying et al., 2002), and similar effects were 
observed in cultured cerebrocortical neurons (Rao et al., 2006), but the mechanisms involved 
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have not been clarified. BDNF signaling induces the phosphorylation of ZBP1 and local synthesis 
of β-actin in growth cones, contributing to growth cone turning (Sasaki et al., 2010). In a recent 
study, ZBP1 was shown to regulate dendritic branching (Perycz et al., 2011). Interestingly, 
knockdown of ZBP1 inhibited the growth of dendritic protrusions in response to BDNF stimulation 
(Eom et al., 2003), suggesting that under limiting amounts of ZBP1 and β-actin mRNA in 
dendrites, neurons are not able to induce robust actin growth following stimulation with BDNF. 
Future studies should address the mechanisms underlying ZBP1-mediated transport of β-actin 
mRNA into dendrites, and possibly other mRNAs, and explore the molecular mechanisms by 
which BDNF regulates β-actin mRNA locally. 
The effect of BDNF on the abundance of dendritic mRNAs was further investigated using a 
culture system that allows the mechanical separation of neurites from cell bodies (Manadas et al., 
2009; Poon et al., 2006). BDNF differentially regulated the dendritic localization of transcripts 
encoding for several translation-related proteins, including initiation and elongation factors, and 
aminoacyl-tRNA synthases (Manadas et al., 2009). However, it is not clear if BDNF regulates the 
delivery of these transcripts to dendrites and/or alters their stability.  
 
1.6.2. Dendritic targeting of BDNF mRNA 
The nuclear events, such as splicing and alternative polyadenylation site selection, may be 
essential determinants for the differential localization of mRNA in the cytoplasm (Giorgi and 
Moore, 2007). Perhaps the best example in mammalian neurons is the targeting of BDNF mRNA 
into dendrites. The presence of two polyadenylation sites in the BDNF transcript results in two 
distinct pools of mRNAs in the brain containing either a short or a long 3’UTR (Timmusk et al., 
1993). The short 3’UTR-carrying mRNAs apparently are restricted to the soma whereas the long 
3’UTR-containing mRNAs are also found in dendrites (An et al., 2008). Nevertheless, BDNF 
constructs carrying a short 3’UTR were shown to be targeted to dendrites in cultured hippocampal 
neurons (Baj et al., 2011; Chiaruttini et al., 2009; Oe and Yoneda, 2010). The short 3’UTR-
mediated dendritic targeting of the transcript may rely on the presence of cytoplasmic 
polyadenylation element (CPE)-like motifs in its sequence (Oe and Yoneda, 2010). The CPE-like 
elements are apparently required for both constitutive and activity-dependent localization of the 
transcript in dendrites (Oe and Yoneda, 2010). In separated studies, the destination of BDNF 
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mRNA was, ultimately, ruled by the presence of 5’UTR exons (Baj et al., 2011; Chiaruttini et al., 
2009). The selective localization of several 5’UTR splice variants in dendrites was coupled to local 
TrkB activation and differentially modulates dendritic complexity (Baj et al., 2011). Importantly, 
blocking the dendritic localization of BDNF mRNA in vivo, reduced BDNF protein levels in 
dendrites and resulted in deficits in dendritic spine pruning and enlargement (An et al., 2008). 
Deficits in dendritic synthesis of BDNF also lead to the selective impairment of LTP in dendrites 
(An et al., 2008). Together, these results suggest a critical role for dendritically synthesized BDNF 
in synaptic plasticity. It was recently demonstrated in hippocampal neurons that somatically 
synthetized BDNF promotes the formation of new dendritic spines whereas dendritically 
synthetized BDNF is a key regulator of spine head growth and pruning (Orefice et al., 2013), 
suggesting differential roles for distinct pools of synthetized BDNF in the regulation of dendritic 
spine number and morphology. 
BDNF multiple transcripts can also be generated by alternative splicing of the 5’UTR region. 
As many as 11 different splice-variants of BDNF mRNA were described in both humans and 
rodents (Aid et al., 2007). Some of these variants show a differential distribution in hippocampal 
laminae in response to different incoming stimuli (Chiaruttini et al., 2008). It is not clear though, 
how the different forms of BDNF mRNA are sorted into distinct subcellular compartments. This 
process most likely requires additional and at the moment unknown factors. Translin binds to the 
coding sequence of BDNF mRNA regulating both constitutive and activity-induced transport of the 
transcript to dendrites (Chiaruttini et al., 2009). It was further demonstrated that, depending on the 
stimuli, translin may be required or not for BDNF mRNA trafficking (Wu et al., 2011). Interestingly, 
exogenous application of BDNF is sufficient to induce the transport of BDNF and TrkB mRNAs 
into dendrites in hippocampal neurons through the activation of the phosphatidylinositol 3-kinase 
(PI3-K) pathway (Righi et al., 2000).  
 
1.6.3. Nuclear history of dendritic-localized mRNPs 
Several RNA-binding proteins that compose the dendritic mRNP complexes are nucleo-
shuttling proteins highly expressed in the nucleus (Giorgi and Moore, 2007). These observations 
per se suggest that some trans-acting factors accompany the mRNA from transcription sites and 
ultimately regulate their localization in dendrites (Giorgi and Moore, 2007). One of the best 
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examples of nuclear-acquired RNA-binding proteins implicated in transcript localization comes 
from the exon junction complex (EJC), a set of proteins involved in mRNA splicing. Several 
proteins of the EJC, including Magoh, Y14, MLN14 and Barentsz, were detected in dendrites 
(Glanzer et al., 2005; Macchi et al., 2003). In particular the EJC protein eukaryotic initiation factor 
(eIF) 4AIII is present in neuronal RNA granules and binds several dendritic mRNAs such as the 
Arc transcript (Giorgi et al., 2007). However, EJC was not involved in the trafficking of Arc mRNA, 
but instead directed the transcript for degradation after translation (Giorgi et al., 2007).  
Another example is related with the RNA-binding protein ZBP1. ZBP1 is mainly cytoplasmic, 
but its association with β-actin mRNA is likely to occur at transcription sites (Oleynikov and 
Singer, 2003; Pan et al., 2007). Interestingly, this interaction appears to be facilitated by ZBP2 
(Pan et al., 2007). ZBP2 is predominantly nuclear but a small fraction of the protein colocalizes 
with cytoplasmic β-actin mRNA in both fibroblasts and neurons (Gu et al., 2002). Overexpression 
of a truncated form of ZBP2 disrupts the dendritic localization of β-actin transcripts (Gu et al., 
2002). Altogether, these results suggest a cooperative role for ZBP1 and ZBP2 in the formation of 
functional nuclear mRNPs, and ultimately in the regulation of β-actin mRNA localization. 
Accordingly, the ZBP2-related protein MARTA1 binds with high affinity the dendritic targeting 
element in MAP2 mRNA (Rehbein et al., 2002) and it is suggested to have a role in both nuclear-
export and dendritic trafficking of MAP2 mRNAs. The importance of nuclear-acquired factors in 
dendritic mRNA localization is also shown by the role played by the nuclear CAP-binding 
complex. The mRNA degradation factor LSm1 was shown to form dendritic-localized mRNPs that 
also contain the nuclear CAP-binding protein CBP80, which associates with mRNA percursors in 
the nucleus (di Penta et al., 2009). These results demonstrate that the LSm1-containing mRNPs 
are assembled in the nucleus.  
The role of the nuclear compartment in the delivery of RNAs to dendrites was also addressed 
in experiments in which labeled RNAs were microinjected in the cytoplasm of hippocampal 
neurons. The transcripts were found along dendrites, showing that the delivery to this 
compartment does not require any nuclear event (Tubing et al., 2010). In most cases though, it is 
not clear how the nuclear history of endogenous dendritically targeted mRNAs regulates their 
localization. 
 
Chapter 1 
44 
1.6.4. Trans-acting factors 
Among the best studied trans-acting factors that contribute to dendritic mRNA localization in 
neurons are the RNA-binding proteins ZBP1, Staufen, Fragile X mental retardation protein 
(FMRP), hnRNP A2/B1, and the cytoplasmic polyadenylation element binding protein (CPEB). 
The ultimate function of the trans-acting factors is to recognize cis-acting elements in the mRNAs 
and target the transcripts to distal dendrites. However, some of these RNA-binding proteins can 
also act as translation repressors (Huttelmaier et al., 2005; Jung et al., 2006; Napoli et al., 2008; 
Richter, 2007), linkers to motor proteins (Dictenberg et al., 2008; Falley et al., 2009) or even 
regulators of mRNA decay (Kim et al., 2005).  
Staufen proteins are among the best characterized proteins regulating mRNA localization in 
many species. In mammals, Staufen is involved in the binding and targeting of mRNAs into 
dendrites (Kiebler et al., 1999; Tang et al., 2001). The Staufen family of proteins comprises two 
members, Staufen1 and Staufen2, which are components of different RNA granules in neurons 
(Duchaine et al., 2002). Staufen2 is mainly expressed in the brain and is necessary for the 
microtubule-dependent delivery of CaMKIIα mRNA to dendrites (Jeong et al., 2007). Staufen1 is 
required for the late phase of long-term potentiation (L-LTP) in the hippocampus (Lebeau et al., 
2008) whereas Staufen2 regulates mGluR-dependent long-term depression (mGluR-LTD) 
(Lebeau et al., 2011), suggesting distinct roles for the two Staufen proteins at the synapse.  
Another important regulator of mRNA localization in neurons is FMRP. FMRP associates with 
several well described dendritic mRNAs, such as CaMKIIα, Arc, MAP1b, PSD95, as well as its 
own mRNA (Bassell and Warren, 2008). Furthermore, FMRP interacts directly with the motor 
protein kinesin to promote the transport of FMRP and cognate mRNAs along dendrites, further 
suggesting a role in the transport of ribonucleoprotein complexes along dendrites (Dictenberg et 
al., 2008). This study, together with the purification of KIF5-associated granules (Kanai et al., 
2004), provided the best evidence for motor-based transport of RNA granules along the 
microtubule cytoskeleton. Another evidence for an interaction of trans-acting proteins and motor-
based transport systems came from studies showing that the dendritic transport of Shank1 mRNA 
requires KIF5C and KIF5-associated protein Staufen1 (Falley et al., 2009). FMRP is also one of 
the best described factors that regulate the translation of mRNAs at the synapse. For instance, 
FMRP can recruit 4E-BP-like cytoplasmic Fmr-interacting protein-1 (CYFIP1) to repress the 
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translation of target mRNAs (Napoli et al., 2008). Recent findings indicate that FMRP can also 
repress the translation of cognate mRNAs through the association with miRNAs (Edbauer et al., 
2010; Muddashetty et al., 2011) and through the reversible stalling of the ribosomes on 
polyribosomes containing FMRP-target mRNAs (Darnell et al., 2011). 
RNG105 is an RNA-binding protein present in discrete RNA granules in dendrites of 
hippocampal neurons where it colocalizes with Staufen and CaMKIIα mRNA (Shiina et al., 2005). 
BDNF induces the release of RNG105 from RNA granules which is coincident with the translation 
of an mRNA reporter near the granules (Shiina et al., 2005). However, the translation of RNG105-
associated mRNAs was still suppressed in the absence of RNG105 (Shiina et al., 2010), 
suggesting that translation repression is not the primary role of RNG105. In fact, the RNG105-
deficient mice showed reduced levels of RNG105-associated mRNAs in dendrites indicating a 
role for RNG105 in the dendritic localization of these mRNAs. 
Another trans-acting factor required for dendritic mRNA transport is the CPEB. CPEB and the 
cytoplasmic polyadenylation complex are well known regulators of translation [(For a review see 
(Richter, 2007)] but less is known about the role of CPEB in mRNA trafficking. CPEB was shown 
to facilitate the transport of CPE (cytoplasmic polyadenylation element)-binding mRNAs to distal 
dendrites (Huang et al., 2003). It was recently shown that CPEB-associated proteins 
bidirectionally regulate the translation of specific mRNAs in dendrites resulting in a bidirectional 
regulation of LTP at hippocampal synapses (Udagawa et al., 2012), but whether CPEB is involved 
in the dendritic localization of those transcripts remains to be investigated. 
 
1.6.5. Molecular composition of RNA granules 
In the recent years, a great effort has been made to characterize the molecular composition of 
the granules responsible for the transport of RNAs. Hirokawa and coworkers purified large RNA 
granules from the mouse brain which were associated with the tail of conventional kinesin KIF5 
(Kanai et al., 2004). These granules contained CaMKIIα and Arc mRNAs as well as 42 different 
proteins. Among the identified proteins there are several well established trans-acting factors 
involved in mRNA localization such as Staufen, FMRP and Pur-α. This proteomic approach also 
led to the identification of new players in mRNA transport such as hnRNP U and the 
Polypyrimidine tract binding protein-associated splicing factor (PSF) (Kanai et al., 2004). 
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Interestingly, several members of the hnRNP family of proteins that were detected in this RNA 
granule preparation were found to accumulate at postsynaptic sites upon neuronal activation 
(Zhang et al., 2012), further supporting their role in local mRNA regulation.  
In a separated study, subcellular fractionation was used to obtain fractions enriched in 
ribonucleoprotein complexes from developing rodent cortex (Elvira et al., 2006). The composition 
of these granules was to some extent different from the KIF5-associated granules described by 
Hirokawa and coworkers (Kanai et al., 2004). First, these granules were enriched in β-actin and 
did not contain CaMKIIα or Arc transcripts. Second, proteomic analysis of these fractions revealed 
several RNA-binding proteins that were not detected in the KIF5-associated granules (Elvira et 
al., 2006). Nevertheless, the two granule preparations had many common components, including 
several hnRNPs, Staufen2, and DEAD-box3 helicase. Interestingly, it was further demonstrated 
that BDNF treatment increased the number of motile DEAD-box3-carrying granules in 
hippocampal neurons (Elvira et al., 2006). Taken together, these results suggest that RNA 
granules are heterogeneous complexes and that some of their components might constitute 
general machinery for mRNA transport whereas others can be added specifically according to the 
mRNA/mRNAs that are transported.  
One of the most important questions remaining in the field is related to the nature and number 
of mRNAs present in each ribonucleoprotein granule. The mRNAs encoding for Arc, CaMKIIα, 
and Neurogranin coassemble in the same set of hnRNP A2/B1-containing granules in cultured 
hippocampal neurons (Gao et al., 2008). Studies using labeled RNAs microinjected into the 
cytoplasm of hippocampal neurons showed that MAP2 and CaMKIIα transcripts were sorted into 
distinct RNA granules in dendrites (Tubing et al., 2010). It was further demonstrated that 
endogenous MAP2, CaMKIIα, and β-actin mRNAs localize in distinct ribonucleoprotein particles 
which, unexpectedly, contained very few mRNA molecules (Mikl et al., 2011). Accordingly, in situ 
hybridization experiments with single molecule sensitivity to study 8 different and well established 
dendritic mRNAs showed that different mRNAs had little or no tendency to cluster together in the 
same granules and most likely were transported singly into dendrites (Batish et al., 2012). These 
recent findings suggest a simpler model in which solitary mRNAs can recruit their specific set of 
proteins and travel to distal dendrites, which may provide finer regulation of distinct mRNAs at 
individual synapses. Nevertheless, multiplexed mRNA trafficking has been observed in 
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mammalian neurons (Gao et al., 2008) as well as in other biological contexts (Martin and 
Ephrussi, 2009). Moreover, RNA granules were observed with the RNA staining dye SYTO14 
which indicates the presence of high RNA content (Knowles et al., 1996; Tang et al., 2001). 
Further research is required to determine the molecular composition of single RNA granules 
and to unravel the mechanisms orchestrating the assembly and the transport of these complexes 
along dendrites.  
 
1.6.6. BDNF regulation of P-bodies 
The population of RNA-containing granules in neurons is heterogeneous. They can be 
classified in RNA transport granules, stress granules, and RNA processing bodies (P-bodies) [(for 
further reading see (Anderson and Kedersha, 2006; Kiebler and Bassell, 2006)]. P-bodies are 
distinct cytoplasmic RNA granules that contain the components of the 5’-3’ mRNA decay, 
nonsense-mediated decay pathway and RNA-induced silencing complex (RISC). It was recently 
shown that BDNF treatment increased the formation of dendritic and somatic P-bodies that 
contain untranslated RNA targeted for repression or degradation (Huang et al., 2012). 
Furthermore, BDNF was shown to induce the translocation of dendritic P-body-like structures 
towards the distal regions of dendrites in hypothalamic neurons (Cougot et al., 2008). These P-
body-like structures often contained ZBP1 and FMRP, two well described RNA-binding proteins 
involved in mRNA transport (Cougot et al., 2008). These findings, together with the emerging 
roles of miRNAs in the regulation of local mRNAs, suggest a close interplay between P-bodies 
and RNA transport granules. Stimulation of hippocampal neurons with BDNF induced the 
dissociation of P-bodies (Zeitelhofer et al., 2008), suggesting a model in which BDNF may relief 
P-bodies-mediated repression or decay. On the other hand, a general increase in miRNA 
biogenesis and in the formation of P-bodies was observed upon BDNF induction of Dicer in 
hippocampal neurons (Huang et al., 2012). Despite the apparent conflicting results, both studies 
demonstrated that P-bodies are dynamic entities that respond to BDNF treatment. Interestingly, it 
was recently reported that P-bodies accumulate at the synapse and release mRNA upon neuronal 
activation (Oh et al., 2013). Future research is needed to investigate whether BDNF regulates the 
mRNA content of this type of granules. 
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1.7. Regulation of hippocampal LTP by BDNF 
Work performed with trkB- or Bdnf-deficient mice showed that an impairment of the BDNF-
TrkB signaling leads to a significant downregulation of early and late phases of LTP in the 
Schaffer collateral-CA1 hippocampal synapses (Korte et al., 1995; Korte et al., 1998; Korte et al., 
1996; Minichiello et al., 1999), which was correlated with a reduction in the performance in certain 
learning tasks (Gruart et al., 2007; Linnarsson et al., 1997; Minichiello et al., 1999; Pozzo-Miller et 
al., 1999; Xu et al., 2000). Importantly, the effects on LTP observed in mice carrying a null 
mutation in the Bdnf gene were reverted upon restoring the expression of the Bdnf gene or 
following treatment with recombinant BDNF (Korte et al., 1996; Patterson et al., 1996), further 
suggesting a role for BDNF in long-term synaptic potentiation in the hippocampus. In agreement 
with these findings, LTP is significantly inhibited when high-frequency stimulation (HFS) is 
performed in the presence of the BDNF and NT4 (neurotrophin-4) scavenger TrkB-IgG or with 
anti-TrkB antibodies (Chen et al., 1999; Figurov et al., 1996; Kang et al., 1997; Korte et al., 1998). 
The Val66Met polymorphism in the Bdnf gene which results in a defect in regulated release of 
BDNF and affects episodic memory (Egan et al., 2003) also leads to an impairment of LTP (Ninan 
et al., 2010), further indicating a role for BDNF in this form of plasticity in the hippocampus. 
However, at this point the timing and relative role of the pre- and postsynaptic region in the 
release of BDNF still remains to be elucidated.  
Facilitatory effects of BDNF in the induction of LTP have also been reported under conditions 
of weak synaptic stimulation that would not normally induce synaptic potentiation in the 
hippocampal CA1 region (Kovalchuk et al., 2002). Bath application of BDNF also triggers a 
sustained enhancement of synaptic transmission in the CA1 region of the hippocampus by a 
mechanism dependent on protein synthesis (Ji et al., 2010; Kang and Schuman, 1996). 
Transcription and translation activities are also required for BDNF-induced long-term potentiation 
at medial perforant path-granule cell synapses in vivo following intrahippocampal infusion of the 
neurotrophin (Messaoudi et al., 2007; Ying et al., 2002). 
The TrkB receptors for BDNF are expressed in axons, nerve terminals and dendritic spines of 
the hippocampal granule and pyramidal neurons of the adult rat hippocampus (as previously 
discussed) raising the question of whether the neurotrophin acts at the pre- and/or postsynaptic 
level in LTP, and the signaling mechanisms involved. The TrkB receptors are coupled to the 
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activation of multiple signaling pathways, including the Ras/ERK pathway and the PI3-K/Akt 
pathway, initiated by interaction of Shc with the phosphorylated receptor, and the phospholipase 
Cγ (PLCγ) (as previously discussed). Studies performed in mice with targeted mutations in either 
the Shc or the PLCγ binding sites of TrkB showed that the latter mechanism is preferentially 
coupled to potentiation of the CA3-CA1 synapse and associative learning (Gruart et al., 2007; 
Minichiello et al., 2002). Furthermore, inhibition of the PLCγ pathway at the pre- and or 
postsynaptic level, by overexpression of the PLCγ pleckstrin homology domain (PH) with a viral 
vector, showed a role for pre- and postsynaptic TrkB receptors in LTP in the hippocampal CA1 
region (Gartner et al., 2006). Interestingly, in this study concurrent inhibition of pre- and 
postsynaptic PLCγ signaling was required to reduce LTP to levels similar to those observed in 
trkB and Bdnf knockout mice. In contrast, blockade of presynaptic or postsynaptic signaling alone 
did not result in a significant reduction of LTP (Gartner et al., 2006). Recruitment of Ca2+ from 
inositol 1,4,5-trisphosphate (IP3)-sensitive intracellular stores was suggested to play a key role in 
LTP downstream of PLCγ activation (Gartner et al., 2006).  
A different study addressed the relative role of pre- and postsynaptic TrkB receptors in LTP 
using mutant mice with reduced expression of the receptor throughout the brain, including the 
CA3 and CA1 regions, and mice lacking TrkB in the hippocampus CA1 region (Xu et al., 2000). 
The LTP was only affected in the former animal model but not in mice lacking TrkB receptors in 
the CA1 region (postsynapse), suggesting that BDNF apparently acts through TrkB 
presynaptically, but not postsynaptically to modulate LTP. 
 In contrast with the reports suggesting a concurrent role of pre- and postsynaptic TrkB 
receptors in LTP in the CA1 region of the hippocampus, a postsynaptic effect was proposed to 
account for the robust induction of LTP at the synapses of the medial perforant path fibers when 
BDNF was applied together with a weak synaptic stimulation that would not normally induce 
synaptic potentiation (Kovalchuk et al., 2002). Although a presynaptic effect of BDNF was not 
ruled out in this paradigm, the differences may be due to the distinct synapses investigated.  
 
1.7.1. Transcription- and translation-independent synaptic regulation by BDNF 
The role of BDNF in the early phase of LTP is likely dependent on the post-translational 
regulation of pre- and postsynaptic proteins. At the presynaptic level the activation of TrkB 
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receptors was shown to upregulate depolarization-evoked glutamate release from isolated 
hippocampal and cerebrocortical synaptosomes (Jovanovic et al., 2000; Pascual et al., 2001; 
Pereira et al., 2006; Simsek-Duran and Lonart, 2008) (Fig. 1.6). Studies performed in cultured 
hippocampal neurons showed that BDNF increases the frequency of miniature excitatory 
postsynaptic currents, further supporting a presynaptic effect of the neurotrophin (Lessmann and 
Heumann, 1998; Li et al., 1998; Schinder et al., 2000; Tyler and Pozzo-Miller, 2001). The rapidly 
recycling pool of synaptic vesicles is targeted by a BDNF-dependent mechanism in the 
hippocampal CA1 region, and this modulation was shown to be necessary for the enhancement of 
exocytosis caused by induction of LTP (Tyler et al., 2006). The recycling of synaptic vesicles 
induced by BDNF requires the presence myosin VI, a minus end-directed actin-based motor, and 
the adaptor protein GIPC1 [PDZ (postsynaptic density-95/Discs large/zona occludens-1) domain-
containing adaptor protein, type 1], which form a complex that can engage TrkB receptors (Yano 
et al., 2006). However, how myosin VI contributes to the BDNF-induced regulation of the 
exocytotic release of glutamate remains to be elucidated.  
The potentiation of glutamate release by BDNF was not observed is cerebrocortical 
synaptosomes isolated from synapsin I and synapsin II deficient mice (Jovanovic et al., 2000), an 
ERK substrate that interacts with small synaptic vesicles. These results suggest that TrkB 
receptor activation coupled to synapsin phosphorylation may dissociate the synaptic vesicles from 
actin filaments, thereby increasing vesicle docking and glutamate release. Accordingly, BDNF 
increased the number of docked vesicles per active zone at CA1 spine synapses in hippocampal 
slice cultures, but since in these experiments the treatment with the neurotrophin was performed 
for 48 h, the effect may involve, at least in part, translation activity (Tartaglia et al., 2001).  
Synaptic potentiation by BDNF is also dependent on the small GTP-binding protein Rab3a, 
which is known to play a role in vesicular trafficking. Rab3a is associated with synaptic vesicles 
and the BDNF-induced upregulation of neurotransmitter release was shown to be impaired in 
cultured hippocampal neurons form Rab3a knockout mice (Alder et al., 2005; Thakker-Varia et al., 
2001). A role for Rab3a in the presynaptic effects of BDNF is further suggested by the results 
showing an impairment of the BDNF-induced potentiation of glutamate release in synaptosomes 
isolated from the CA1 region of Rim1α (Rab3a interacting molecular 1 α) knockout mice (Simsek-
Duran and Lonart, 2008). Rim1α is a component of Rab3a molecular pathway which is 
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phosphorylated by an ERK-dependent mechanism following stimulation of CA1 nerve terminals 
with BDNF. However, the Rim1α downstream targets in BDNF-induced potentiation of glutamate 
release remain to be identified. 
BDNF-induced modulation of glutamate receptors is likely to contribute to the effects of this 
neurotrophin on E-LTP (Fig. 1.6). BDNF activation of postsynaptic TrkB receptors was shown to 
induce the phosphorylation of plasma membrane-associated NMDA receptors, as shown for the 
GluN1 and GluN2B subunits (Lin et al., 1998; Suen et al., 1997), which may account for BDNF-
induced increase in the receptor open probability observed in cultured hippocampal neurons 
(Levine et al., 1998). Accordingly, the effects of BDNF on the electrophysiological properties of 
NMDA receptors depend on GluN2B subunits (Levine and Kolb, 2000). Later, evidence was 
provided for a direct link between TrkB and NMDA receptors phosphorylation by a tyrosine kinase 
Fyn (Mizuno et al., 2003). More recently, it was demonstrated that BDNF modulates the 
expression and trafficking of NMDA receptors in hippocampal neurons (Caldeira et al., 2007b). 
 
 
Figure 1.6 - Modulation of glutamatergic synapses by BDNF. BDNF may activate pre- or postsynaptic 
TrkB receptors with distinct effects on the glutamatergic synaptic transmission. At the presynaptic level, 
BDNF upregulates glutamate release. Activation of postsynaptic TrkB receptors also upregulate NMDA and 
AMPA receptor activity by different mechanisms. In particular Fyn kinase activated by TrkB receptors 
interacts with NMDAR and increases the open probability of the ion channel. BDNF-TrkB can also induce 
cation influx through TRPC3 channels facilitating the entry of Ca2+ through voltage-gated calcium channels 
and the activity of NMDA receptors. Ca2+ influx through NMDAR activates CamKIIα which in turn contributes 
to the positive regulation of AMPAR and NMDAR with a consequent induction and expression of LTP. BDNF 
also modulates the trafficking and membrane insertion of AMPA receptors. From (Minichiello, 2009). 
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It is widely accepted that trafficking of AMPA receptors to the synaptic plasma membrane has 
an essential role in LTP (Malenka, 2003b). BDNF was also shown to increase the phosphorylation 
of GluA1 AMPA receptor subunits in cultured organotypic hippocampal slices and increased 
synaptic delivery of AMPA receptors within about 30 min (Caldeira et al., 2007a), further 
contributing to an upregulation of the postsynaptic response to glutamate release. Similar effects 
of BDNF on the synaptic accumulation of GluA1 containing AMPA receptors were reported in 
cultured cortical (Nakata and Nakamura, 2007) and hippocampal neurons (Fortin et al., 2012). 
The rapid pre- and postsynaptic events induced by BDNF, mediated by phosphorylation of 
existing proteins, are likely to be transient and therefore may contribute to E-LTP. Additional 
mechanisms should contribute to the sustained synaptic changes that occur during L-LTP. 
 
1.7.2. BDNF and regulation of translation machinery  
BDNF promotes translation of specific mRNAs by regulating the activity of the protein 
synthesis machinery. Translation is initiated with the formation of the eIF4F complex, followed by 
recruitment of the ribosome and the mRNA molecule. The eIF4F is comprised by the eIF4E 
subunit, which binds the 5’-capped mRNAs, the eIF4A, responsible for unwinding the secondary 
structure of mRNAs, and the eIF4G, which bridges the transcript to the 43S pre-initiation complex. 
The formation of this complex and induction of translation activity is promoted by phosphorylation 
of eIF4E-binding proteins (4EBPs) (Pestova et al., 2007), which prevents their interaction of 
eIF4e. The initiation steps of translation are followed by recruitment of elongation factors, 
including the eukaryotic elongation factor (eEF) 2, which promote the translocation of the new 
protein chain from the A-site to the P-site of the ribosome (Taylor et al., 2007).  
The initiation and elongation steps of translation are considered rate-limiting, being subjected 
to regulation at multiple sites (Herbert and Proud, 2007; Santos et al., 2010). BDNF is thought to 
act at different levels to increase translation activity, by altering the phosphorylation of proteins 
involved in the initiation and elongation steps of protein synthesis. Stimulation of cultured 
cerebrocortical neurons with BDNF was shown to induce the phosphorylation of eIF4E and 
4EBP1, by activating the ERK and PI3-K signaling pathways, respectively (Takei et al., 2004). 
Furthermore, the BDNF-induced 4EBP1 phosphorylation was sensitive to mTOR inhibition with 
rapamycin (Takei et al., 2004). A BDNF-induced increase in the phosphorylation of 4EBP1, 
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p70S6 kinase and its substrate ribosomal S6 protein was also demonstrated in the dendrites of 
cultured cortical neurons and in synaptoneurosomes (subcellular fraction containing the pre- and 
postsynaptic regions) isolated from the brain cortex (Takei et al., 2004). The mTOR-dependent 
phosphorylation of 4EBP1 enhances cap-dependent translation, by inducing eIF4F complex 
formation, whereas the activation of the S6 kinase pathway enhances translation initiation of 5’-
oligopyrimidine tract-containing mRNAs, such as those coding for ribosomal proteins and 
elongation factors (Fumagalli and Thomas, 2000). Therefore, the effects of BDNF on protein 
synthesis in dendrites are likely to be mediated by at least two translation initiation pathways.  
An additional effect of BDNF on translation initiation is mediated by phosphorylation of the 
guanine nucleotide exchange factor eIF2B (Takei et al., 2001). This initiation factor catalyzes the 
exchange of eIF2.GDP to eIF2.GTP, which is required for the assembly of the 
eIF2.GTP.Met.tRNAi complex (Rhoads, 1999) and for priming each 40S ribosomal subunit. 
Studies performed in cultured cortical neurons showed that BDNF increases the phosphorylation 
of glycogen synthase kinase-3β, which is known to regulate the eIF2B activity, and this may 
constitute an additional mechanism to promote translation activity following activation of the TrkB 
receptors by BDNF (Takei et al., 2001).  
Several lines of evidence suggest that the effects of BDNF in synaptic potentiation may be 
mediated, at least in part, by promoting translation initiation. A BDNF-induced increase in the 
phosphorylation of eIF4E, which is correlated with enhanced rates of translation (Gingras et al., 
2004), was also observed in dentate gyrus (DG) following infusion of BDNF to induce LTP 
(BDNF-LTP) and in DG synaptoneurosomes stimulated with BDNF (Kanhema et al., 2006).  
Furthermore, BDNF infusion into the DG of anesthetized animals was found to increase eIF4E 
total protein levels, further suggesting that eIF4E upregulation induces local protein synthesis at 
the synapse, and may contribute to the effects of BDNF in synaptic potentiation. A role for mTOR 
was also shown in the late phase LTP at hippocampal CA1 synapses induced by presynaptic 
tetanic stimulation and in the BDNF-induced synaptic potentiation (Tang et al., 2002). Based on 
studies with conditional expression of a dominant negative form of MEK1 in the postnatal murine 
forebrain it was suggested that the translation efficiency necessary for establishing long-term 
synaptic plasticity may involve the functional interplay between mTOR- and the ERK-dependent 
signaling pathways (Kelleher et al., 2004).  
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BDNF also regulates translation activity by acting at the elongation step. In cultured cortical 
neurons BDNF was shown to increase the phosphorylation (activation) of eukaryotic elongation 
factor 1A (eEF1A), which is known to recruit aminoacyl-transfer RNA (tRNA) to the A-site of 
ribosomes when bound to GTP (Inamura et al., 2005). eEF2, a GTP-binding protein required for 
the second step of elongation (ribosomal translation), is also regulated by BDNF, although 
contrasting results were obtained in different preparations. Local infusion of BDNF was shown to 
induce a rapid and transient increase in eEF2 phosphorylation in the hippocampal dentate gyrus, 
under conditions that induce LTP (BDNF-LTP) (Kanhema et al., 2006). This alteration in eEF2 
phosphorylation at Thr56 is typically associated with a reduction in the interaction of the 
elongation factor with ribosomes, thereby decreasing global protein synthesis (Nairn and Palfrey, 
1987; Ryazanov et al., 1991; Ryazanov et al., 1988), but an increase in the translation of some 
dendritic mRNAs (e.g. αCaMKII and Arc) upon eEF2 phosphorylation has also been reported 
(Belelovsky et al., 2005; Chotiner et al., 2003; Marin et al., 1997; Park et al., 2008; Scheetz et al., 
2000). However, in contrast with the results obtained following injection of BDNF in the dentate 
gyrus, the neurotrophin was without effect on eEF2 phosphorylation in synaptoneurosomes 
isolated from the same region, suggesting that the arresting of elongation may be limited to non-
synaptic sites. At the synapse, BDNF induces the phosphorylation of eIF4E (see above), thereby 
increasing protein synthesis, whereas in non-synaptic regions translation activity may be 5’-cap-
independent and mediated by IRES [internal ribosomal entry site; (Costa-Mattioli et al., 2009)]. 
The regulation of eEF2 in neurons may be more complex and will require further investigation, 
since studies performed in cultured cerebrocortical neurons showed a decrease in the 
phosphorylation of this elongation factor following acute and chronic stimulation with BDNF, which 
favors the interaction with the ribosomes and protein synthesis (Inamura et al., 2005; Nairn and 
Palfrey, 1987; Ryazanov et al., 1988; Takei et al., 2009). Interestingly, neuronal activity in 
hippocampal cultures was also shown to have differential effects on eEF2 phosphorylation in 
dendrites and in the soma (Verpelli et al., 2010). The activity-induced eEF2 phosphorylation in 
dendrites is mediated via activation of metabotropic glutamate receptors and correlates with 
protein synthesis (e.g. dendritic synthesis of BDNF). Furthermore, in this model the activity-
induced synthesis of BDNF increases spine maturation and density (Verpelli et al., 2010), but 
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direct in vivo evidence for local synthesis of BDNF in response to LTP-inducing activity is still not 
available.  
 
1.7.3. BDNF and spine plasticity 
Synaptic stimulation under conditions that induce LTP of excitatory synapses is also 
associated with sustained structural alterations in the postsynaptic region, including an increase in 
the number of dendritic spines and their volume (Kasai et al., 2010). BDNF may contribute to 
some of these alterations since the sustained enlargement of synaptic spines at the hippocampal 
CA3-CA1 synapses in response to LTP-inducing synaptic stimulation was shown to depend on 
endogenous BDNF and required protein synthesis (Tanaka et al., 2008). A role for BDNF in 
structural spine plasticity is further supported by studies with exogenous application of the 
neurotrophin to dissociated cultures of hippocampal neurons and hippocampal slice cultures 
(Alonso et al., 2004; Amaral and Pozzo-Miller, 2007; Ji et al., 2010; Tyler and Pozzo-Miller, 2003; 
Tyler and Pozzo-Miller, 2001). BDNF stimulation increases synaptic spine density by a 
mechanism dependent on the Ras/ERK pathway (Alonso et al., 2004) and the transient receptor-
potential cation channel subfamily C (TRPC) type 3 (Amaral and Pozzo-Miller, 2007). Studies 
performed in hippocampal slices from adult rats showed that BDNF mediates the theta-burst 
stimulation-induced increase in actin polymerization in dendritic spines, through regulation of p21-
activated kinase (PAK) and ADF (actin-depolymerising factor)/cofilin (Rex et al., 2007). An 
increase in actin polymerization in spines may also arise from activation of m-calpain through 
ERK-dependent phosphorylation, as shown in cultured neurons (Zadran et al., 2010). F-actin 
polymerization in spines plays a key role in LTP maintenance in vivo (Fukazawa et al., 2003) and, 
therefore, these alterations may underlie some of the effects of BDNF in long-term synaptic 
potentiation. 
 
1.7.4. BDNF-induced changes in the neuronal proteome  
The analysis of the neuronal proteome in a given brain region or in cell cultures is a useful 
approach to evaluate which are the proteins regulated by certain stimuli, but it does not provide 
information regarding the subcellular localization of the nascent proteins. A gel-based proteome 
profiling of the long-term (12 h) effects of BDNF in cultured hippocampal neurons identified 29 
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proteins that were upregulated and 17 proteins downregulated, for a total of 46 proteins altered by 
BDNF (Manadas et al., 2009). Bioinformatic analysis of the proteins using GOMiner showed an 
upregulation of proteins related to RNA metabolic processes and cellular protein metabolic 
processes, such as proteolysis (related to the ubiquitin-proteasome system) and translation 
(regulators of translation initiation and elongation) (Manadas et al., 2009). These results suggest 
that BDNF regulates the proteome by acting both on de novo protein synthesis and by affecting 
the rate of degradation of proteins targeted by the ubiquitin-proteasome system (Manadas et al., 
2009), but provide no evidence regarding local translation at the synapse. 
The first experimental findings suggesting a role for BDNF in the activation of local translation 
in dendrites of hippocampal were obtained using a reporter in which the coding sequence of GFP 
was flanked by the 5’- and 3’UTR regions from CaMKIIα, providing both dendritic mRNA 
localization and translational regulation (Aakalu et al., 2001). This was later supported by studies 
showing effects of BDNF on the translation machinery in dendrites of cultured cerebrocortical 
neurons (Takei et al., 2004) as well as in synaptoneurosome preparations (Kanhema et al., 2006; 
Takei et al., 2004). The effect of BDNF on the synaptic proteome was analysed in more detail in 
synaptoneurosomes isolated from cultured cortical neurons, using multidimensional protein 
identification technology (MudPIT) and relative quantification by spectra counting. Since 
synaptoneurosomes were isolated 30 min after stimulation of the neurons with BDNF it was 
suggested that the alterations observed were due to local protein synthesis at the synapse. This 
study showed 410 proteins regulated by BDNF in synaptoneurosomes, 214 of which were 
upregulated and 196 were found to be downregulated (Liao et al., 2007).  
In addition to the proteins identified in the proteomics analysis discussed above, target 
oriented studies have shown effects of BDNF in total expression of AMPA and NMDA receptor 
subunits in cultured hippocampal and cortical neurons (Caldeira et al., 2007a; Caldeira et al., 
2007b; Fortin et al., 2012; Guire et al., 2008; Narisawa-Saito et al., 1999; Small et al., 1998). 
Interestingly, stimulation of hippocampal neurons with BDNF also increased the synaptic 
accumulation of GluA1 AMPA receptor subunit, by a mechanism dependent on mTOR and 
Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) (Caldeira et al., 2007a; Fortin et al., 
2012; Guire et al., 2008). BDNF also upregulated GluA1 protein levels in rat forebrain 
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synaptoneurosomes, further indicating that the neurotrophin induces local translation of AMPA 
receptors at the synapse (Schratt et al., 2004).  
The anchoring and stabilization of glutamate receptors at the synapse is controlled by scaffold 
proteins which interact with other postsynaptic density (PSD) components, including signaling 
molecules. BDNF was also shown to upregulate the PSD scaffold protein Homer2 in rat forebrain 
synaptoneurosomes (Schratt et al., 2004), suggesting an effect of the neurotrophin in 
strengthening the postsynaptic machinery involved in the response to glutamate. Furthermore, 
BDNF increased the protein levels of the PSD scaffold proteins SAP97 (Synapse-associated 
protein 97), GRIP1 (glutamate receptor-interacting protein 1) and Pick1 (protein interacting with C 
kinase 1) in cultured cerebrocortical neurons (Jourdi et al., 2003). BDNF also induces the 
translation of signaling proteins, as shown for CaMKIIα (Takei et al., 2004). The Ca2+/calmodulin-
dependent protein kinase II is a major constituent of the PSD and plays a structural role in 
enlarging and strengthening the synapse in the late phases of LTP (Lisman et al., 2012).  
Arc is a postsynaptic protein encoded by a gene belonging to the class of immediate-early 
genes (IEGs), which are rapidly and transiently transcribed in response to synaptic activity (Link 
et al., 1995; Steward et al., 1998), playing an important role in synaptic plasticity in the 
hippocampus [reviewed in (Bramham et al., 2010)]. The dendritic localization and translation of 
the Arc mRNA has been extensively studied (Messaoudi et al., 2007; Rao et al., 2006; Steward et 
al., 1998; Steward and Worley, 2001; Yin et al., 2002; Ying et al., 2002), and BDNF was shown to 
increase dendritic Arc mRNA and protein levels in cultured cortical neurons (Rao et al., 2006). A 
role for Arc in LTP was shown in experiments with intrahippocampal infusion of antisense (AS) 
oligodeoxynucleotides to inhibit Arc protein expression, which impaired the maintenance phase of 
LTP without affecting its induction (Guzowski et al., 2000). Furthermore, a sustained local Arc 
synthesis in dendrites is necessary for the maintenance of LTP (Messaoudi et al., 2007). 
Interestingly, intrahippocampal infusion of BDNF also resulted in the accumulation of Arc 
transcripts in dendrites and triggered long-term potentiation (BDNF-LTP) at medial perforant path-
granule cell synapses in vivo by an Arc-dependent mechanism (Messaoudi et al., 2007; Ying et 
al., 2002). Despite the evidence indicating an effect of BDNF in the Arc translation, Arc mRNA 
was not present in the group of transcripts identified in the polysomal fraction following stimulation 
of cerebrocortical neurons with BDNF (Schratt et al., 2004). This apparent discrepancy may 
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suggest that BDNF is preferentially coupled to the translation of the Arc mRNA at the synapse. In 
agreement with this hypothesis, BDNF was shown to upregulate Arc protein levels in 
synaptoneurosomes in a rapid and relatively selective manner without increasing overall protein 
synthesis (Yin et al., 2002). 
Although it is presently clear that Arc plays a role in LTP induced by HFS and in BDNF-LTP, 
the mechanism(s) involved are not fully elucidated. The upregulation of Arc may act in synaptic 
potentiation by promoting the phosphorylation and consequent inhibition of cofilin, an actin-
binding protein which regulates actin polimerization. Accordingly, the induction of LTP in the 
hippocampal CA1 region (in brain slices) and in the dentate gyrus (in vivo) was shown to promote 
the phosphorylation of cofilin, thereby inhibiting its activity and increasing actin polimerization 
(Chen et al., 2007; Fukazawa et al., 2003). The infusion of Arc AS 2 h post-HFS was shown to 
decrease the amount of phospho-cofilin present in dentate gyrus homogenates, which correlates 
with the loss of nascent F-actin at medial perforant path synapses and blockade of LTP 
consolidation (Messaoudi et al., 2007). The same study showed that jasplakinolide, an F-actin-
stabilizing drug, blocked the Arc AS effect on LTP (Messaoudi et al., 2007), further suggesting 
that Arc couples translation activation to F-actin expansion and LTP stabilization. These findings 
suggest that Arc-induced cytoskeleton remodeling is a key event in the formation of a stable L-
LTP, which is characterized by an expansion of the PSD and enlargement of the dendritic spines 
(Bosch and Hayashi, 2012). In addition to the effects on the cytoskeleton mediated by Arc, BDNF 
may also regulate the actin cytoskeleton through upregulation of RhoA protein levels, as 
described in synaptoneurosomes isolated from the mouse forebrain (Troca-Marin et al., 2010). 
RhoA is a regulator of actin polymerization (Luo, 2000), but it is not known whether the BDNF-
induced upregulation of this member of the Rho GTPase family contributes to the effects of BDNF 
in synaptic plasticity. 
Synaptic vesicle proteins and proteins related to their traffic were also shown to be 
upregulated by BDNF (Melo et al., 2013; Tartaglia et al., 2001; Thakker-Varia et al., 2001) but 
additional studies are required to determine whether some of these alterations are extended to 
the synapse. Taken together, the BDNF-induced changes in the neuronal proteome described 
above suggest several putative mechanisms that may contribute to synaptic potentiation by 
BDNF.  
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Figure 1.7 - BDNF-induced changes in synaptic proteome and cytoskeleton alterations. Activation of 
TrkB receptors with BDNF stimulates the Src-family tyrosine kinase Fyn, which phosphorylates the GluN2B 
subunits of NMDA receptors, thereby increasing their activity and synaptic transmission (1). TrkB receptor 
activation triggers three different signaling pathways with different actions on the postsynaptic site (1). PLCγ 
converts phosphatidylinositol 4,5-bisphosphate into diacylglycerol (DAG) and IP3; the latter activates IP3 
receptors localized in the endoplasmic reticulum (ER), releasing Ca2+ from intracellular stores (2). DAG 
activates the TRPC3 channels which further increase the intracellular calcium concentration (3) leading to 
activation of CaMKK (4). This kinase phosphorylates and activates both Akt and its effector CaMKI (5). Akt is 
also activated by the PI3-K signaling pathway downstream of TrkB receptor stimulation (1). Consequently, 
Akt upregulates mTOR activity (6), and this is followed by activation of the translational machinery (7). BDNF 
was shown to regulate the translation of GluA1 subunits locally and to induce the insertion of GluA1-
containing AMPA receptors in the membrane (8). CaMKI enhances the incorporation of these receptors in 
the postsynaptic membrane (8), which was shown to depend on actin polymerization (9). Arc is an IEG 
rapidly translated in dendrites upon BDNF stimulation (7), being necessary to keep cofilin in the 
phosphorylated state and making possible F-actin elongation (9). 
 
1.7.4.1. miRNAs as mediators of BDNF-induced alteration in the proteome 
miRNAs are non-coding RNAs that, together with RISC, repress the translation of target 
transcripts [for a review see (Chekulaeva and Filipowicz, 2009)]. It is increasingly evident that 
miRNAs post-transcriptionally regulate localized mRNAs (Konecna et al., 2009) and that some of 
the effects of BDNF in the central nervous system are mediated through alteration of their 
expression and/or activity (Table 1.1). The BDNF-induced synthesis of LIM domain kinase-1 
(LIMK1) in dendrites through local relief of the activity of miR-134 in translation repression was 
the first demonstration that the synaptic effects of the neurotrophin could be mediated by 
regulation of miRNAs (Schratt et al., 2006). Interestingly, there is still residual BDNF induction of a 
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reporter mRNA translation when miR-134 cannot bind LIMK1, suggesting the presence of 
additional mechanisms for regulation of BDNF-induced translation of LIMK1 (Schratt et al., 2006).   
BDNF and synaptic activity were shown to increase the transcription of miR-134, which was 
coupled to the down-regulation of Pumilio2 (Pum2) mRNA to promote dendritogenesis in 
hippocampal neurons (Fiore et al., 2009). Accordingly, neurons lacking Pum2 show enhanced 
dendritic arborization (Vessey et al., 2010). Pum2 is an RNA-binding protein present in discrete 
RNA-containing particles, which negatively regulates eIF4E translation (Vessey et al., 2010). 
Interestingly, loss of Pumilio impairs long-term memory in Drosophila (Dubnau et al., 2003). In a 
separated study, miR-134 function was associated with synaptic plasticity and memory formation 
in rodents (Gao et al., 2010). The authors showed a role for SIRT1 in synaptic plasticity via miR-
134-dependent regulation of cAMP-response element-binding protein (CREB) and BDNF 
expression (Gao et al., 2010). Altogether, miR-134 appears to be an important mediator of BDNF 
actions in the nervous system. BDNF-induced upregulation of miR-134 promotes dendritogenesis 
via down-regulation of Pum2 mRNA (Fiore et al., 2009) whereas miR-134 inactivation in dendrites 
upon BDNF stimulation is coupled to LIMK1 translation and spine growth (Schratt et al., 2006). 
Furthermore, miR-134 itself is able to regulate BDNF levels (Gao et al., 2010).  
More recently, an embracing study demonstrated that the dual regulation of miRNAs 
biogenesis by the neurotrophin BDNF plays an important role in BDNF-induced protein synthesis 
(Huang et al., 2012). BDNF treatment induced a downregulation of the Let7-family of miRNAs 
through Lin28, and relieved the repression prompted by these miRNAs (Huang et al., 2012). In 
contrast, a general increase in miRNA biogenesis through Dicer was reported in response to 
BDNF stimulation and this dual regulation of miRNA biogenesis determines and confers 
selectivity to BDNF-mediated protein synthesis (Huang et al., 2012). Although the presented 
mechanism occurs globally in the cell, the regulation of BDNF-induced translation by miRNAs 
most likely affect protein synthesis in different subcellular compartments such as in dendrites.  
Additional studies identified other miRNAs regulated by BDNF. Application of this neurotrophin 
induces miR-125b and ectopic expression of miR-125b promotes neurite outgrowth in a human 
neuroblastoma cell line (Le et al., 2009). In a similar system, BDNF-induced neurite outgrowth 
was inhibited after silencing HuD, a neuronal RNA-binding protein, or overexpressing miR-375 
(Abdelmohsen et al., 2010). In addition, it was recently shown that miR-9 represses MAP1b 
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translation and responds locally to BDNF to promote axon branching (Dajas-Bailador et al., 2012). 
Another miRNA under the regulation of BDNF is miR-132. This miRNA is induced in cultured 
cortical neurons by BDNF through the activation of CREB and enhance dendritic growth by 
inhibiting the translation of a GTPase-activating protein, P250GAP (Kawashima et al., 2010; 
Remenyi et al., 2010; Vo et al., 2005). Similarly, miR-212 was shown to be upregulated in cortical 
neurons upon BDNF stimulation (Remenyi et al., 2010). The effect of BDNF on the upregulation 
of miR-132 and miR-212 was dependent on the activation of ERK pathway and the downstream 
MSK1 (mitogen- and stress-activated kinase 1) (Remenyi et al., 2010). Importantly, blocking the 
endogenous miR-132 results in a decrease of BDNF-dependent upregulation of several synaptic 
proteins such as the glutamate receptor subunits GluN2A, GluN2B and GluA1 (Kawashima et al., 
2010). The direct targets of miR-132 that contribute for BDNF regulation of glutamate receptors 
remain to be identified.  
Together, the available data suggest a critical role for BDNF-regulated miRNAs in the control 
of neuronal development and function. Future research is needed to clarify the mechanisms 
mediating miRNAs synthesis, trafficking and actions in central nervous system. It will be of great 
interest to develop methodologies that allow the simultaneous observation of miRNAs and their 
targets in living systems. Interestingly, it was reported that the entire molecular machinery 
necessary for miRNAs biogenesis is present near synapses (Lugli et al., 2012) supporting the 
idea that miRNA synthesis may occur locally. If so, it would be important to investigate the nature 
of the different pools of miRNAs at the synapse (locally synthesized vs transported) and 
determine which of those, or if both, account for the role of BDNF in synaptic regulation. 
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Table 1.1 – Effects of BDNF on miRNA expression and functional implications 
miRNA Target mRNA BDNF regulation and neuronal function Ref. 
miR-134 LIMK1 • Inactivated in dendrites • Regulates spine growth in hippocampal neurons 1 
miR379-
410 cluster Pum2 (via miR-134) 
• Increased transcription through Mef2 activation 
• Promotes dendritogenesis in cultured hippocampal 
neurons 
2 
miR-132 P250GAP • Highly induced • Promotes neurite outgrowth in cultured cortical neurons 3 
miR-
212/132 
locus - 
• Increased transcription via ERK1/2- and MSK1/2-
dependent and -independent mechanisms 4 
miR-132 - 
• Highly induced 
• Contributes to BDNF-dependent upregulation of glutamate 
receptors subunits GluN2A, GluN2B and GluA1 in cultured 
cortical neurons 
5 
miR-9 MAP1b 
• Short- or long-term stimulation of axons with BDNF 
decreases or increases axonal miR-9 levels, respectively 
• Regulates axon extension and branching in cultured 
cortical neurons 
6 
Let-7a,  
Let-7b, 
 Let- 7f, 
miR-107, 
miR-143 
and others 
not 
described 
- 
• General increase in miRNA biogenesis through activation 
of Dicer 
• Downregulation of Let-7 family members as well as miR-
107 and miR-143 
• Dual regulation of BDNF-induced protein synthesis 
• Regulation of BDNF-dependent dendrite arborization 
7 
miR-375 HuD • Inhibition of BDNF-induced neurite outgrowth in BE(2)-M17 cells 8 
miR-125b 10 putative targets 
identified 
• Upregulated 
• Promotes neurite outgrowth in SH-SY5Y cells 9 
miR-124a - • Upregulated • Promotes neurite outgrowth in SH-SY5Y cells 9 
 
(1) (Schratt et al., 2006); (2) (Fiore et al., 2009); (3) (Vo et al., 2005); (4) (Remenyi et al., 2010); (5) 
(Kawashima et al., 2010); (6) (Dajas-Bailador et al., 2012); (7) (Huang et al., 2012); (8) (Abdelmohsen et al., 
2010); (9) (Le et al., 2009) 
 
1.7.4.2. BDNF-induced changes in the transcription activity and synaptic proteome  
The role of BDNF in the L-LTP, which is dependent on transcription activity, suggests that 
changes in gene expression underlie some of the effects of the neurotrophin. This hypothesis is 
based on studies showing induction of LTP by exogenously applied BDNF at the medial perforant 
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path-granule cell synapses in vivo (Messaoudi et al., 1998), an effect that is blocked by the 
transcription inhibitor actinomycin D (Messaoudi et al., 2002). Furthermore, BDNF induces the 
expression of genes coding for regulators of synaptic activity, such as Arc (Ying et al., 2002; 
Zheng et al., 2009) and several synaptic vesicle proteins, including vesicular glutamate 
transporters (Melo et al., 2013; Tartaglia et al., 2001). In 2006 Wibrand and colleagues identified 
several genes co-upregulated together with Arc during BDNF-induced LTP in the dentate gyrus, 
including genes that code proteins with functions in excitatory synaptogenesis, axon guidance 
and glutamate receptor clustering (Wibrand et al., 2006). 
A recent study using a microfluidic device that allows the isolation of the dendritic compartment 
showed that BDNF acts on dendrites of cultured cortical neurons to induce a dendrite-to-nucleus 
signal that upregulates the expression of the IEGs Arc and c-Fos (Cohen et al., 2011). The effect 
of BDNF in the signaling from dendrites to the nucleus depends on MEK1/2 (MAPK and ERK 
kinase, type 1/2) and did not require glutamate signaling. Intriguingly, the effects of dendritic 
BDNF on gene expression require TrkB activity mainly on the soma compartment suggesting the 
existence of an endosome-like signaling pathway (Cohen et al., 2011). Furthermore, BDNF 
induces c-Fos and Arc by different mechanisms since the Ca2+ concentration in the soma and in 
the dendritic compartments influenced the expression of Arc but not c-Fos (Cohen et al., 2011). 
Additional studies are required to identify other genes that are specifically regulated following 
activation of dendritic receptors for BDNF.  
To contribute to the long-term potentiation of the synapse that was initially stimulated, the 
newly synthesized mRNAs or the translated proteins should be targeted to a specific synapse. 
The proteins locally translated at the synapse in response to BDNF stimulation could function in 
the capture of the neurotrophin-induced RNA granules or proteins traveling along dendrites, as 
predicted by the synaptic tagging and capture hypothesis (Redondo and Morris, 2011), but this 
remains to be investigated. 
Long-term treatment of hippocampal slice cultures with BDNF was shown to upregulate 
synaptophysin, synaptobrevin and synaptotagmin protein levels (Tartaglia et al., 2001). However, 
it remains to be determined whether activation of presynaptic TrkB receptors by BDNF, which is 
followed by the transport of TrkB-BDNF complexes as part of signaling endosomes (Ha et al., 
2008; Watson et al., 2001; Xie et al., 2012; Ye et al., 2003), upregulates the expression of genes 
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coding for presynaptic proteins. If this is the case, the newly synthesized proteins could be then 
delivered to the synapse, thereby contributing to an upregulating of glutamate release. The 
anterograde axonal transport of the proteins may be further enhanced by upregulating KIF1A 
(Kondo et al., 2012), a motor protein involved in the transport of synaptic vesicle precursors, 
including synaptophysin, synaptotagmin and Rab3A (Okada et al., 1995; Yonekawa et al., 1998). 
Future studies are required to fully understand the role of this pathway in the L-LTP and the 
mechanisms involved. 
 
 
Figure 1.8 - BDNF-induced local translation at the synapse and upregulation of gene expression. 
TrkB receptor activation upon BDNF binding increases the accumulation of synaptic vesicles at the active 
zone in the presynaptic region, thereby potentiating synaptic transmission (1). BDNF-TrkB complex can be 
internalized and retrogradely transported towards the cell body (2). Once in the soma the active receptors 
may change gene expression and mRNA translation, and newly synthesized proteins may be then 
transported along the axon together with preexisting proteins (3). The BDNF-TrkB complex may also induce 
postsynaptic responses (4), including the disassembly of the RNA granules (5), through activation of different 
signaling pathways. RBPs-associated mRNAs become therefore available for translation, either at free 
polysomes or at the ER-associated ribosomes (6). BDNF-TrkB “signaling endosomes” are also transported 
from the dendritic spine to the cell body (7), where it leads to the transcription of IEGs in a MEK1/2 and 
ERK1/2 dependent manner (8). In dendrites, RNA granules containing mRNAs are transported along 
microtubules and can be “recruited” by an active dendritic spine or they may continue the movement towards 
more distal sites (9). 
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1.8. hnRNP family of proteins 
Heterogeneous nuclear ribonucleoproteins (hnRNPs) constitute a large family of proteins that 
bind nascent transcripts and package them into hnRNP particles (Dreyfuss et al., 1993; Pinol-
Roma et al., 1988; Pullman and Martin, 1983). This family includes 20 proteins with sizes ranging 
from 34 to 120 kDa that were named hnRNP A1 to hnRNP U (Pinol-Roma et al., 1988). Each 
protein contains at least one RNA-binding motif such as the RNA recognition motif (RRM), hnRNP 
K homology domain (KH) or the arginine/glycine rich domain (Han et al., 2010; Krecic and 
Swanson, 1999) (Fig. 1.9). Several hnRNPs possess other non-standard RRM referred as 
atypical RRMs (aRRMs) (Han et al., 2010). 
 
   
 
 
 
 
 
 
 
 
Figure 1.9 - Structural domains of the hnRNP proteins. RRM, RNA recognition motif; aRRM, atypical 
RNA recognition motif; KH, K homology domain; Gly-Rich, Glycine-Rich domain. ‘A’ represents hnRNP A0, 
A1, A2/B1 and A3 that are structurally similar. From (Han et al., 2010). 
 
Another key characteristic of hnRNPs is the fact that they undergo nucleocytoplasmic shuttling 
(Pinol-Roma and Dreyfuss, 1992). Although hnRNPs are mainly expressed in the nucleus there 
are few exceptions. For example, an isoform of hnRNP M is a membrane-bound receptor 
(Bajenova et al., 2003). Also, hnRNP Q is mainly found in the cytoplasm (Mizutani et al., 2000) 
and is known to be involved in the transport of mRNA in neuronal dendrites (Bannai et al., 2004). 
Furthermore, hnRNP A2/B1 is one of the best described trans-acting factors that regulates mRNA 
localization in oligodendrocytes (Ainger et al., 1997; Munro et al., 1999) and neurons (Gao et al., 
2008; Muslimov et al., 2006; Muslimov et al., 2011; Shan et al., 2003). The members of the 
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hnRNP family of proteins regulate several aspects of nucleic acid metabolism, including 
packaging of nascent transcripts, splicing, mRNA transport, stability and translation (Han et al., 
2010). 
 
1.8.1. The trans-acting factor hnRNP A2/B1 and mRNA transport 
hnRNP A2/B1 is perhaps the best described trans-acting protein involved in the mRNA 
trafficking in oligodendrocytes and neurons. This member of the hnRNP family was originally 
described as the trans-acting factor that recognizes a cis-acting element present in the myelin 
basic protein (MBP) (Ainger et al., 1997). Because it is recognized by hnRNP A2/B1, the 21-
nucleotide cis-acting element is called A2 response element (A2RE). Further studies 
demonstrated that the MBP mRNA is recruited and transported in RNA granules through 
association with hnRNP A2/B1 (Ainger et al., 1997; Carson et al., 1998; Hoek et al., 1998; Munro 
et al., 1999). The first evidence supporting a role for hnRNP A2/B1 in the trafficking of mRNAs in 
neuronal dendrites was provided by studies where A2RE-carrying mRNAs were injected in 
hippocampal neurons (Shan et al., 2003). In this study, mutations that abrogate the binding of 
injected mRNAs to hnRNP A2/B1 were found to compromise their dendritic localization (Shan et 
al., 2003). It was further demonstrated that hnRNP A2/B1 is required for the dendritic localization 
of Arc, CaMKIIα and Neurogranin mRNAs, which appear to cluster in the same hnRNP A2/B1-
containing granules (Gao et al., 2008). Moreover, hnRNP A2/B1 is necessary for the delivery of 
the noncoding BC1 RNA and PKMζ mRNA to distal dendritic domains (Muslimov et al., 2006; 
Muslimov et al., 2011). Interestingly, it was shown that hnRNP A2/B1 directly binds and recruits 
hnRNP E1 to RNA transport granules, inhibiting the translation of A2RE-containing mRNAs in 
oligodendrocytes (Kosturko et al., 2006). On the other hand, activation of Fyn kinase results in the 
phosphorylation of hnRNP A2/B1 and stimulates the translation of a MBP A2RE-containing 
reporter (White et al., 2008). 
 
1.8.2. hnRNP K structure and function 
hnRNP K has a wide variety of nuclear and cytoplasmic functions, including mRNA 
transcription (Lynch et al., 2005; Ostrowski et al., 2003; Stains et al., 2005), splicing (Cao et al., 
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2012; Expert-Bezancon et al., 2002), and regulation of mRNA stability (Fukuda et al., 2009; 
Skalweit et al., 2003) and translation (Feliers et al., 2007; Habelhah et al., 2001; Ostareck-
Lederer et al., 2002; Ostareck et al., 1997; Yano et al., 2005; Yoon et al., 2013). hnRNP K binds 
single or double stranded nucleic acids, especially in CU/CT rich regions via its three K homology 
(KH) domains (Bomsztyk et al., 2004; Fenn et al., 2007; Grishin, 2001). Furthermore, it contains a 
nuclear localization signal (NLS) and a nuclear shuttling domain (KNS) (Michael et al., 1997) (Fig. 
1.10). The functional versatility of hnRNP K arises from its modular structure with the three KH 
domains that can interact with RNA and ssDNA, and its K interactive (KI) region that can recruit a 
wide variety of factors, including kinases and factors that regulate splicing, mRNA stability and 
translation [for a review see (Bomsztyk et al., 2004)]. In fact, hnRNP K seems to be a centre for a 
vast network of interactions, with 114 binding partners identified until now (Mikula et al., 2006). 
The protein is thought to act as a “docking plattform” to integrate signaling cascades by promoting 
the cross-talk between kinases and factors involved in nucleic acid metabolism (Bomsztyk et al., 
2004). 
 
Figure 1.10 - Structure of hnRNP K. The three K homogy domains (KH), the localization signal (NLS), the 
nuclear shuttling domain (KNS) and the K interactive region (KI) are represented. Adapted from (Mikula and 
Ostrowski, 2010). 
 
hnRNP K function may also be modulated by phosphorylation. In particular, two studies 
demonstrated how the hnRNP K-mediated translational control may be regulated by 
phosphorylation. First, the binding of hnRNP K to c-Src activates this enzyme and leads to the 
phosphorylation of hnRNP K. The c-Src-mediated phosphorylation of hnRNP K results in the 
translational activation of silenced mRNAs (Ostareck-Lederer et al., 2002). Second, the activation 
of ERK1/2 resulted in the phosphorylation and cytoplasmic accumulation of hnRNP K. The 
cytoplasmic increase of hnRNP K protein represses differentiation control element (DICE)-
mediated translation (Habelhah et al., 2001). Another study showed that tyrosine phosphorylation 
of the hnRNP K protein regulates hnRNP K protein-protein and protein-RNA interactions 
(Ostrowski et al., 2000). Accordingly, the hnRNP K-mRNA complexes were disrupted by tyrosine 
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phosphorylation of hnRNP K, suggesting that the binding of hnRNP K to RNA may be responsive 
to the extracellular stimulus that activate tyrosine kinases (Ostrowski et al., 2000).  
Several findings also suggest hnRNP K as a key player in the regulation of p53, cell cycle 
arrest, and in the response to DNA damage (Huarte et al., 2010; Lee et al., 2012; Moumen et al., 
2005; Pelisch et al., 2012). Accordingly, a recent study demonstrate that phosphorylation of 
hnRNP K is likely to have a major role in integrating DNA damage signals to fine-tune p53-
dependent transcriptional responses (Moumen et al., 2013).  
hnRNP K was also shown to play a role in the regulation of actin dynamics. The protein 
interacts directly with the regulator of actin dynamics N-WASP via its KI domain (Yoo et al., 2006), 
regulating N-WASP-induced cell spreading and filopodia formation in mouse fibroblasts (Yoo et 
al., 2006).  
 
1.8.2.1. Roles of hnRNP K in neuronal physiology 
The function of hnRNP K in neurons is now starting to be unravelled. A recent study 
demonstrated that hnRNP K interacts with the Abelson-interacting protein 1 (Abi1) at postsynaptic 
sites in hippocampal neurons (Proepper et al., 2011). Abi1 belongs to a multiprotein complex that 
activates the WAVE protein family (Le Clainche and Carlier, 2008) and is localized in dendritic 
spines and postsynaptic densities (PSDs) where it plays an important role in regulating 
cytoskeleton reorganization and synaptic maturation (Courtney et al., 2000). Accordingly, hnRNP 
K knockdown results in a significant increase in filopodia formation and decreases the number of 
mature synapses, an effect that mimics the neuronal morphology in the absence of Abi1 
(Proepper et al., 2011). In a separated study, hnRNP K knockdown was shown to disrupt 
forskolin-induced neurite outgrowth in PC12 cells (Cao et al., 2012). However, in this case the 
effect was attributed to the role of hnRNP K in the control of alternative splicing induced by 
forskolin. In addition, hnRNP K interacts with the RNA-binding protein Hu and represses the 
translation of p21 mRNA, antagonizing Hu function and promoting neurite outgrowth in 
neuroblastoma cells (Yano et al., 2005). Another study showed the association of endogenous 
neurofilament mRNAs with hnRNP K in developing cortex (Thyagarajan and Szaro, 2008), 
suggesting that hnRNP K and neurofilament mRNAs may constitute a post-transcriptional module 
that regulates the cytoskeleton compositions in neurons. 
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 Recently, hnRNP K was shown to bind the serotonin transporter (SERT) mRNA in 
immortalized serotoninergic rat embryonic mid-brain cells (RN46A) and in mouse brain tissue, 
and evidence was provided for the translational control conferred by this ribonucleoprotein (Yoon 
et al., 2013). In Xenopus laevis, hnRNP K is also required for the efficient nuclear export and 
translation of multiple cytoskeletal-related mRNAs that are essential for axonal-development (Liu 
et al., 2008; Liu and Szaro, 2011) and optic axon regeneration (Liu et al., 2012). Furthermore, 
hnRNP K (among other hnRNPs) was identified as a component of transport RNA granules in 
neurons (Elvira et al., 2006), detected in synaptoneurosomal fractions (Liao et al., 2007) and at 
the postsynaptic densities in hippocampal neurons (Proepper et al., 2011). Given the nucleo-
shuttling nature of hnRNP K and its ability to act as a scaffold protein integrating mRNA and 
proteins in the same ribonucleoprotein complex, it is tempting to speculate a major role for hnRNP 
K in mRNA transport to distal domains in neurons. However, despite the evidence here 
presented, the precise function of hnRNP K in neurons is still poorly understood. 
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Objectives of the present work 
The main goal of this work is to investigate the regulation of the transport of hnRNP A2/B1 and 
hnRNP K in hippocampal neurons, and the interaction of the latter protein with selected 
transcripts, which is likely to play a role in synaptic plasticity in the hippocampus.  
 
As previously mentioned, hnRNP A2/B1 plays a major role in the trafficking of mRNAs along 
dendrites but whether and how this process is regulated remains to be determined. Since several 
forms of synaptic plasticity require dendritic protein synthesis, including BDNF-mediated long-
term potentiation, in the work described in chapter 3 we investigated how synaptic activity and 
BDNF regulate the distribution of hnRNP A2/B1 in cultured hippocampal neurons. Given its 
function in the control of mRNA localization in the dendritic compartment, and the role of local 
translation at the synapse in plasticity events, we focused our attention in the study of the 
dendritic- and synaptic-localized hnRNP A2/B1. Furthermore, the use of polysomal fractions 
obtained from synaptoneurosomes isolated from adult rat hippocampus allowed us to investigate 
whether hnRNP A2/B1 plays a role in translational control of synaptic-localized mRNAs.  
 
Recent evidence led us to hypothesize that hnRNP K may also be a component of 
ribonucleoprotein complexes involved in the dendritic transport of mRNAs. In the work reported in 
chapter 4 we investigated the cytoplasmic distribution of the protein in hippocampal neurons 
under resting conditions and upon neuronal activation or in response to BDNF. We have 
previously shown that hnRNP K associates with several transcripts that encode proteins with 
roles in synaptic plasticity. Furthermore, previous results from our laboratory showed that BDNF 
stimulation induces the dissociation of hnRNP K-bound transcripts from the ribonucleoprotein 
complexes in cultured hippocampal neurons. Thus, here we studied the role of BDNF in the 
regulation of hnRNP K-bound mRNAs in synaptic preparations obtained from adult rat 
hippocampus. In addition, using a model of LTP induced in the perforant path-dentate gyrus 
synapse in live anesthetized rats, we determined whether hnRNP K and hnRNP K-associated 
mRNAs are regulated in vivo. Importantly, we show that this form of synaptic potentiation requires 
TrkB activation, presumably by BDNF. Furthermore, we also used a proteomic approach to 
identify hnRNP K-interacting proteins in the rat hippocampus. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Experimental Procedures 
 
 
 

 73 
 
Experimental Procedures 
2.1. Hippocampal Cultures  
High-density hippocampal cultures were prepared from the hippocampi of E18-E19 Wistar rat 
embryos, after treatment with trypsin (0.06%; 15 min incubation at 37°C; GIBCO - Life 
Technologies) and deoxyribonuclease I (5.36 mg/ml) in Ca2+- and Mg2+-free Hanks’ balanced salt 
solution (5.36 mМ KCl, 0.44 mM KH2PO4, 137 mM NaCl, 4.16 mM NaHCO3, 0.34 mM 
Na2HPO4·2H2O, 5 mM glucose, 1 mM sodium pyruvate, 10 mM HEPES, and 0.001% phenol red). 
The hippocampi were then washed with Hanks’ balanced salt solution containing 10% fetal bovine 
serum (GIBCO - Life Technologies), to stop trypsin activity, and transferred to Neurobasal 
medium (GIBCO - Life Technologies) supplemented with SM1 supplement (1:50 dilution, 
STEMCELL Technologies), 25 µM glutamate, 0.5 mM glutamine, and 0.12 mg/ml gentamycin 
(GIBCO - Life Technologies). The cells were dissociated in this solution and then plated in 6-well 
plates (85.5 x 103 cells/cm2) coated with poly-D-lysine (0.1 mg/ml). The cultures were maintained 
in a humidified incubator of 5% CO2/95% air at 37°C for 14-15 days, and then stimulated with 100 
ng/ml BDNF (Peprotech) for the indicated periods of time. Where indicated, neurons were 
stimulated with 50 µM bicuculline (Tocris), 2.5 mM 4-AP (Tocris) and 10 µM glycine (Sigma-
Aldrich) to increase synaptic activity, or depolarized with KCl (30 mM). The experiments were 
performed in a basal saline solution (132 mM NaCl, 4 mM KCl, 1.4 mM MgCl2, 2.5 mM CaCl2 , 6 
mM glucose, and 10 mM HEPES at final pH of 7.4). For KCl depolarization experiments, neurons 
were treated with a saline solution containing 102 mM NaCl, 34 mM KCl, 1.4 mM MgCl2, 1 mM 
CaCl2 , 6 mM glucose, and 10 mM HEPES at final pH of 7.4. 
Low-density hippocampal cultures were prepared as previously described (Kaech and Banker, 
2006). Briefly, hippocampi were dissected from E18 rat embryos and the cells were dissociated 
using trypsin (0.25%). Neurons were plated at a final density of 1-5 x 104 cells/dish on poly-D-
lysine-coated glass coverslips in neuronal plating medium (MEM supplemented with 10% horse 
serum, 0.6% glucose and 1 mM pyruvic acid). After 2-4 h the coverslips were flipped over an 
astroglial feeder layer in Neurobasal medium (GIBCO - Life Technologies) supplemented with 
SM1 supplement (1:50 dilution, STEMCELL Technologies), 25 µM glutamate, 0.5 mM glutamine 
and 0.12 mg/ml gentamycin (GIBCO - Life Technologies). The neurons grew face down over the 
feeder layer but were kept separate from the glia by wax dots on the neuronal side of the 
coverslips. To prevent overgrowth of glial cells, neuron cultures were treated with 5 µM cytosine 
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arabinoside (Sigma-Aldrich) after 3 DIV. Cultures were maintained in a humidified incubator with 
5% CO2/95% air at 37C for up to 2 weeks, feeding the cells once per week. At DIV 14-15 the 
neurons were stimulated for 30 min with 100 ng/ml BDNF (Peprotech) or with 50 µM bicuculline 
(Tocris), 2.5 mM 4-AP (Tocris) and 10 µM glycine (Sigma-Aldrich), to increase synaptic activity. 
Where indicated, cells were pre-treated for 30 min with the Trk receptor inhibitor SHN722 (1 µM) 
(Gomes et al., 2012; Martin et al., 2011) or with the scavenger of extracellular ligands of TrkB 
receptors TrkB-Fc (1 µg/ml) (R&D Systems) before stimulation with 100 ng/ml BDNF (Peprotech) 
or with the cocktail solution containing bicuculline (50 µM bicuculline, 2.5 mM 4-AP and 10 µM 
glycine), respectively. Alternatively, the cells were incubated with 100 ng/ml BDNF (Peprotech) for 
3 h. The experiments were performed in a basal saline solution (132 mM NaCl, 4 mM KCl, 1.4 
mM MgCl2 , 2.5 mM CaCl2 , 6 mM glucose, and 10 mM HEPES at a final pH 7.4). 
 
2.2. Compartmentalized system to culture neurons  
High-density hippocampal cultures were prepared from the hippocampi of E18-E19 Wistar rat 
embryos, as described above. The cells were plated at a density of 80 000 cells/cm2 in 3 µm pore 
75 mm polyethylene terephthalate (PET) membrane filter inserts (Corning) coated with poly-D-
lysine (0.1 mg/ml) as previously described (Manadas et al., 2009; Poon et al., 2006). The cultures 
were maintained in a humidified incubator of 5% CO2/95% air at 37°C for 14-15 days and then 
stimulated with 100 ng/ml BDNF (Peprotech) for the indicated periods of time. 
 
2.3. Preparation of hippocampal culture extracts 
Hippocampal cultures were washed twice with ice-cold PBS, and once more with PBS buffer 
supplemented with 1 mM dithiothreitol (DTT) and a cocktail of protease inhibitors (0.1 mM 
phenylmethylsulfonyl fluoride (PMSF) and CLAP [1 µg/ml chymostatin, 1 µg/ml leupeptin, 1 µg/ml 
antipain, 1 µg/ml pepstatin; Sigma]). The cells were then lysed with RIPA buffer (150 mM NaCl, 
50 mM Tris-HCl, pH 7.4, 5 mM EGTA, 1% Triton, 0.5% DOC and 0.1% SDS at a final pH 7.5) 
supplemented with 50 mM sodium fluoride (NaF), 1.5 mM sodium ortovanadate (Na3VO4) and the 
cocktail of protease inhibitors. After sonication and centrifugation at 16,100 x g for 10 min at 4°C, 
protein in the supernatants was quantified using the Bicinchoninic acid (BCA) assay kit (Pierce), 
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and the samples were denaturated with 2x concentrated denaturating buffer (125 mM Tris, pH 
6.8, 100 mM glycine, 4% SDS, 200 mM DTT, 40% glycerol, 3 mM Na3VO4, and 0.01% 
bromophenol blue) for 5 min at 95°C. The proteins of interest were then analysed by Western 
blot. 
 
2.4. Adult rat total hippocampal extracts 
Hippocampi were dissected from adult Wistar rats and the tissue was minced with scissors 
and homogenized with a glass homogenizer in 10 volumes of ice-cold supplemented RIPA buffer 
as indicated for the preparation of extracts from hippocampal cultures. The homogenate was 
sonicated and centrifuged at 16,100 x g for 10 min at 4°C, and the protein in the supernatants 
was quantified using the Bicinchoninic acid (BCA) assay kit (Pierce). The samples were aliquoted 
at -20°C until further use. 
 
2.5. Synaptoneurosome preparation 
Synaptoneurosomes were prepared as previously described with slight modifications (Yin et 
al., 2002). Briefly, 6-8 hippocampi were dissected from adult Wistar rats and the tissue was 
minced with scissors and homogenized with a glass homogenizer in a buffer containing 0.32 M 
sucrose, 10 mM HEPES-Tris pH 7.4 and 0.1 mM EGTA. After centrifugation for 3 min at 1,000 x 
g, the supernatant was collected and passed initially through nylon membranes (150 and 50 µm, 
VWR) and finally through an 8 µm pore size filter (Millipore, MA). The flow-through was 
centrifuged for 15 min at 10,000 x g, and the pellet was resuspended in incubation buffer (in mM: 
8 KCl, 3 CaCl2, 5 Na2HPO4, 2 MgCl2, 33 Tris, 72 NaCl, 100 sucrose). All the procedure was done 
at 4°C. Synaptoneurosomes were incubated or not with 50 ng/ml BDNF (Peprotech) for 10 min at 
30°C and were then centrifuged at maximum speed, in a Minispin microcentrifuge for 30 s. The 
pellet was resuspended in RIPA buffer supplemented as indicated for the extract preparation, 
followed by sonication and protein quantification using the BCA method. The samples were 
processed for RNA co-immunoprecipitation assays. For the analysis of polysomal profiles, 
synaptoneurosomes were prepared from adult rats (12-13 weeks) as described previously (Troca-
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Marin et al., 2010), with minor alterations. The hippocampi of 6 adult rats were used in each 
preparation, and the final washing steps were performed by centrifugation at 33,000 x g. 
 
2.6. Gel electrophoresis and Western blot 
Proteins were resolved by SDS-PAGE in 10% polyacrylamide gels. For Western blot analysis, 
proteins were transferred onto a PVDF membrane (Millipore) by electroblotting (40V, overnight at 
4ºC). The membranes were blocked for 1 h with skin milk and 0.1% Tween 20 in TBS [(20 mM 
Tris, 137 mM NaCl, pH 7.6 (TBS-T)], and probed with the primary antibody overnight at 4ºC. 
Following several washes with TBS-T, the membranes were incubated with an alkaline 
phosphatase-conjugated IgG secondary antibody (anti-mouse or anti-rabbit, depending on the 
primary antibody host-species) for 1 h at room temperature. The membranes were then washed 
again and immunostaining was visualized by the enhanced chemifluorescence method (ECF) on 
a Storm 860 Gel and Blot Imaging System (GE Healthcare, Carnaxide, Portugal). For the analysis 
of total extracts from dentate gyrus homogenates, horseradish peroxidase (HRP)-conjugated 
secondary antibodies were used and immunostaining was developed using chemiluminescence 
reagents (ECL, Amersham Biosciences). In this case the blots were scanned using Gel DOC EQ 
(Bio-Rad). Antibodies for Western blot were as follows: anti-hnRNP A2/B1 (sc-53531, 1:1000; 
Santa Cruz Biotechnology), anti-hnRNP K (sc-28380, 1:1000; Santa Cruz Biotechnology), anti-
Staufen1 (AB5781, 1:1000; Millipore), anti-eEF2 (ab40812, 1:12.500; Abcam), anti-rpS6 (2217, 
1:1000; Cell Signaling Technology), anti-RBMX (sc-48796, 1:1000; Santa Cruz Biotechnology). 
When indicated, anti-ẞ-tubulin (T7816, 1:30.000; Sigma-Aldrich), anti-ẞ-actin (A5441, 1:5000, 
Sigma-Aldrich) and anti-GAPDH (sc32233, 1:5000; Santa Cruz Biotechnology) antibodies were 
used as loading control. 
 
2.7. Polysome preparation 
Synaptoneurosomes prepared from adult rats (12-13 weeks) were lysed in 800 µl of lysis 
buffer [15 mM Tris-HCl, pH 8, 5 mM MgCl2, 0.3 M NaCl, 0.5 mM DTT, 0.1 mg/ml Cycloheximide 
and 1% Triton X-100] supplemented with a cocktail of protease inhibitors (0.1 mM PMSF; CLAP: 
1 µg/ml chymostatin, 1 µg/ml leupeptin, 1 µg/ml antipain, 1 µg/ml pepstatin; Sigma-Aldrich) and 
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50U/ml of RNase inhibitor (SUPERaseIn™, Ambion Applied Biosystems). Membranous structures 
were removed by spinning at 12,000 x g for 10 min. The resulting supernatant was loaded on a 
10-50% linear sucrose gradient [prepared in 20 mM Tris-HCl, pH 8, 140 mM KCl, 5 mM MgCl2, 0.5 
mM DTT, 0.1 mg/ml Cycloheximide and 5U/ml of RNase inhibitor (SUPERaseIn™, Ambion 
Applied Biosystems)] and spun at 35,000 rpm for 180 min (4°C) using a SW41 rotor (Beckman 
Coulter). Each gradient was separated into 10 fractions, with approximately 1.2 ml each. Equal 
volumes (30 µl) of the first nine fractions isolated from the 10-50% linear sucrose gradient were 
denatured and protein samples were separated by SDS-PAGE, transferred to PVDF membranes 
(Millipore, Madrid, Spain) and immunoblotted. 
 
2.8. Immunoprecipitation assays 
Antibody-immobilized beads were prepared by incubating 6 µg of hnRNP K or Mouse IgG 
antibodies with 100 µl of Protein G PLUS-Agarose beads (Santa Cruz Biotechnology), overnight 
at 4ºC in NT2 2x buffer containing 100 mM Tris-HCl, 300 mM NaCl, 2 mM MgCl2, 0.1% IGEPAL, 
pH 7.4, and supplemented with 1 mM dithiothreitol (DTT) and a cocktail of protease inhibitors (0.1 
mM phenylmethylsulfonyl fluoride (PMSF), CLAP [1 µg/ml chymostatin, 1 µg/ml leupeptin, 1 µg/ml 
antipain, 1 µg/ml pepstatin; Sigma]). The immobilized antibodies were incubated with 1 mg of 
protein for 1 h at 4ºC, and the beads were washed twice (2 min centrifugations, 2,000 x g) with 
NT2 1x buffer (at 4ºC) and once with NT2 1x buffer supplemented with 1M Urea. After an 
additional wash using the NT2 1x buffer, the supernatant was discarded and the final pellet, 
containing the immunoprecipitated hnRNP bound to the antibody-immobilized beads, was 
resolved by SDS-PAGE followed by in-gel protein detection using the Silver or colloidal 
Coomassie staining methods. Where indicated, precipitates were subjected to Western blot 
analysis. For RNA co-immuprecipitations, the NT2 buffer was supplemented with 50U/ml of 
RNase inhibitor (SUPERaseIn™, Ambion Applied Biosystems) and the TRIzol Reagent 
(Invitrogen) was immediately added to the pellet. The RNA was extracted according to 
manufacturer’s instructions. For the RNA co-immunoprecipitations performed using total extracts 
from dentate gyrus homogenates, the same procedure was performed with minor changes: 50 µl 
of Protein G Sepharose 4 Fast Flow (Ge Healthcare) beads and 500 µg of protein were used for 
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the immunoprecipitations and the NT2 buffer was supplemented with cOmplete, Mini EDTA-free 
protease inhibitors cocktail (Roche) and 40U/ml RiboLockRNase inhibitor (Thermo Fischer). 
 
2.9. Silver staining for in-gel protein detection 
Silver staining was performed as previously described (O'Connell and Stults, 1997). Briefly, 
the proteins in the gel were fixed for 30 min using a fixative solution containing 25% methanol and 
25% acetic acid. The gel was washed in 50% ethanol and 30% ethanol and then sensitized with 
sodium thiosulfate (0.2 g/l) for only 1 min to avoid peptide recovery from the gel. After washing 
twice with water, the gel was stained with silver nitrate (2 g/l) for 20 min and developed in a 
solution containing 37% formaldehyde (0.7 ml/l), 30 g/l sodium carbonate and 10 mg/l sodium 
thiosulfate until bands become visible (about 20 min). After stopping the staining with a solution 
containing Tris (50 g/l) and 2.5% acetic acid, the gel was stored in water at 4°C. 
 
2.10. Colloidal Coomassie staining 
Colloidal Comassie staining was performed as previously described (Candiano et al., 2004), 
with minor modifications. Gels were allowed to stain overnight in a solution containing 10% 
ammonium sulfate, 10% phosphoric acid, 20% methanol and 0.2% Coomassie Brilliant Blue G-
250 dye (20279, Pierce). Once the desired staining was obtained, the gels were washed with 
water and the lanes were immediately cut with a scalpel. The resulting gel fragments were 
transferred to a 1.5 ml tube containing water and stored until further use. 
 
2.11. Protein identification by liquid chromatography coupled to mass 
spectrometry analysis (LC-MS/MS) 
 
Protein identification was performed as previously described (Chen et al., 2011). Briefly, 
immunoprecipitates were separated through SDS-PAGE and the gel was stained with colloidal 
Coomassie blue. The stained gel was cut into five slices for each gel lane and the bands were 
excised and subjected to tryptic-digestion. The resulting peptides were separated through 
capillary HPLC using a capillary reverse phase C18 column. The capillary HPLC system with 
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auto-sampler/auto-injector (Eksigent nano LC-ultra 1D) was equipped with a 5 mm Pepmap 100 
C18 (Dionex) trapping column (300 µm ID, 5 µm particle size), a capillary C18 column and a 200 
mm home-made Alltima C18 analytical column (100 m ID, 3 µm particle size). Protein 
identification was carried out on the Electrospray LTQ-Orbitrap (Thermo Fisher Scientific) with a 
Stainless Steel Nano-bore emitter (Proxeon, 30 µm ID). 
 
2.12. RNA isolation and RNA quantification 
After immunoprecipitation of hnRNP K with a specific antibody, the co-immunoprecipitating 
RNAs were immediately isolated using TRizol reagent (Invitrogen) following the manufacturer’s 
specifications. After the addition of chloroform and phase separation, the RNA was precipitated by 
the addition of isopropanol. The precipitated RNA was washed once with 75% etanol, centrifuged, 
air-dried and resuspended in 10 µl of RNase-free water (GIBCO - Invitrogen). In parallel 
experiments the non-specific binding of RNAs to Protein G PLUS-Agarose beads (or Protein G 
Sepharose 4 Fast Flow beads) was determined and the RNAs were resuspended in the same 
volume of RNase-free water. The RNA concentration was determined using NanoDrop (Thermo 
Scientific) and samples were stored at -80°C until further use. 
 
2.13. Cell body and neurite total RNA 
Total RNA was extracted from 14-15 DIV hippocampal neurons cultured in 3 µm pore 75 mm 
PET membrane filter inserts. To avoid contamination between the two cellular compartments, the 
neurites grown on the bottom of the filter were carefully scraped and immediately added to TRIzol 
Reagent (Invitrogen). The cell bodies and neuronal processes present in the inner compartment 
of the insert were directly lysed in TRIzol Reagent. The remaining steps were performed 
according to manufacturer’s instructions and as described above. RNA quality and integrity was 
assessed using the Experion automated gel-electrophoresis system (Bio-Rad) and the RNA 
concentration was determined using NanoDrop (Thermo Scientific). 
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2.14. Reverse transcription 
For first strand cDNA synthesis 500-1000 ng of isolated RNA was mixed with 4 µl of 5x iScript 
Reaction Mix, 1 µl of Reverse Transcriptase and Nuclease-free water, up to a total volume of 20 
µl per experimental condition (iScript™cDNA Synthesis Kit, Bio-Rad). This kit utilizes a blend of 
oligo (dT) and random hexamer primers in the reaction mix. The reaction was performed at 25ºC 
for 5 min, followed by 30 min at 42ºC, for primer annealing to the template and cDNA synthesis, 
respectively. The reverse transcriptase was then denatured for 5 min at 85ºC, and the sample 
cooled to 4ºC, before storage at -20ºC until further use. 
 
2.15. Primer design 
Primers for qRT-PCR were designed by Beacon Designer 7 software (Premier Biosoft 
International, Palo Alto, CA). The following considerations were taken: 1) GC content about 50%; 
2) annealing temperature (Ta) between 55 ± 5°C; 3) secondary structures and primer dimers were 
avoided; 4) primer length 18-24 bp; 5) final product length 100-200 bp. See Table 2.1 for the list of 
primers and corresponding sequences: 
Table 2.1- Primer sequences 
Genes Primer Forward Sequence (5’- 3’) Primer Reverse Sequence (5’- 3’) 
Hnrnpa2 GCTACGGAGGTGGTTATG AGTTAGAAGGTTGCTGGTTAT 
Ppia TTTGGGAAGGTGAAAGAAGGC ACAGAAGGAATGGTTTGATGGG 
Hnrnpk AACACTCAGACAACAATCA TCCTCCAATAAGAACAACTC 
Grin1  CGGCTCTTGGAAGATACAG GAGTGAAGTGGTCGTTGG 
Gria1  ACTACATCCTCGCCAATCTG AGTCACTTGTCCTCCATTGC 
Bdnf TAACCTCGCTCATTCATTA TCAACTCTCACTCACCTT 
Camk2b GCTATACGACGATATTGG TCTTGGTGTTAATGATCT 
Hprt1 CCTTGACTATAATGACCACTTC GCCACATCAACAGGACTC 
Bdnf TGGGACTCTGGAGAGCGTGAATGG CGGGACTTTCTCCAGGACTGTGAC 
Bdnf (cds) GATGACCATCCTTTTCCTTAC ATTCACGCTCTCCAGAGTCC 
 
Hnrnpa2, heterogeneous nuclear ribonucleoprotein A2; Ppia, Peptidylprolylisomerase A; Hnrnpk, 
heterogeneous nuclear ribonucleoprotein K; Grin1, glutamate receptor ionotropic NMDA 1; Gria1, glutamate 
receptor ionotropic AMPA 1; Bdnf, brain-derived neurotrophic factor; Camk2b, calcium/calmodulin-
dependent protein kinase II beta; Hprt1, hypoxanthine guanine phosphoribosyltransferase 1. 
 
For mRNA measurements in hnRNP K immunoprecipitates prepared from dentate gyrus total 
homogenates, two additional sets of primers for Bdnf (two bottom primers in Table 2.1) were 
used. One of these primers was designed to target the Bdnf coding sequence [Bdnf (cds)]. 
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2.16. Quantitative RT-PCR 
Quantitative PCR was performed using the SsoFast™ EvaGreen Supermix (172-5201; Bio-
Rad). 2 µl of 1:10 diluted cDNA was used and the final concentration of each primer was 250 nM 
in a final volume of 20 µl. The thermocycling reaction was initiated with activation of Taq DNA 
polymerase by heating at 95°C during 30 s, followed by 45 cycles of a 10 s denaturation step at 
95°C, a 30 s annealing step at the optimal primer temperature of annealing, and a 30 s elongation 
step at 72°C. The fluorescence was measured after the extension step by the iQ5 Multicolor Real-
Time PCR Detection System (Bio-Rad). After the thermocycling reaction, the melting step was 
performed with slow heating, starting at 55°C and with a rate of 0.5°C per 10 s, up to 95°C, with 
continuous measurement of fluorescence to allow the detection of nonspecific products. To 
measure the mRNA co-immunoprecipitated with hnRNP K from dentate gyrus total homogenates, 
the qRT-PCR reaction was performed in a final volume of 8 µl with 2x SYBR Green Master Mix 
(Bio-Rad), and using a LightCycler 480 (Roche). The reaction was initiated with a pre-
amplification step of 3 min at 95°C, followed by 45 cycles of a 10 s denaturation step at 95°C, a 
10 s annealing step at the optimal primer temperature of annealing, a 10 s elongation step at 
72°C, and warming from 65°C to 95°C for the melting curve 
 
2.17. Processing and analysis of qRT-PCR data 
The comparative Ct method (2-(ΔΔCt)) was used to quantitate the relative gene expression 
across the experimental conditions. The threshold cycle (Ct) represents the detectable 
fluorescence signal above background resulting from the accumulation of amplified product, and 
is a proportional measure of the starting target sequence concentration. Ct was measured on the 
exponential phase and, for every run, Ct was set at the same fluorescence value. Data analysis of 
the log-transformed expression data was performed using the GenEx (MultiD Analysis, Sweden) 
software for Real-time PCR expression profiling. 
 
2.18. Immunocytochemistry 
Hippocampal neurons (low-density) were fixed in 4% sucrose/paraformaldehyde (in PBS) for 
15 min at room temperature and permeabilized with 0.3% Triton X-100 in PBS. The neurons were 
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then incubated with 10% BSA in PBS, for 30 min at 37°C, to block non-specific staining, and 
incubated overnight at 4°C with the primary antibodies diluted in 3% BSA in PBS. The following 
primary antibodies and dilutions were used: anti-hnRNP A2/B1 (sc-53531, 1:200; Santa Cruz 
Biotechnology), anti-hnRNP K (sc-28380, 1:200; Santa Cruz Biotechnology), anti-MAP2 (ab5392, 
1:10.000, Abcam), anti-PSD95 (D27E11, 1:200; Cell Signaling) and anti-Staufen1 (AB5781, 
1:250; Millipore). The cells were washed 6 times with PBS for 2 min and incubated with Alexa 
Fluor 568 (1:500, Invitrogen), Alexa Fluor 488 (1:500; Invitrogen) and AMCA (1:200; Jackson 
ImmunoResearch) conjugated secondary antibodies, for 45 min at 37°C. After washing the cells 6 
times with PBS for 2 min, the coverslips were mounted with a fluorescence mounting medium 
(DAKO).  
 
2.19. Microscopy and quantitative fluorescence analysis 
Imaging was performed on a Zeiss Observer Z.1 microscope using a 63x 1.4 NA oil objective. 
Images were quantified using the ImageJ image analysis software. For quantitation, sets of cells 
were cultured and stained simultaneously, and imaged using identical settings. The protein 
signals were analysed after setting the thresholds, and the recognizable clusters under those 
conditions were included in the analysis. The number, area and the integrated intensity of hnRNP 
A2/B1 or hnRNP K particles in dendrites were determined and represented per dendritic area. For 
colocalization analysis, regions around thresholded puncta were overlaid as a mask in the PSD95 
(or Staufen1) channel, and the integrated intensity, area and number of colocalized particles 
determined. 
 
2.20. HFS-induced LTP in the dentate gyrus in live anesthetized rats 
2.20.1. Animals and pre-surgical treatment 
The animals used in this study were Sprague-Dawley outbreed strain (M&B A/S, Ry, Denmark) 
weighing a 250-300 g at the time of use. Animals were housed in a temperature- and light-
controlled vivarium (21 ± 1°C; 12:12 hour artificial circadian rhythm) and supplied with a high 
protein diet type MR1 (Special Diet Services) and water for at least 1 week before surgery. 
Animals were retrieved from the animal facility into the lab in separate cages and were 
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anesthetized with Urethane (250 mg/ml; 1.4-1.8 mg/kg) according to their individual weight. 
Urethane was administered via intraperitoneal injection. The first injection contained 1/3 of the 
total dosage and after 5 min the animal was weighed for accurate measurements and the final 2/3 
of the anesthetic was given. 
 
2.20.2. Stereotaxic surgery and electrode positioning 
Rats were positioned in a stereotaxic frame (David Kopfs Instruments, USA) with the upper 
incisor bar 2 mm below the interaural line (skull flat position), the ear bars placed at the side of the 
head in the natural jaw sockets and a nose-and-tooth bar supported by the upper jaw of the 
animal (Fig. 2.1A). If required, supplemental doses of urethane were given to maintain a surgical 
level of anesthesia. Rectal temperature was maintained at 36°C with a thermostatically controlled 
electric heating pad. A scalpel was used to make a 1.5 cm longitudinal cut on the top of animals 
head. Four bulldog clamps (FST, Germany) were used to reflect the skin giving open access to 
the scalp. The surface of the scalp was kept dry and free from blood. Burr holes were drilled in the 
appropriate location for the insertion of the stimulating and recording electrodes (Fig. 2.1A). A 
sharp needle was used to incise the dura to facilitate the penetration of the electrodes. Two holes 
were drilled anterior to bregma in the frontal bone to attach the ground and reference electrodes 
(Fig. 2.1A). The stimulation electrodes were bipolar, concentric, stainless steel, and with a vertical 
tip separation of 500 µm (SNEX 100; Rhodes Medical Instruments, Woodland Hills, CA) (Fig. 
2.1B-left). The recording electrodes were Teflon coated 7-strand stainless steel (or tungsten) 
wires (#7955/7960, A-M System Inc, USA) of approximately 8-10 cm length. The ground and 
reference electrodes were Teflon coated 7-strand stainless steel wires (#7925/7935, A-M System 
Inc, USA). Stereotaxic coordinates for the unilateral stimulation of the medial perforant path fibers 
in the angular bundle were as follows (in mm, relative to bregma): 7.9 posterior and 4.2 lateral. 
Stereotaxic coordinates for recording in the hilar region of the dentate gyrus were as follows (in 
mm, relative to bregma): 3.9 posterior and 2.3 lateral (Fig. 2.1A). When positioned on the 
accurate coordinates, both stimulation and recording electrodes were gradually lowered down to 
their final position. The final depth for the stimulation and recording electrodes was 2.2-2.8 and 
3.3 mm below dura, respectively.  
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2.20.3. in vivo electrophysiology and intrahippocampal infusion 
After the correct positioning of the electrodes, the medial perforant path fibers in the angular 
bundle were unilaterally stimulated and the evoked field potentials (fEPSP) were recorded in the 
hilar region of the dentate gyrus. After stabilization, baseline was recorded for 20 min. Test pulses 
were applied at 0.033 Hz throughout the experiment except during the period of high-frequency 
stimulation (HFS). The intensity of the stimulus for test pulses and for HFS was set to the intensity 
that evoked 1/3 of maximum population spike. The HFS paradigm to induce long-term 
potentiation (LTP) consisted of eight pulses of 400 Hz, repeated four times at 10 s intervals. 
Three sessions of HFS were given at intervals of five minutes. Intrahippocampal infusions were 
made using a stainless steel cannula system (Plastics One, Roanoke, VA) consisting of an outer 
guide tube (24 gauge) and an inner infusion tube (31 gauge). The guide cannula was beveled 
sharp at the tip to facilitate brain insertion. The recording electrode was attached to the guide 
cannula and cut so that the distance between the electrode and the tip of the inner infusion 
cannula was 0.8-0.9 mm (Fig. 2.1B-right). The guide cannula-electrode assembly was slowly 
lowered until a positive-going field EPSP (fEPSP) of maximum slope was obtained in the dentate 
hilus. The infusion cannula was then inserted so that the tip protruded 300 µm below the end of 
the guide cannula. The infusion site was located 700 µm above the hilar recording site 
(corresponding to deep CA1 stratum lacunosum-moleculare), and 300-400 µm above the medial 
perforant path-granule cell synapses. The response was allowed to stabilize for 1 h. After 
baseline recordings (20 min) the infusions were performed with a pump that ensures the gradual 
infusion of 1 µl TrkB-Fc (100 µg/µl, 688-TK) or IgG-Fc (100 µg/µl,110-HG) (R&D Systems) over a 
12.5 minute time period. HFS was performed 18 min after the infusion. 
 
2.20.4. Dissection and preparation of dentate gyrus homogenates 
At the end of the electrophysiological recording, the rats were decapitated and the brain rapidly 
removed and transferred to a glass plate covered with ice-cold saline-soaked filter paper. The 
dentate gyrus and the hippocampal CA1 and CA3 regions were rapidly dissected and stored in 
eppendorf tubes instantly frozen in a mixture of 96% methanol and dry ice. Samples were kept at 
-80°C until further use. The dentate gyri were homogenized in 400 µl ice-cold RIPA buffer (150 
mM NaCl, 50 mM Tris–HCl, pH 7.4, 5 mM EGTA, 1% Triton, 0.5% DOC and 0.1% SDS at a final 
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pH 7.5) containing 50 mM sodium fluoride (NaF) and supplemented with cOmplete, Mini EDTA-
free protease inhibitors cocktail (Roche), and 40U/ml RiboLock RNase inhibitor (Thermo Fischer). 
A fraction of the homogenate sample was set aside for Western blot analysis and the remaining 
homogenate used for the RNA co-immunoprecipitation experiments. 
 
2.20.5. Field potential analysis 
The fEPSP was analysed using the software Datawave Experimental Workbench (Data Wave 
Systems, USA). Between two points on the fEPSP, five points were randomly selected to 
calculate the steepness of the slope (Fig. 2.1C). Data files were coverted to ASCII format and 
further analysed in the Microsoft Office Excel 2010 (Microsoft Corporation, USA). fEPSP is 
presented as percentage change from baseline. 
 
 
Figure 2.1 - (A) Image of a rat positioned in a stereotaxic frame during the surgery process. White arrows 
point to the ground and reference electrodes, bregma, the hole drilled to insert the recording electrode and 
the hole drilled to insert the stimulation electrode, from the top to the bottom, respectively. (B) Stimulation 
electrode (left) and a recording electrode with an attached guide cannula (right). (C) Between the two points 
indicated in the fEPSP slope (1 and 2), five points were randomly selected to calculate the steepness. B and 
C were adapted from (Berentsen, 2009). 
 
2.21. Statistical analysis 
Statistical analysis was performed using Student’s t test and one-way ANOVA followed by the 
Dunnett’s or Bonferroni’s test, as indicated in the figure captions. 
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3.1. Summary 
Dendritic protein synthesis plays a critical role in several forms of synaptic plasticity, including 
BDNF (brain-derived neurotrophic factor)-mediated long-term synaptic potentiation. Dendritic 
transcripts are typically transported in a repressed state as components of large ribonucleoprotein 
complexes, and then translated upon stimulation at, or near, activated synapses. hnRNP A2/B1 is 
one of the best described trans-acting factors involved in dendritic mRNA trafficking, but how the 
transport of the protein in dendrites is regulated has not been characterized. Here we found that a 
fraction of hnRNP A2/B1 colocalizes with Staufen1 in dendrites of cultured hippocampal neurons, 
suggesting that the two proteins are present in the same granules. Accordingly, both hnRNP 
A2/B1 and Staufen1 were identified in synaptic mRNP-fractions, and Staufen1 was also 
associated with synaptic polysomes. Neuronal activity and BDNF treatment increased hnRNP 
A2/B1 protein levels in dendrites and induced the delivery of this protein to synaptic sites. 
Although the activity-dependent upregulation in dendritic hnRNP A2/B1 was independent of TrkB 
receptor activation, the accumulation of the ribonucleoprotein in synaptic sites required, at least in 
part, the contribution of endogenous released BDNF. The neurotrophin BDNF also upregulated 
the hnRNP A2/B1 mRNA in the soma but was without effect on the abundance of neuritic-
localized hnRNP A2/B1 transcripts. These results show that the distribution of hnRNP A2/B1 is 
regulated by BDNF and by neuronal activity, and this effect may play a role in BDNF-induced 
plasticity events. 
 
3.2. Introduction 
Experience-dependent changes in synapse structure and function are thought to underlie 
learning and memory formation (Kandel, 2001). Some of these modifications require activity-
dependent transport and translation of dendritic-localized mRNAs, with concomitant alterations in 
the proteome (Sutton and Schuman, 2006). These biochemical, structural and functional 
alterations are required for several forms of synaptic plasticity, including brain-derived 
neurotrophic factor (BDNF)-mediated long term potentiation (LTP) (Leal et al., 2013).  
Dendritic mRNAs are usually packaged into large messenger ribonucleoprotein complexes 
(mRNPs) in the cell body and transported along the microtubule cytoskeleton until they reach their 
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destination. During this process, the transcripts are usually kept in a dormant state and then 
translated upon synaptic activation (Bramham and Wells, 2007). One of the best described RNA-
binding protein involved in mRNA trafficking in both oligodendrocytes and neurons, is the 
heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) (see section 1.8.1). Given the 
nature of some of the hnRNP A2/B1-associated transcripts, the protein may play a role in long-
term synaptic potentiation. Staufen1 is another RNA-binding protein present in neuronal RNA 
granules that migrate along dendrites of hippocampal neurons (Kiebler et al., 1999; Kohrmann et 
al., 1999), regulating the transport of mRNA (Kanai et al., 2004; Tang et al., 2001). Neuronal 
mRNPs are heterogeneous structures that may contain Staufen1 and hnRNP A2/B1 (Elvira et al., 
2006; Kanai et al., 2004).  
Several transcripts are transported to dendrites upon synaptic activity, including mRNAs 
containing A2RE-like elements in their sequences, such as the mRNAs encoding for the activity-
regulated cytoskeleton-associated protein (Arc), CaMKIIα and BDNF (Gao et al., 2008; Havik et 
al., 2003; Link et al., 1995; Lyford et al., 1995; Raju et al., 2011; Rook et al., 2000; Steward et al., 
1998; Steward and Worley, 2001; Thomas et al., 1994; Tongiorgi et al., 1997). In addition, the 
accumulation of Arc and BDNF transcripts in dendrites is also induced by the neurotrophin BDNF 
(Messaoudi et al., 2007; Rao et al., 2006; Righi et al., 2000; Ying et al., 2002). Although the 
BDNF mRNA may be transported along dendrites through interaction with other RNA-binding 
proteins (Chiaruttini et al., 2009; Oe and Yoneda, 2010), these findings suggest that the transport 
of hnRNP A2/B1 in dendrites may be regulated by neuronal activity.  
Here we show that hnRNP A2/B1 protein colocalizes in a subset of Staufen1-containing 
granules in dendrites of hippocampal neurons and is in part present at the synapse under resting 
conditions. hnRNP A2/B1 and Staufen1 were both identified in mRNP-fractions isolated from adult 
hippocampal synaptoneurosomes, being Staufen1 associated with synaptic polysomes. We also 
show that synaptic activity and the neurotrophin BDNF increase the levels of hnRNP A2/B1 in 
dendrites and induce the accumulation of the protein in synaptic sites. Importantly, BDNF 
mediates the synaptic accumulation of hnRNP A2/B1 induced by neuronal activity.  
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3.3. Results  
hnRNP A2/B1 is required for the dendritic localization of mRNAs encoding proteins that are 
relevant for synaptic plasticity, such as CaMKIIα and Arc (Gao et al., 2008). Staufen1 is another 
well described trans-acting factor localized in dendritic RNA granules (Kiebler et al., 1999; 
Kohrmann et al., 1999) that regulates the transport of mRNA (Kanai et al., 2004; Tang et al., 
2001), and this protein was shown to play a role in protein synthesis-dependent long-term 
synaptic potentiation in hippocampal pyramidal neurons (Lebeau et al., 2008). Both Staufen1 and 
hnRNP A2/B1 are present in neuronal mRNPs (Elvira et al., 2006; Kanai et al., 2004) but whether 
these proteins localize in the same set of granules is unknown. We stained cultured hippocampal 
neurons (14-15 DIV) using antibodies against hnRNP A2/B1, Staufen1, and the dendritic marker 
MAP2, and the results show that hnRNP A2/B1 exhibits a punctate distribution along dendrites 
and often localizes in particles that also contain Staufen1 (Fig. 3.1A-white arrows). Colocalization 
analysis demonstrate that a significant fraction (22.42 ± 1.89%, n=37 cells from three independent 
preparations) of dendritic hnRNP A2/B1 signal colocalizes with Staufen1 (Fig. 3.1A’). These 
results suggest that hnRNP A2/B1 and Staufen1 can assemble in the same mRNPs. However, a 
significant fraction of the puncta containing hnRNP A2/B1 and Staufen1 did not colocalize.  
Dendritic-localized mRNAs are typically transported in a dormant state until the translational-
block is relieved upon activity at the synapse (Bramham and Wells, 2007). To test if hnRNP 
A2/B1 is present at the synapse, we analysed the colocalization with the postsynaptic marker 
PSD95, in cultured hippocampal neurons (14-15 DIV) (Fig. 3.1B; Fig. 3.1B’). A considerable 
fraction of dendritic hnRNP A2/B1 (11.19 ± 0.85%; n=71 cells from six independent preparations) 
localizes at PSD95-positive clusters (Fig. 3.1B-white arrows; Fig. 3.1B’). Similarly, a significant 
percentage of total PSD95-positive synapses contain hnRNP A2/B1 (7.68 ± 0.47%; n=48 cells 
from four independent prepararations) (data not shown). Taken together, these observations 
suggest that hnRNP A2/B1 is present in synaptic sites under resting conditions. In addition, we 
detected hnRNP A2/B1 in the mRNPs, but not in the polysomal-fractions, obtained from 
synaptoneurosomes isolated from rat hippocampus (Fig. 3.1C). In contrast with hnRNP A2/B1, 
which was excluded from polysomal fractions isolated from hippocampal synaptoneurosomes, 
Staufen1 was present in both mRNPs- and polysomal-associated fractions (Fig. 3.1C). 
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Figure 3.1 - hnRNP A2/B1 is present in synaptic mRNPs and colocalizes with Staufen1 in dendrites of 
hippocampal neurons. (A) Cultured hippocampal neurons (14-15 DIV) immunostained for hnRNP A2/B1 
(red), Staufen1 (green) and the dendritic marker MAP2 (blue) show a punctate distribution of hnRNP A2/B1 
along dendrites which is partly colocalized in particles that also contain Staufen1 (white arrows). Scale bars 
= 25 µm and 3 µm for low and high magnification images, respectively. The images are representative of 
three different experiments performed in independent preparations, with a total of 37 cells analysed. (A’) The 
fraction of dendritic hnRNP A2/B1 signal that colocalizes with Staufen1 was analysed using ImageJ software 
(mean ± SEM). (B) Cultured hippocampal neurons (14-15 DIV) immunostained for MAP2 (blue), hnRNP 
A2/B1 (red) and PSD95 (green) show that hnRNP A2/B1 is present in synaptic sites as indicated by the 
colocalization with the postsynaptic marker PSD95 (white arrows). Scale bars = 25 µm and 4 µm for low and 
high magnification images, respectively. The images are representative of six different experiments 
performed in independent preparations, with a total of 71 cells analysed. (B’) The percentage of dendritic 
hnRNP A2/B1 signal that colocalizes with PSD95 was analysed using ImageJ software (mean ± SEM). (C) 
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Co-sedimentation of synaptoneurosomal proteins using a 10-50% linear sucrose gradient. The polysomes 
and mRNPs (non-polysomal fractions) were detected by UV absorbance at 254 nm and the gradient was 
collected in 9 fractions. Equal volumes from each fraction were analysed by SDS-PAGE and Western blot 
using antibodies that recognize hnRNP A2/B1, Staufen1, elongation factor eEF2 and ribosomal protein S6 
(rpS6). The results are representative of three (hnRNP A2/B1), two (staufen1), four (eEF2) and three (rpS6) 
different experiments performed in independent synaptoneurosomal preparations.  
 
Altogether, these findings strongly suggest that hnRNP A2/B1 and Staufen1 can assemble to 
some extent in the same granules in dendrites of hippocampal neurons and localize in synaptic 
mRNPs under basal conditions 
Several transcripts are transported to dendrites and dendritic spines upon neuronal activation, 
including the mRNAs for Arc (Link et al., 1995; Lyford et al., 1995; Steward et al., 1998; Steward 
and Worley, 2001), β-actin (Tiruchinapalli et al., 2003), CaMKIIα (Havik et al., 2003; Rook et al., 
2000; Thomas et al., 1994), TrkB and BDNF (Tongiorgi et al., 1997). The mRNAs encoding for 
Arc, CaMKIIα and BDNF have A2RE sequences in their sequence (Gao et al., 2008; Raju et al., 
2011) and the Arc and CaMKIIα transcripts appear to be transported along dendrites in an hnRNP 
A2/B1-dependent manner (Gao et al., 2008). However, it remains to be determined whether the 
hnRNP A2/B1-dependent mRNA transport is a constitutive or regulated process. Therefore, we 
investigated if synaptic activity changes the levels of hnRNP A2/B1 in dendrites and regulates the 
delivery of this protein into synapses. For that purpose, we stimulated cultured hippocampal 
neurons (14-15 DIV) for 30 min with a cocktail solution with bicuculline to increase the excitatory 
activity of the neuronal network (Hardingham et al., 2002). Bicuculline treatment significantly 
increased the integrated intensity, as well as the number and area of hnRNP A2/B1 puncta in 
dendrites (Fig. 3.2A, B, C, D) and in synaptic sites (Fig. 3.2A-white arrows, E, F, G). Since the 
increase in synaptic levels of hnRNP A2/B1 could be a result of the general increase observed in 
dendrites, we also analysed the percentage of dendritic hnRNP A2/B1 signal that colocalizes with 
the synaptic marker PSD95. We found that synaptic activity also increased the percentage of 
dendritic hnRNP A2/B1 that is present at the synapse (Fig. 3.2H), suggesting that there is a 
preferential increase in the delivery of hnRNP A2/B1 into synaptic sites, which is not only due to 
the overall change that occurs in dendrites.  
The neurotrophin BDNF plays a key role in several forms of synaptic plasticity (Waterhouse 
and Xu, 2009). Some of the actions of BDNF in the CNS rely, in part, on the ability of this 
neurotrophin to change synaptic proteome through the regulation of the delivery of dendritic-
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localized transcripts and by regulating local protein synthesis at the synapse (Leal et al., 2013; 
Santos et al., 2010). Furthermore, several activity-inducing paradigms were shown to induce the 
release of endogenous BDNF (Kuczewski et al., 2009; Lessmann and Brigadski, 2009). 
Therefore, we investigated whether the endogenous released BDNF was involved in the 
bicuculline-induced regulation of hnRNP A2/B1. For that purpose we took advantage of the TrkB-
Fc chimera, an effective extracellular scavenger of TrkB ligands which has been widely used to 
access BDNF functions in the CNS. TrkB-Fc application did not block bicuculline-induced 
increase in dendritic hnRNP A2/B1 puncta intensity and area (Fig. 3.2A, B, and C) but partially 
prevented the increase on synaptic hnRNP A2/B1 observed upon bicuculline treatment (Fig. 3.2A-
white arrows, E, F, and G). Altogether, our data indicate that the activity-dependent delivery of 
hnRNP A2/B1 into synaptic sites depends on the release of BDNF and extracellular activation of 
TrkB receptors. In contrast, the accumulation of hnRNP A2/B1 in dendrites upon synaptic activity 
does not require the actions of endogenous released BDNF.  
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Figure 3.2 - Synaptic activity increases hnRNP A2/B1 in dendrites and induces the delivery of hnRNP 
A2/B1 to the synapse by a BDNF-dependent mechanism. Cultured hippocampal neurons (14-15 DIV) 
were stimulated or not with bicuculline (50 µM), 4-AP (2.5 mM) and glycine (10 µM), for 30 min. Where 
indicated, neurons were treated with the extracellular scavenger of TrkB ligands TrkB-Fc (1 µg/ml) for 30 min 
and then stimulated or not with bicuculline in the presence of the BDNF scavenger. The cells were 
immunostained for hnRNP A2/B1 (red), MAP2 (blue), and PSD95 (green) (A). White arrows indicate PSD95-
positive clusters that also contain hnRNP A2/B1 (A). The integrated fluorescence intensity, area and number 
of hnRNP A2/B1 puncta in dendrites (B, C, and D) and at the synapse (as defined by the signal of hnRNP 
A2/B1 that overlaps with PSD95) (E, F, and G) was analysed using ImageJ software and represented per 
dendritic area. The percentage of dendritic hnRNP A2/B1 signal that colocalizes with PSD95 was also 
analysed (H). Results are normalized to control and are averaged of 3-7 different experiments performed in 
independent preparations. For the analysis of dendritic-localized hnRNP A2/B1 puncta, Ctr (n=87 cells); Bic 
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(n=64 cells); TrkB-Fc (n=47 cells); TrkB-Fc + Bic (n=48 cells). For the analysis of synaptic-localized hnRNP 
A2/B1 puncta, Ctr (n=76 cells); Bic (n=54 cells); TrkB-Fc (n=35 cells); TrkB-Fc + Bic (n=35 cells). Error bars, 
mean ± SEM. Statistical analysis was performed by one-way ANOVA, followed by Bonferroni’s test. n.s. Not 
significant, * P<0.05; ** P<0.01; *** P<0.001. Scale bar = 4 µm. 
 
Thus, we next investigated whether the exogenous application of BDNF alters the dendritic 
and synaptic distribution of hnRNP A2/B1 in hippocampal neurons. Cultured hippocampal 
neurons (14-15 DIV) were stimulated with 100 ng/ml BDNF for 30 min in the presence or in the 
absence of the Trk receptor inhibitor SHN722 (1 µM) (Gomes et al., 2012; Martin et al., 2011). 
BDNF treatment resulted in a significant increase of hnRNP A2/B1 integrated intensity, area and 
puncta number in dendrites (Fig. 3.3A, B, C, and D) and in synaptic sites (Fig. 3.3A-white arrows, 
E, F, and G). Inhibition of Trk receptor activity with SHN722 induced a modest increase in hnRNP 
A2/B1 puncta area and integrated intensity in dendrites (Fig. 3.3A, B, and C). Nevertheless, 
further stimulation with BDNF had no effect in every parameter evaluated in both dendritic and 
synaptic hnRNP A2/B1 particles, showing that the effects of BDNF were mediated by Trk 
receptors. Taken together, our findings indicate that the neurotrophin BDNF induces a robust 
accumulation of hnRNP A2/B1 in dendrites and at the synapse in hippocampal neurons by 
activation of Trk (presumably TrkB) receptors.  
Control experiments showed no significant changes in total hnRNP A2/B1 protein levels in 
cultured hippocampal neurons stimulated with BDNF or following synaptic activity, as determined 
by Western blot (supplementary Fig. 3.1), suggesting that effects observed on hnRNP A2/B1 
distribution upon neuronal activation, or in response to BDNF treatment, are not due to a global 
upregulation of hnRNP A2/B1 protein in the cells 
The dendritic transcriptome is not yet fully characterized but a recent study using deep RNA 
sequencing in microdissected synaptic neuropil (stratum radiatum and lacunosum moleculare) 
segments from the CA1 region of the adult rat hippocampus, allowed the identification of 
approximately 2550 mRNAs in dendrites and/or axons (Cajigas et al., 2012), including the hnRNP 
A2/B1 mRNA (Cajigas et al., 2012). Using a neuronal culture system that allows the mechanical 
separation of neurites from cell bodies (Manadas et al., 2009; Poon et al., 2006) we investigated 
the effect of BDNF on the levels of hnRNP A2/B1 transcripts in the two compartments. qRT-PCR 
experiments showed that BDNF treatment for 2 h significantly increased the hnRNP A2/B1 mRNA 
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in the soma but had no effect on the abundance of the transcript in the neurite compartment (Fig. 
3.4).  
 
Figure 3.3 - BDNF induces the accumulation of hnRNP A2/B1 in dendrites and at the synapse in 
hippocampal neurons. Cultured hippocampal neurons (14-15 DIV) were stimulated or not with 100 ng/ml 
BDNF for 30 min. The role of Trk receptor activity in BDNF-induced regulation of hnRNP A2/B1 distribution 
was tested using the inhibitor SHN722. Where indicated, neurons were treated for 30 min with 1 µM SHN722 
and then stimulated or not with 100 ng/ml BDNF in the presence of the inhibitor. The cells were 
immunostained for hnRNP A2/B1 (red), MAP2 (blue), and PSD95 (green) (A). White arrows indicate PSD95-
positive clusters that also contain hnRNP A2/B1 (A). The integrated fluorescence intensity, area and number 
of hnRNP A2/B1 puncta in dendrites (B, C, and D) and at the synapse (as defined by the signal of hnRNP 
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A2/B1 that overlaps with PSD95) (E, F, and G) was analysed using ImageJ software and represented per 
dendritic area. The percentage of dendritic hnRNP A2/B1 signal that colocalizes with PSD95 was also 
analysed (H). Results are normalized to control and are the average of 3-6 different experiments performed 
in independent preparations. For the analysis of dendritic-localized hnRNP A2/B1 puncta, Ctr (n=73 cells); 
Bic (n=64 cells); TrkB-Fc (n=47 cells); TrkB-Fc + Bic (n=48 cells). For the analysis of synaptic-localized 
hnRNP A2/B1 puncta, Ctr (n=62 cells); Bic (n=67 cells); TrkB-Fc (n=37 cells); TrkB-Fc + Bic (n=35 cells). 
Error bars, mean ± SEM. Statistical analysis was performed by one-way ANOVA, followed by Bonferroni’s 
test. n.s. Not significant, * P<0.05; ** P<0.01; *** P<0.001. Scale bar = 4 µm. 
 
 
Figure 3.4 - BDNF upregulates hnRNP A2/B1 mRNA in the cell body compartment of hippocampal 
neurons. Cultured hippocampal neurons (14-15 DIV) were stimulated or not with 100 ng/ml BDNF, for 30 
min or 2 h. The cell body mRNA was mechanically separated from the transcripts of neurites and 500-1000 
ng of RNA from each compartment was used in the reverse transcription reaction. The analysis of hnRNP 
A2/B1 mRNA levels was performed by qRT-PCR using Ppia as internal control gene. The results are the 
average ± SEM of five (cell body compartment) or seven (neurite compartment) independent transcription 
reactions, performed in different preparations. Statistical analysis of logtransformed expression data was 
performed by one-way ANOVA, followed by Dunnet’s test. * P< 0.05. 
 
3.4. Discussion 
In this work we show that hnRNP A2/B1 is partly colocalized with the RNA granule protein 
Staufen1 in dendrites of cultured hippocampal neurons and is also found at synapses. 
Furthermore, we found that hnRNP A2/B1 protein levels are rapidly increased in dendrites and 
synapses of hippocampal neurons upon neuronal activation or BDNF stimulation. Together, these 
results point to a tight regulation of the dendritic distribution of hnRNP A2/B1, and do not favor a 
model of constitutive delivery of the protein. This is particularly relevant since hnRNP A2/B1 is a 
trans-acting factor involved in the transport of several mRNAs along dendrites (Gao et al., 2008; 
Muslimov et al., 2006; Muslimov et al., 2011; Shan et al., 2003). BDNF plays an important role in 
the protein synthesis-dependent late phase of LTP induced by high-frequency stimulation in the 
hippocampus CA1 region (Chen et al., 1999; Kang and Schuman, 1996) and BDNF-induced 
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synaptic potentiation has also been reported, both in vitro (Kang and Schuman, 1996) and in vivo 
(Messaoudi et al., 2002; Ying et al., 2002). 
The observed increase in the dendritic distribution and synaptic clustering of hnRNP A2/B1 in 
hippocampal neurons stimulated with BDNF, suggest that the neurotrophin may act, at least in 
part, by regulating the transport of mRNAs during plasticity-related events. In particular, the 
BDNF-induced clustering of hnRNP A2/B1 at the synapse may bring the Arc and CaMKII mRNAs 
(among others) that are locally translated and may contribute to the protein synthesis-dependent 
late phase of LTP. Accordingly, intrahippocampal infusion of BDNF resulted in the accumulation 
of Arc transcripts in dendrites and triggered long-term potentiation (BDNF-LTP) at medial 
perforant path-granule cell synapses in vivo (Messaoudi et al., 2007; Ying et al., 2002). 
Furthermore, exogenous application of BDNF is sufficient to induce the transport of A2RE-
containing mRNAs, such as BDNF (Righi et al., 2000) and Arc (Rao et al., 2006) transcripts into 
dendrites. Although synaptic activity and BDNF stimulation increased hnRNP A2/B1 protein levels 
and clustering in dendrites, the effect of neuronal activity was insensitive to the presence of TrkB-
Fc, indicating that it is not mediated by the release of endogenous BDNF. This contrasts with the 
synaptic delivery of the protein upon neuronal activation, which is likely to require the activation of 
TrkB receptors by BDNF. Further research is needed to clarify the differential mechanisms 
induced by synaptic activity and BDNF that promote the accumulation of hnRNP A2/B1 in 
dendrites.  
Processing-bodies (P-bodies), which are typically involved in mRNA degradation or storage 
(Anderson and Kedersha, 2006; Kiebler and Bassell, 2006), are transported to synapses and 
release mRNAs upon synaptic activation (Oh et al., 2013). Several components of RNA transport 
granules, such as ZBP1 and FMRP, were localized in P-bodies in mammalian neurons (Cougot et 
al., 2008), supporting the hypothesis that these two types of granules may be structurally related. 
In contrast with previous findings (Zeitelhofer et al., 2008), a recent study raised the possibility 
that some of the P-bodies might contain Staufen1 in mammalian neurons (Oh et al., 2013). Since 
Staufen1 and hnRNP A2/B1 are likely to assemble in the same granules to some extent (Fig. 
3.1A-white arrows, A’) it will be important to investigate the nature and functional significance of 
these structures. Given the evidence reported here, it is tempting to speculate that Staufen1 and 
hnRNP A2/B1 might also constitute a pool of storage silent-foci that respond to neuronal 
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activation and BDNF, in addition to the role in dendritic mRNA transport. Interestingly, we found 
that Staufen1 is present in synaptic polysomal fractions (Fig. 3.1C) suggesting a role for this 
protein not only in the delivery but also in the translational control of synaptic-localized mRNAs. 
To our knowledge this is the first indication that Staufen1 may play a role in the translational 
control at the synapse in mammalian neurons. This is in agreement with the results showing the 
presence of Staufen proteins in polysomal fractions isolated from COS7 and HeLa cell lines (Luo 
et al., 2002; Marion et al., 1999), and with the role of Staufen1 in the translational control of 
mRNAs (Dugre-Brisson et al., 2005). 
The fractionation studies showed that hnRNP A2/B1 is present in the mRNPs but not in the 
polysomal-fractions obtained from synaptoneurosomes isolated from rat hippocampus. Because 
polysomes are sites of active translation (Bagni et al., 2000; Weiler et al., 1997), these results 
suggest that although hnRNP A2/B1 plays a role in the delivery of mRNAs into synaptic sites it is 
unlikely to be present during active translation of the target mRNAs at the synapse. This contrasts 
with the role of hnRNP A2/B1 in oligodendrocytes, where the protein enhances the translation of 
A2RE-carrying mRNAs following phosphorylation by the Fyn kinase (Kosturko et al., 2006; White 
et al., 2008). On the other hand, the direct binding of hnRNPE1 to hnRNP A2/B1 apparently 
represses the translation of its target mRNAs (Kosturko et al., 2006).  
Using a culture system that allows a physical separation of the soma and neurite 
compartment, we found that stimulation of cultured hippocampal neurons with BDNF increased 
the hnRNP A2/B1 mRNA only in the former compartment. The BDNF-induced upregulation of 
hnRNP A2/B1 mRNA in cell bodies may provide a layer to support the effect of the neurotrophin 
on the hnRNP A2/B1 protein localization in dendrites or even to contribute to the wide variety of 
functions that hnRNP A2/B1 plays in the nucleus. The lack of effect of BDNF on the dendritic 
levels of hnRNP A2/B1 mRNA contrasts with the effects observed for transcripts encoding several 
translation-related proteins (Manadas et al., 2009). Although the abundance of hnRNP A2/B1 
mRNA in neurites remained unchanged following BDNF treatment, it is not possible to rule out the 
existence of subtle changes with a magnitude under the limit of sensitivity of the technique. 
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3.5. Conclusions 
Overall, our study provides strong evidence supporting the dendritic accumulation of hnRNP 
A2/B1 in response to synaptic activity and upon BDNF treatment, most likely through independent 
and distinct mechanisms. Similarly, the activity-dependent BDNF-mediated synaptic delivery of 
hnRNP A2/B1 further suggests a role for hnRNP A2/B1 in local mRNA metabolism and is likely to 
play a role in plasticity-related events.  
 
3.6. Supplementary Figures 
 
Supplementary Figure 3.1 - hnRNP A2/B1 total protein levels are not significantly altered following 
synaptic activity or BDNF treatment in hippocampal neurons. (A) High-density primary hippocampal 
neurons cultured for 14-15 DIV were incubated with or without 100 ng/ml BDNF (1.5 h, 3 h, 6 h and 8 h) as 
indicated. Total hnRNP A2/B1 protein levels were detemined by Western blot and ẞ-tubulin was used as 
loading control. The results are the average ± SEM of 4-5 different experiments, performed in independent 
preparations. (B) High-density primary hippocampal neurons cultured for 14-15 DIV were stimulated or not 
with bicuculline (50 µM), 4-AP (2.5 mM) and glycine (10 µM), or depolarized with KCl (30 mM) for 30 min. 
Total hnRNP A2/B1 protein levels were determined by Western blot and ẞ-actin was used as loading control. 
The results are the average ± SEM of 3 independent experiments, performed in distinct preparations. 
Statistical analysis was performed by one-way ANOVA, followed by Dunnet’s test. 
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and Synaptic Activity: in vitro and in vivo Evidence 
 
The experiments shown on panel 4.5A were performed by Diogo Comprido  
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4.1. Summary 
Dendritic protein synthesis plays a critical role in several forms of synaptic plasticity, including 
BDNF (brain-derived neurotrophic factor)-mediated long-term synaptic potentiation. Dendritic 
transcripts are typically transported in a repressed state as components of large ribonucleoprotein 
complexes, and then translated upon stimulation at, or near, activated synapses. hnRNP K is 
present in neuronal mRNPs but whether it is involved in the regulation of local mRNA metabolism 
at the synapse is unknown. Here we found that a fraction of hnRNP K colocalizes with Staufen1 in 
dendrites of cultured hippocampal neurons, suggesting that the two proteins may be found in the 
same granules. Neuronal activity and BDNF treatment increased hnRNP K levels in dendrites and 
induced the delivery of this protein to synaptic sites. Studies with hippocampal 
synaptoneurosomes showed that several hnRNP K-bound mRNAs, including the transcripts 
coding for GluA1, GluN1 and BDNF, are released from hnRNP K-containing mRNPs locally at the 
synapse in response to BDNF stimulation. Similarly, these mRNAs are differentially regulated 
during high-frequency (HFS)-induced long term potentiation (LTP) in the dentate gyrus in live 
anesthetized rats, an in vivo model of synaptic potentiation requiring the activation of TrkB 
receptors, presumably by BDNF. In additional studies we found that hnRNP K may interact with 
several RNA-binding proteins, which may also contribute to the alterations in hnRNP K interaction 
with mRNAs reported here. Taken together, these results show that hnRNP K and hnRNP K-
associated mRNAs are regulated by synaptic activity and BDNF, both in vitro and in vivo, and 
suggest hnRNP K as an important regulator of neuronal function, particularly in BDNF-induced 
plasticity events. 
 
4.2. Introduction 
Experience-dependent changes in synapse structure and function are thought to underlie 
learning and memory formation (Kandel, 2001). The activity-dependent transport and translation 
of dendritic-localized mRNAs, with a concomitant change in the synaptic proteome, contribute to 
some of these modifications (Sutton and Schuman, 2006). The biochemical, structural and 
functional alterations resulting from local translation are required for several forms of synaptic 
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plasticity, including brain-derived neurotrophic factor (BDNF)-mediated long-term potentiation 
(LTP) (Leal et al., 2013).  
Several transcripts are transported to dendrites and dendritic spines upon neuronal activation, 
including the mRNAs for Arc (Link et al., 1995; Lyford et al., 1995; Steward et al., 1998; Steward 
and Worley, 2001), β-actin (Tiruchinapalli et al., 2003), CaMKIIα (Havik et al., 2003; Rook et al., 
2000; Thomas et al., 1994), TrkB and BDNF (Tongiorgi et al., 1997). In addition, the accumulation 
of Arc and BDNF transcripts in dendrites is also induced by the neurotrophin BDNF (Messaoudi et 
al., 2007; Rao et al., 2006; Righi et al., 2000; Ying et al., 2002). Dendritic mRNAs are typically 
transported along dendrites in a repressed state, as components of large messenger 
ribonucleoprotein complexes (mRNPs). Upon docking at their final destination, the mRNA content 
present in these granules is released and translated in response to synaptic activation (Bramham 
and Wells, 2007). The neuronal mRNPs are heterogeneous structures composed by a wide 
variety of proteins, including the RNA-binding proteins hnRNP K and Staufen1 (Elvira et al., 2006; 
Kanai et al., 2004). Staufen1 is present in neuronal RNA granules that migrate along dendrites of 
hippocampal neurons (Kiebler et al., 1999; Kohrmann et al., 1999), regulating the transport of 
mRNA (Kanai et al., 2004; Tang et al., 2001). Although the role of hnRNP K in the regulation of 
several aspects of nucleic acids metabolism, such as transcription, splicing or translation 
(Bomsztyk et al., 2004) is well established, the function of the protein in the CNS is poorly 
understood. hnRNP K was shown to interact with Abelson-interacting protein 1 (Abi1) at 
postsynaptic sites and to modulate dendritic spine morphology in hippocampal neurons (Proepper 
et al., 2011). Furthermore, BDNF stimulation increases hnRNP K protein levels in 
synaptoneurosomes isolated from cortical neurons (Liao et al., 2007). Despite these reports, the 
possible role of hnRNP K in the transport and/or translation of dendritic-localized mRNAs remains 
to be investigated. 
BDNF is released at the synapse upon high-frequency stimulation (Aicardi et al., 2004), and 
this neurotrophin is required for the maintenance of LTP (Figurov et al., 1996; Korte et al., 1998; 
Minichiello et al., 2002). Furthermore, BDNF application can induce protein synthesis-dependent 
synaptic potentiation in vitro (Kang and Schuman, 1996) and in vivo (Messaoudi et al., 2002). 
Here we show that BDNF stimulation and neuronal activity induce the rapid delivery of hnRNP K 
into synapses in cultured hippocampal neurons. Synaptic activity rapidly increases hnRNP K 
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protein levels in dendrites whereas prolonged treatment with BDNF is required to produce similar 
effects. We also found that several hnRNP K-associated mRNAs, such as the transcripts for 
GluN1, GluA1 and BDNF, are released from hnRNP K-containing mRNPs in synaptoneurosomes 
stimulated with BDNF. A similar effect was observed for some of these transcripts 30 min upon 
HFS-induced LTP in the medial perforant path-granule cell synapses in the dentate gyrus of live 
anesthetized rats. Importantly, we showed that activation of TrkB, presumably by BDNF, is 
required for synaptic potentiation in this in vivo model. 
 
4.3. Results 
4.3.1. Neuronal activity and BDNF stimulation upregulate the dendritic levels of 
hnRNP K  
 
The available evidence suggests that hnRNP K is a component of neuronal mRNPs (Elvira et 
al., 2006) but the distribution of this protein in neurons remains to be investigated. Staufen1 is a 
well described trans-acting factor localized in dendritic RNA granules (Kiebler et al., 1999; 
Kohrmann et al., 1999) and is known to regulate the transport of mRNA (Kanai et al., 2004; Tang 
et al., 2001). This protein was shown to play a role in protein synthesis-dependent long-term 
synaptic potentiation in hippocampal pyramidal neurons (Lebeau et al., 2008). To investigate 
whether hnRNP K is present in dendritic-localized granules we stained cultured hippocampal 
neurons (14-15 DIV) using antibodies against hnRNP K, Staufen1, and the dendritic marker 
MAP2. The results show that hnRNP K exhibits a punctate distribution along dendrites (Fig. 4.1A) 
which is in agreement with the hypothesis of hnRNP K being a component of neuronal mRNPs 
involved in dendritic mRNA transport. Furthermore, hnRNP K often localizes in Staufen1-
containing particles (Fig. 4.1A-white arrows). Colocalization analysis demonstrate that a 
significant fraction (19.77 ± 1.58%, n=30 cells from three independent preparations) of the 
dendritic hnRNP K signal colocalizes with Staufen1 (Fig. 4.1A’) suggesting that hnRNP K and 
Staufen1 can assemble, to some extent, in the same mRNPs. However, a significant fraction of 
the puncta containing hnRNP K and Staufen1 did not colocalize. 
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Figure 4.1 - hnRNP K is present in synaptic sites under resting conditions and colocalizes with 
Staufen1 in dendrites of hippocampal neurons. (A) Cultured hippocampal neurons (14-15 DIV) 
immunostained for hnRNP K (red), Staufen1 (green) and the dendritic marker MAP2 (blue) show that hnRNP 
K exhibits a punctate distribution along dendrites and may localize in particles that also contain Staufen1 
(white arrows). Scale bars = 20 µm and 4 µm for low and high magnification images, respectively. The image 
is representative of 3 different experiments performed in independent preparations with a total of 30 cells 
analysed. (A’) The fraction of dendritic hnRNP K signal that colocalizes with Staufen1 was analysed using 
ImageJ software. Error bars, mean ± SEM; (19.77 ± 1.58% n=30). (B) Cultured hippocampal neurons (14-15 
DIV) immunostained for MAP2 (blue), hnRNP K (red) and PSD95 (green) show that hnRNP K is present in 
synaptic sites as indicated by the colocalization with the postsynaptic marker PSD95 (white arrows). Scale 
bars = 20 µm and 5 µm for low and high magnification images, respectively. The image is representative of 8 
different experiments performed in independent preparations with a total of 80 cells analysed. (B’) The 
percentage of dendritic hnRNP K signal that colocalizes with PSD95 was analysed using ImageJ software. 
Error bars, mean ± SEM (15.91 ± 1.35% n=80).  
 
Dendritic-localized mRNAs are typically transported in a dormant state until the translational-
block is relieved by synaptic activity (Bramham and Wells, 2007). To test if hnRNP K is present at 
the synapse, we analysed the colocalization with the postsynaptic marker PSD95, in cultured 
hippocampal neurons (14-15 DIV) (Fig. 4.1B; Fig. 4.1B’). A considerable fraction of dendritic 
hnRNP K (15.91 ± 1.35%; n=80 cells from eight independent preparations) localizes at PSD95-
positive clusters (Fig. 4.1B-white arrows; Fig. 4.1B’). Taken together, these observations suggest 
that hnRNP K may localize in dendritic particles that also contain Staufen1 and is present in 
synaptic sites under resting conditions. 
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Several transcripts are transported to dendrites and dendritic spines upon neuronal activation, 
including the mRNAs encoding for Arc (Link et al., 1995; Lyford et al., 1995; Steward et al., 1998; 
Steward and Worley, 2001), β-actin (Tiruchinapalli et al., 2003), CaMKIIα (Havik et al., 2003; 
Rook et al., 2000; Thomas et al., 1994), TrkB and BDNF (Tongiorgi et al., 1997). Therefore, we 
investigated if synaptic activity changes the levels of hnRNP K in dendrites and regulates the 
delivery of the protein into synaptic sites. For that purpose, we stimulated cultured hippocampal 
neurons (14-15 DIV) for 30 min with a cocktail solution with bicuculline to increase the excitatory 
activity of the neuronal network (Hardingham et al., 2002). Bicuculline treatment significantly 
increased the integrated intensity, as well as the number and area of hnRNP K puncta in 
dendrites (Fig. 4.2A, B, C, D), and the intensity of hnRNP K clusters in synaptic sites (Fig. 4.2A- 
white arrows, I). 
We next questioned whether the effects observed on hnRNP K distribution upon neuronal 
activation require changes in total hnRNP K protein levels. For this purpose, cultured 
hippocampal neurons (14-15 DIV) were stimulated with the cocktail solution that contain 
bicuculline to increase synaptic activity, or with KCl (30 mM), and the hnRNP K protein levels 
were determined by Western blot. Interestingly, bicuculline stimulation did not change hnRNP K 
total protein levels (Fig. 4.3), in contrast with the effect of KCl depolarization which decreased 
total hnRNP K protein levels (Fig. 4.3). These results indicate that effects of bicuculline 
stimulation of hnRNP K protein levels in dendrites are not due to a global upregulation of the 
ribonucleoprotein in the cells. 
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Figure 4.2 - Synaptic activity induces the accumulation of hnRNP K in dendrites and the delivery of 
the protein into synaptic sites. Cultured hippocampal neurons (14-15 DIV) were stimulated or not with 100 
ng/ml BDNF or with bicuculline (50 µM), 4-AP (2.5 mM) and glycine (10 µM), for 30 min. The cells were 
immunostained for hnRNP K (red), MAP2 (blue), and PSD95 (green) (A). White arrows indicate PSD95-
positive clusters that also contain hnRNP K (A). The fluorescence intensity, area and the number of hnRNP 
K puncta in dendrites (B, C and D) and at the synapse (as defined by the signal of hnRNP K that overlaps 
with PSD95) (I, J and K) was analysed using ImageJ software and represented per dendritic area. The 
percentage of dendritic hnRNP K signal that colocalizes with PSD95 was also analysed (L). Results are 
normalized to control and are the average of five (Ctr and Bic) or three (BDNF) independent experiments 
performed in different preparations. Ctr (n=47 cells); Bic (n=50 cells); BDNF (n=22 cells). Error bars, mean ± 
SEM. Statistical analysis was performed by one-way ANOVA, followed by Dunnet’s test.* P<0.05; ** P<0.01; 
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*** P<0.001. Scale bar = 4 µm. (E) Cultured hippocampal neurons (14-15 DIV) were stimulated or not with 
100 ng/ml BDNF for 3 h, and immunostained for hnRNP K (red) and MAP2 (blue). The images are 
representative of two different experiments performed in independent preparations with a total of 18 (Ctr) 
and 23 (BDNF 3 h) cells analysed. Scale bar = 4 µm. (F, G and H) The integrated intensity, area and number 
of hnRNP K puncta in dendrites was analysed using ImageJ software. Error bars, mean ± SEM (Ctr n=18; 
BDNF 3 h n=23). Statistical analysis was performed using unpaired Student’s t test. * P<0.05; ** P<0.01. 
 
The neurotrophin BDNF plays a key role in several forms of synaptic plasticity (Waterhouse 
and Xu, 2009). Some of the actions of BDNF in the CNS rely, in part, on the ability of this 
neurotrophin to change the synaptic proteome by inducing the delivery of dendritic-localized 
transcripts and by promoting local protein synthesis at the synapse (Leal et al., 2013; Santos et 
al., 2010). BDNF is stored in vesicles of the regulated secretory pathway, being released in 
response to synaptic activity (Kuczewski et al., 2009; Lessmann and Brigadski, 2009). Thus, we 
next investigated whether BDNF regulates the dendritic and synaptic distribution of hnRNP K in 
hippocampal neurons. To do so, we stimulated cultured hippocampal neurons (14-15 DIV) with 
BDNF (100 ng/ml) for 30 min. We found that BDNF treatment under these conditions has no 
effect on the levels of hnRNP K in dendrites (Fig. 4.2A, B, C, D). However, incubation of the cells 
with BDNF for 30 min slightly increased the hnRNP K integrated intensity at the synapse 
(although it did not reach statistical significance), the number of synaptic puncta and the 
percentage of hnRNP K in synaptic sites (Fig. 4.2A-white arrows, I, L), although statistical 
significance was obtained only under the latter conditions. These results suggest that short-term 
stimulation with BDNF specifically modulates hnRNP K at the synapse. Interestingly, longer 
periods of stimulation with BDNF (3 h) resulted in a significant increase in the integrated intensity 
and area of hnRNP K-containing particles in dendrites (Fig. 4.2E, F, G), showing a differential 
regulation of hnRNP K distribution by transient or sustained activation of TrkB receptors. 
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Figure 4.3 - hnRNP K total protein levels are downregulated upon KCl depolarization in hippocampal 
neurons. High-density primary hippocampal neurons cultured for 14-15 DIV were stimulated or not with 
bicuculline (50 µM), 4-AP (2.5 mM) and glycine (10 µM), or depolarized with KCl (30 mM) for 30 min. Total 
hnRNP K protein levels were assessed by Western blot and β-actin was used as loading control. The results 
are the average ± SEM of 3 independent experiments, performed in different preparations. Statistical 
analysis was performed by one-way ANOVA, followed by Dunnet’s test. * P< 0.05 
 
The dendritic transcriptome is not yet fully characterized but a recent study using deep RNA 
sequencing in microdissected synaptic neuropil (stratum radiatum and lacunosum moleculare) 
segments from the CA1 region of the adult rat hippocampus allowed the identification of 
approximately 2550 mRNAs in dendrites and/or axons (Cajigas et al., 2012), including the hnRNP 
K mRNA (Cajigas et al., 2012). Using a neuronal culture system that allows the mechanical 
separation of neurites from cell bodies (Manadas et al., 2009; Poon et al., 2006) we investigated 
the effect of BDNF on the levels of hnRNP K transcripts in the two compartments. qRT-PCR 
experiments showed that BDNF treatment (30 min and 2 h) had no significant effect on the 
abundance of hnRNP K mRNA in both cell body- and neurite-compartments (Fig. 4.4). Therefore, 
the delayed effects of BDNF on the hnRNP K protein levels in dendrites cannot be attributed to 
the transport of new transcripts to this compartment. 
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Figure 4.4 - BDNF stimulation does not change hnRNP K mRNA levels in the cell body and neurite 
compartments. Cultured hippocampal neurons (14-15 DIV) were stimulated or not with 100 ng/ml BDNF, for 
30 min or 2 h. The cell body and neurite mRNA was isolated after mechanical separation of the two 
compartments, and 500-1000 ng of RNA was used in each case for the reverse transcription reaction. The 
analysis of hnRNP K mRNA levels was performed by qRT-PCR using Ppia as internal control gene. The 
results are the average ± SEM of five (cell body compartment) or seven (neurite compartment) independent 
transcription reactions, performed in different preparations. Statistical analysis of logtransformed expression 
data was performed by one-way ANOVA, followed by Dunnet’s test. 
 
4.3.2. BDNF stimulation downregulates the interaction of hnRNP K with different 
mRNAs in hippocampal synaptoneurosomes 
 
Previous studies from our laboratory used RNP immunoprecipitation assays (RIP) followed by 
DNA microarray to identify the transcripts associated with hnRNP K in hippocampal neurons. This 
study identified thousands of hnRNP K-associated transcripts, including mRNAs encoding 
proteins with well established roles in synaptic plasticity such as GluN1, GluA1, CamKIIβ or BDNF 
(Comprido, 2011). A similar approach was used to evaluate the effect of BDNF stimulation on the 
hnRNP K-bound transcripts in hippocampal neurons and the results showed that 51% of hnRNP 
K-associated transcripts were regulated by BDNF. The large majority (99.9%) of these mRNAs 
were partially released within 10 min of stimulation with the neurotrophin. This clearly shows a 
massive effect of BDNF on the dissociation of mRNAs from hnRNP K and/or hnRNP K-associated 
proteins (Comprido, 2011).  
Since hnRNP K may be localized at synaptic sites under resting conditions (Fig. 4.1B) 
(Proepper et al., 2011), we next tested if BDNF regulates the association of hnRNP K with target 
mRNAs locally at the synapse. For that purpose, synaptoneurosomes isolated from adult rat 
hippocampus were stimulated with 50 ng/ml BDNF for 10 min and the levels of transcripts co-
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immunoprecipitated with hnRNP K were evaluated through qRT-PCR. We found that BDNF 
decreases the amount of GluA1, GluN1, CamKIIβ, hnRNP K and BDNF mRNAs co-
immunoprecipitated with hnRNP K (Fig. 4.5A) suggesting that, as previously observed at the 
whole cell level, BDNF also induces the dissociation of mRNAs from hnRNP K-containing 
complexes at synaptic sites. These findings strongly suggest a role for hnRNP K in the regulation 
of mRNA metabolism locally at the synapse. 
The hnRNP K protein interactome is vast and has been studied in several biological contexts 
(Bomsztyk et al., 2004; Mikula et al., 2006), but so far no proteomic study was performed in the 
CNS. Some of the hnRNP K-associated transcripts identified in cultured hippocampal neurons 
(Comprido, 2011) may in fact interact with hnRNP K binding proteins, and the effects of BDNF 
may reflect alterations in the interaction of those mRNAs with hnRNP K binding partners. To 
characterize the hnRNP K binding partners in the nervous system we used a proteomic approach, 
and the RNP was immunoprecipitated from the adult rat hippocampus. Figure 4.5B shows hnRNP 
K immunoprecipitation from total extracts of adult rat hippocampus. The immunoprecipitates were 
separated through SDS-PAGE and the proteins in the gel were stained using Silver (Fig. 4.5C) or 
colloidal Coomassie (data not shown) staining methods. We found that hnRNP K 
immunoprecipitation pulled-down several proteins that were absent in the control 
immunoprecipitation performed with IgG (Fig. 4.5C-blue arrows). The lanes corresponding to the 
hnRNP K or IgG immunoprecipitations were excised from the gel and further analysed by LC-
MS/MS analysis. Only proteins that were not present in the control immunoprecipitation 
performed with IgG and with a minimum of two peptides (with eight or more amino acids) were 
considered hnRNP K binding partners and used for further analysis. 
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Figure 4.5 - BDNF induces the release of hnRNP K-associated mRNAs at the synapse. (A) 
Synaptoneurosomes isolated from rat hippocampus were stimulated or not with BDNF for 10 min and 
hnRNP K was immunoprecipitated using equal amounts of synaptoneurosomal extracts. The levels of 
GluA1, GluN1, CaMKIIβ, hnRNP K and BDNF transcripts co-immunoprecitated with hnRNP K were assayed 
by qRT-PCR. The results are presented as mean ± SEM normalized to non-stimulated synaptoneurosomes 
and are the average ± SEM of 4 independent experiments performed in 4 different transcription reactions. ** 
P<0.01; * P<0.05; *** P<0.001; as determined by the Student’s t-test. (B) hnRNP K immunoprecipitation from 
total rat hippocampus homogenates (1 mg). Western blot analysis of the immunoprecipitates shows that 
hnRNP K is detected in the corresponding immunoprecipitation (IP) but not in the control IP performed with 
IgG. (C) Several proteins are specifically pulled-down by hnRNP K in co-immunoprecipitation experiments. 
The immunoprecipitates were subjected to a gel electrophoresis followed by in-gel protein detection by Silver 
staining. Immunorecipitation of hnRNP K pulled-down several proteins (blue arrows) that were absent in the 
control IP performed with IgG. In parallel experiments, the gels were stained with colloidal Coomassie and 
the bands were excised and processed for LC-MS/MS analysis. (D) hnRNP K interacts with RBMX (hnRNP 
G) in rat hippocampus. hnRNP K was immunoprecipitated from hippocampal homogenates. The 
immunoprecipitates were separated through SDS-PAGE and immunoblotted using antibodies against 
hnRNP K, hnRNP A2/B1, and RBMX. Precipitation of hnRNP K also pulled-down RBMX (bottom). The 
interaction between hnRNP K and hnRNP A2/B1 (suggested by LC-MS/MS data) was not confirmed (top).  
 
The proteins co-immunoprecipitated with hnRNP K and identified by LC-MS/MS were analysed 
with the GoMiner tool that uses the GO (Gene Ontology) algorithm. This approach allows 
grouping the proteins according to their function and/or localization. We identified a vast number 
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of hnRNPs as interactors of hnRNP K (see Table 4.1). Interestingly, the majority of the proteins 
identified are also RNA-binding proteins involved in several aspects of RNA metabolism (Table 
4.1), and some of those were previously described as hnRNP K interactors in rat hepatoma cells 
(Mikula et al., 2006). We did not detect any of the described kinases that associate with hnRNP K 
(Bomsztyk et al., 2004), similarly to the results previously reported in rat hepatoma cells (Mikula et 
al., 2006). A wide variety of ribosomal proteins were found to interact with hnRNP K (Table 4.1) 
(Mikula et al., 2006). Our results show new putative binding partners for hnRNP K, such as the 
GTPase-activating protein Asap1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 1), 
Camk2a (calcium/calmodulin-dependent protein kinase II alpha) and Syngr1 (Synaptogyrin-1), 
which were grouped into cytoskeleton and/or synaptic regulation proteins (Table 4.1), suggesting 
that indeed hnRNP K is very likely to have a role in synaptic RNA metabolism and/or cytoskeleton 
regulation. 
Table 4.1 - hnRNP K-interacting proteins identified by LC-MS/MS. 
 
Proteins are named with their gene symbols and grouped according to their function and/or localization, as 
determined with the GoMiner tool that uses the GO (Gene Ontology) algorithm. 
 
To validate this proteomic study we performed immunoprecipitation experiments with the anti-
hnRNP K antibody followed by Western blot analysis of the immunoprecipitates. This approach 
allowed the detection of RBMX (hnRNP G) in the hnRNP K co-immunoprecipitates (Fig. 4.5D-
bottom). However, we could not confirm the interaction between hnRNP K and hnRNP A2/B1 
(Fig. 4.5D-top). 
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4.3.3. HFS-induced LTP in the dentate gyrus differentially modulates the 
interaction of hRNP K with the transcripts 
 
Given the evidence here reported, we next questioned whether hnRNP K and hnRNP K-
associated mRNAs are regulated by synaptic activity in vivo. To address this question we used a 
model of HFS-induced LTP in the dentate gyrus of live anesthetized rats. The LTP at medial 
perforant path-granule cell synapses induced by HFS prompt the transport of Arc (Messaoudi et 
al., 2007; Panja et al., 2009; Steward et al., 1998) and Matrix Metalloproteinase 9 (MMP9) 
(Dziembowska et al., 2012) mRNAs into dendrites. Intrahippocampal infusion of BDNF also 
resulted in the accumulation of Arc transcripts in dendrites and triggered long-term potentiation 
(BDNF-LTP) at medial perforant path-granule cell synapses in vivo (Messaoudi et al., 2002; Ying 
et al., 2002).  
The medial perforant path fibers in the angular bundle were unilaterally stimulated and the 
evoked field excitatory postsynaptic potential (fEPSP) was recorded in the hilar region of the 
dentate gyrus (Fig. 4.6A, B). LTP was induced by spaced stimulation consisting of three sessions 
of HFS (4 trains of 400 Hz, eight pulses) with 5 min between sessions. This paradigm induces a 
robust and sustained increase in the fEPSP (Fig. 4.6C). The fEPSP is presented in percentage 
change from the baseline (Fig. 4.6C) and represents the slope measured between two points in 
the fEPSP (see methods for more details). To test whether TrkB signaling mediates the HFS-
induced LTP in vivo in the dentate gyrus, we took advantage of TrkB-Fc, an effective extracellular 
scavenger of TrkB ligands which has been widely used to access BDNF function in the CNS. 
Intrahippocampal infusion of TrkB-Fc (1 µl, 100 µg, 12.5 min) prior to HFS induces a selective 
impairment of HFS-induced increase in the evoked fEPSP measured in the hilar region of the 
dentate gyrus (Fig. 4.6D), indicating that TrkB signaling is required for the induction of this form of 
synaptic potentiation. Conversely, infusion of IgG-Fc (1 µl, 100 µg, 12.5 min) did not change 
significantly the non-decremental enhancement of the fEPSP induced by HFS (Fig. 4.6D). 
To investigate the effect of LTP induction in the interaction of hnRNP K with mRNAs the 
dentate gyrus was dissected 30 min after HFS as described above (at the end of experiments 
shown in Fig. 4.6C), and the tissue was processed for Western blot and co-immunoprecipitation 
assays. We evaluated putative changes in the interaction of hnRNP K with the mRNAs for GluA1, 
GluN1, hnRNP K and BDNF (two distinct sets of primers), and the effect of HFS on the total 
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content of the same transcripts in dentate gyrus homogenates. The effect of HFS-induced LTP in 
both total (Fig. 4.7A) and co-immunoprecipitated (Fig. 4.7B) RNAs was determined by qRT-PCR. 
HFS resulted in a massive increase in the total abundance of BDNF mRNA (Fig. 4.7A) and 
significantly increased total GluN1 mRNA levels (Fig. 4.7A), but no effect was observed for the 
total GluA1 and hnRNP K mRNA content (p>0.05). HFS decreased the hnRNP K mRNA levels 
associated with hnRNP K protein (Fig. 4.7B) suggesting that, as previously demonstrated in 
response to BDNF stimulation, synaptic activity induces the dissociation of hnRNP K-containing 
complexes. Interestingly, BDNF mRNA levels are increased in the co-immunoprecipitates 30 min 
post-HFS (Fig. 4.7B), but this is likely to be related with the massive increase in the total number 
of transcripts induced by synaptic potentiation (Fig. 4.7A). HFS also induced a small decrease in 
the interaction of hnRNP K with GluN1 mRNA, and slightly upregulated the interaction with GluA1 
transcripts, but these effects were not statistically significant. Control experiments showed no 
changes in total hnRNP K protein levels 30 min post-HFS (Fig. 4.7C) as determined by Western 
blot, indicating that the differences observed in the interaction with mRNAs are not due to 
alterations in the total amount of protein expressed. 
 
 
 
 119 
 
Regulation of hnRNP K and hnRNP K-associated mRNAs 
 
Figure 4.6 - TrkB activation is required for the induction of HFS-induced LTP in the dentate gyrus in 
vivo. Experiments were performed in live anesthetized rats. (A) The schematic represents the hippocampus 
on the left and right side of the forebrain. (B) The electrodes were positioned for selective unilateral 
stimulation of the medial perforant path fibers in the angular bundle and for recording the evoked field 
potentials in the hilar region of the dentate gyrus. (C) Time course plots showing changes in the medial 
perforant path-evoked fEPSP slope expressed in percentage of the baseline. Values are means ± SEM. Test 
pulses were applied at 0.033 Hz. The HFS paradigm (indicated by arrows) consisted of eight pulses of 400 
Hz, repeated four times at 10 s intervals. Three sessions of HFS were given at intervals of five min. n=6 for 
each time point. (D) Time course plots showing changes in the medial perforant path-evoked fEPSP in rats 
receiving TrkB-Fc (1µl, 100 µg, 12.5 min) or IgG-Fc (1µl, 100 µg, 12.5 min) infusion before HFS (arrows). 
Values are means ± SEM and are expressed in percentage of the baseline. Test pulses were applied at 
0.033 Hz. HFS was applied in three series of 400 Hz bursts separated by 5 min. TrkB-Fc (1µl, 100 µg) or 
IgG-Fc (1µl, 100 µg) were infused in the dorsal dentate gyrus at 0.08 µl/min during the period indicated by 
the black bar. Test pulses were not given during the HFS period. n=5 (TrkB-Fc infusion); n=1 (IgG-Fc 
infusion). A and B were adapted from (Panja et al., 2009). 
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Figure 4.7 - hnRNP K-associated mRNAs are differentially regulated during HFS-induced LTP in the 
dentate gyrus in vivo. (A) The variation of hnRNP K, GluA1, GluN1 and BDNF mRNA levels was assayed 
by qRT-PCR using total RNA samples obtained from dentate gyrus homogenates collected 30 min post-HFS 
(at the end of the experiments shown in Fig. 4.6C) and the non-stimulated contralateral control tissue. For 
the reverse transcription, 500 ng of total RNA was used. The results are presented as mean ± SEM 
normalized to the contralateral non-stimulated dentate gyrus and Hprt1 (hypoxanthine guanine 
phosphoribosyl transferase 1) was used as internal control gene. Results are the average ± SEM of 6 
experiments (n=6 DG) analysed in 3 independent preparations (2 DG were analysed together in each 
preparation). Two distinct sets of primers were used for BDNF (BDNF and BDNF cds). *** P<0.001; * 
P<0.05; as determined by the Student’s t-test. (B) The levels of hnRNP K, GluA1, GluN1 and BDNF 
transcripts co-immunoprecitated with hnRNP K were assayed by qRT-PCR. hnRNP K protein was 
immunoprecipitated from equal amounts (500 µg) of total extracts from homogenized dentate gyrus collected 
30 min post-HFS (at the end of the experiments shown in Fig. 4.6 C) and the contralateral tissue. 500 ng of 
co-immunoprecipitated RNA was used in the reverse transcription reaction. The results are presented as 
mean ± SEM normalized to the contralateral dentate gyrus and are the average ± SEM of 6 experiments 
(n=6 DG), as described above. Two distinct sets of primers were used for BDNF (BDNF and BDNF cds). ** 
P<0.01; * P<0.05; as determined by the Student’s t-test. (C) hnRNP K protein levels were measured by 
Western blot using dentate gyrus homogenate samples collected 30 min post-HFS (at the end of the 
experiments shown in Fig. 4.6C) and the contralateral non-stimulated tissue. The results are the average ± 
SEM of 6 experiments (n=6 DG), as described above, and are presented as the percentage change in 
hnRNP K protein levels in the treated dentate gyrus relative to the non-stimulated contralateral tissue. 
GAPDH was used as loading control. 
 
Using a similar approach we evaluated how hnRNP K and hnRNP K-bound mRNAs are 
regulated 2 h upon LTP induction in the medial perforant path-granule cell synapses. We 
observed that LTP induced by HFS was sustained for two hours (Fig. 4.8A). The levels of total 
(Fig. 4.8B) and co-immunoprecipitated (Fig. 4.8C) mRNA for hnRNP K, GluA1, GluN1, and BDNF 
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2h post-HFS were accessed by qRT-PCR. We observed a significant decrease in total GluA1 
mRNA levels and a striking increase in BDNF mRNA abundance (Fig. 4.8B), although in this case 
it did not reach statistical significance. All the co-immunoprecipitated mRNAs were apparently 
increased 2 h post-HFS (Fig. 4.8C), although the effects were not statistically significant, 
suggesting that the hnRNP K-bound mRNAs are differentially regulated during different stages of 
HFS-LTP. Western blot analysis of total extracts from dentate gyrus total homogenates showed 
that hnRNP K total protein levels did not change 2 h post-HFS (Fig. 4.8D), indicating that the 
differences observed in the interaction with mRNAs are not due to alterations in the total amount 
of protein expressed. 
 
 
Figure 4.8 - Regulation of hnRNP K-bound mRNAs at 2 h after induction of LTP in the dentate gyrus 
synapses in vivo. (A) Time course plots showing changes in the medial perforant path-evoked fEPSP slope 
before and after HFS. Values are means ± SEM and are represented as percentage from baseline. Test 
pulses were applied at 0.033 Hz. HFS (indicated by arrows) was applied in three series of 400 Hz bursts 
separated by 5 min. n=6 for each time point. (B) The variation of hnRNP K, GluA1, GluN1 and BDNF mRNA 
levels was assayed by qRT-PCR of total RNA samples obtained from dentate gyrus homogenates collected 
2 h post-HFS (at the end of experiments shown in A) and from the contralateral non-stimulated tissue. For 
the reverse transcription, 500 ng of total RNA was used. The results are presented as mean ± SEM 
normalized to the contralateral non-stimulated dentate gyrus and Hprt1 (hypoxanthine guanine 
phosphoribosyl transferase 1) was used as internal control gene. Results are the average ± SEM of 6 
experiments (n=6 DG) analysed in 3 independent preparations (2 DG were analysed together in each 
preparation). Two distinct sets of primers were used for BDNF (BDNF and BDNF cds). * P<0.05 as 
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determined by the Student’s t-test. (F) The levels of hnRNP K, GluA1, GluN1 and BDNF transcripts co-
immunoprecitated with hnRNP K were assayed by qRT-PCR. hnRNP K protein was immunoprecipitated 
from equal amounts (500 µg) of total extracts from homogenized dentate gyrus collected 2 h post-HFS (at 
the end of the experiments shown in A) and from the non-stimulated contralateral tissue. 500 ng of co-
immunoprecipitated RNA was used in the reverse transcription reaction. The results are presented as mean 
± SEM normalized to the contralateral dentate gyrus and are the average ± SEM of 6 experiments (n=6 DG), 
as described above. Two distinct sets of primers were used for BDNF (BDNF and BDNF cds). (D) hnRNP K 
protein levels were measured by Western blot using dentate gyrus homogenate samples collected 2 h post-
HFS (at the end of the experiments shown in A) and from the contralateral non-stimulated tissue. The results 
are the average ± SEM of 6 independent experiments (n=6 DG), as described above, and are presented as 
the percentage of change in hnRNP K expression in the treated dentate gyrus relative to the non-stimulated 
contralateral tissue. GAPDH was used as loading control. 
 
4.4. Discussion 
Herein, we showed a punctate distribution of hnRNP K in dendrites of hippocampal neurons 
consistent with the idea that the protein is present in neuronal mRNPs (Elvira et al., 2006). 
hnRNP K was partially localized in dendritic particles that also contain Staufen1 (Fig. 4.1A-white 
arrows, A’) further supporting the hypothesis that hnRNP K has a role in the dendritic transport of 
mRNAs. We further showed that hnRNP K is present at excitatory synapses under resting 
conditions in primary hippocampal neurons (Fig. 4.1B, B’) as previously demonstrated (Proepper 
et al., 2011). Whether the delivery of hnRNP K into synaptic sites was a constitutive or regulated 
process was unknown. Here we found that synaptic activity and BDNF induce the accumulation of 
hnRNP K in dendrites and in synaptic sites, as observed for hnRNP A2/B1 (Chapter 3) and other 
hnRNPs (Zhang et al., 2012). Studies performed in hippocampal synaptoneurosomes stimulated 
with BDNF showed a decrease in the interaction of hnRNP K with transcripts relevant in synaptic 
plasticity (GluA1, GluN1, BDNF and CaMKIIβ), suggesting a role for this ribonucleoprotein in the 
regulation of local protein synthesis required for the late phase of LTP. However, the interaction of 
hnRNP K with the transcripts investigated showed a more complex pattern of response when the 
protein was immunoprecipitated from the dentate gyrus after induction of LTP, possibly due to the 
increased complexity of the system. 
The results of the immunocytochemistry experiments showed that the hnRNP K puncta is only 
partly colocalized with Staufen 1, indicating that it is distributed in different types of structures 
along dendrites. Interestingly, although some proteins that associate with Staufen1 were not 
detected in hnRNP K-mRNPs in HEK293 cells (Brendel et al., 2004), Staufen1-mRNPs contain 
other hnRNPs (e.g. hnRNP U) that were found to interact with hnRNP K in adult rat hippocampus 
in the proteomic study that we performed (Table 4.1). These results, and the observation that not 
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all Staufen1 puncta present in dendrites colocalize with hnRNP K, suggest that Staufen1 is 
present in different types of granules. 
Quantitative immunocytochemistry experiments showed a rapid effect (30 min) of neuronal 
activity on the dendritic accumulation of hnRNP K, in contrast with a delayed response (3 h) 
resulting from the stimulation with BDNF. The rapid accumulation of hnRNP K in dendrites 
induced by neuronal activity was correlated with an increased accumulation at the synapse. 
Interestingly, treatment of hippocampal neurons with 100 ng/ml BDNF for 30 min increased the 
accumulation of hnRNP K at the synapse, although the results were not statistically significant, 
without affecting the total protein levels in dendrites. These results suggest that BDNF specifically 
regulates the synaptic-localized hnRNP K, but whether this effect is mediated by local protein 
synthesis remains to be determined. Considering the low percentage of hnRNP K that is 
expressed at the synapse, this mechanism may allow a significant upregulation in local hnRNP K 
protein levels without affecting the total protein content in dendrites. In fact, local translation was 
proposed to mediate the effects of BDNF on hnRNP K protein levels in synaptoneurosomes 
isolated from cultured cerebrocortical neurons (Liao et al., 2007). Alternatively, the BDNF-induced 
upregulation of hnRNP K protein levels at the synapse may be due a redistribution of the protein 
within the dendrites, so that the total protein content is not affected. When hippocampal neurons 
were incubated with BDNF for a longer period of time (3 h) there was a significant increase in 
hnRNP K puncta intensity and area in dendrites (Fig. 4.2E, F, G), suggesting the activation of 
distinct physiological responses. Additional studies are required to determine whether long 
incubations with BDNF also have an impact on hnRNP K protein accumulation at the synapse. 
Consistent with the idea that hnRNP K is specifically and differentially regulated in different 
compartments of the cell, synaptic activity did not change total hnRNP K protein levels, both in 
vitro and in vivo.  
Using a culture system that allows a physical separation of the soma and neurite 
compartment, we found that stimulation of cultured hippocampal neurons with BDNF did not 
change hnRNP K mRNA in both cell bodies and neurites. These findings indicate that most likely 
this neurotrophin does not regulate hnRNP K total mRNA levels in these subcellular 
compartments. Furthermore, no changes were observed in the total mRNA for hnRNP K in the 
dentate gyrus after induction of LTP in vivo. Taken together, these results suggest that the 
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expression of hnrnpk is not affected significantly by neuronal activity. The lack of effect of BDNF 
on the dendritic levels of hnRNP K mRNA contrasts with the effects observed for transcripts 
encoding several translation-related proteins (Manadas et al., 2009). 
Interestingly, KCl depolarization decreased hnRNP K total protein levels in primary 
hippocampal neurons (Fig. 4.3). Although the physiological significance of this observation may 
be questionable considering that KCl induces a permanent depolarization of the membrane, this 
result per se is a good indicator that hnRNP K is regulated in an activity-dependent manner. 
Previous results from our laboratory identified several transcripts associated with hnRNP K in 
cultured hippocampal neurons, such as the mRNAs encoding for hnRNP K, GluA1, GluN1 and 
BDNF (Comprido, 2011). Furthermore, BDNF was shown to induce the dissociation of these 
mRNAs from hnRNP K-containing ribonucleoprotein complexes in cultured hippocampal neurons 
(Comprido, 2011). Interestingly, stimulation with BDNF upregulates GluA1 (Schratt et al., 2004), 
hnRNP K and CaMKIIβ (Liao et al., 2007) protein levels in synaptoneurosomes. GluN1 mRNA is 
also among the RNAs that are present in both soma and dendrites (Benson, 1997; Gazzaley et 
al., 1997; Schratt et al., 2004) and is associated with RNA granules (Krichevsky and Kosik, 2001). 
The BDNF transcript is one of the best studied dendritic-localized mRNAs (see section 1.6.2). A 
recent study also identified the transcripts for CamKIIβ, GluN1, GluA1 and BDNF in dendrites 
and/or axons in hippocampal neuropil (Cajigas et al., 2012). Given these observations, and since 
hnRNP K is present at the synapse under resting conditions (Fig. 4.1B-white arrows, B’), we have 
also evaluated whether BDNF induces the release of these mRNAs from the hnRNP K-containing 
complexes in synaptoneurosomal fractions isolated from adult rat hippocampus. The results 
obtained show that BDNF prompts the dissociation of the GluA1, hnRNP K, GluN1, BDNF and 
CaMKIIẞ transcripts from the hnRNP K-carrying mRNPs locally at the synapse.  
In addition to the effects of BDNF on hnRNP K observed in this work, a previous study 
reported the effects of the neurotrophin in the dissociation of granules containing RNG105 (Shiina 
et al., 2005). Interestingly, as we observed for hnRNP K, RNG105 also colocalizes with Staufen 
proteins in dendrites of hippocampal neurons. BDNF induces the release of RNG105 from RNA 
granules and this effect is coincident with the translation of an mRNA reporter near the granules 
(Shiina et al., 2005). However, the translation of RNG105-associated mRNAs was still 
suppressed in the absence of RNG105 (Shiina et al., 2010), suggesting that translation 
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repression is not the primary role of RNG105. In fact, the RNG105-deficient mice showed reduced 
levels of RNG105-associated mRNAs in dendrites indicating a role for RNG105 in the dendritic 
localization of these mRNAs.  
hnRNP K is a well known regulator of translation (Bomsztyk et al., 2004). The protein was 
shown to activate the translation of silenced mRNAs upon c-Src-mediated phosphorylation 
(Ostareck-Lederer et al., 2002). Accordingly, the hnRNP K-mRNA complexes were disrupted by 
tyrosine phosphorylation of hnRNP K suggesting that the binding of hnRNP K to RNA may be 
responsive to extracellular stimuli that activate tyrosine kinases (Ostrowski et al., 2000). 
Considering that the signaling activity induced by BDNF in hippocampal neurons induces the 
phosphorylation of hnRNP K at Serine 302 (Comprido, 2011), it is tempting to propose a model in 
which the activation of TrkB receptors would induce the phosphorylation of hnRNP K with the 
concomitant release of hnRNP K-bound mRNAs from the hnRNP K-carrying mRNPs, allowing the 
local translation of these transcripts at the synapse. Future research is required to determine 
whether hnRNP K is involved in the dendritic delivery of these transcripts and/or in the 
translational control at the synapse. 
The landscape of hnRNP K protein-protein interactions is extensive and well described in 
several biological contexts (Bomsztyk et al., 2004; Mikula et al., 2006). In neurons though, with 
the exception of target oriented studies, it remains largely unknown. Herein, we showed that a 
large number of RNA-binding proteins and regulators may interact with hnRNP K in adult rat 
hippocampus (Table 4.1). It is therefore difficult to determine whether each of the mRNAs that co-
immunoprecipitated with hnRNP K bind directly or indirectly to the protein. Future studies should 
address this question, for instance by performing EMSA (electrophoretic mobility shift assay) 
experiments. Importantly, as previously demonstrated in rat hepatoma cells (Mikula et al., 2006), 
other hnRNPs were found to interact with hnRNP K in adult rat hippocampus (Table 4.1). Several 
of those hnRNPs and hnRNP K were identified in two of the largest proteomic studies performed 
until now that tried to unravel the protein composition of neuronal mRNPs (Elvira et al., 2006; 
Kanai et al., 2004), suggesting that hnRNP K, together with other hnRNP K-interacting hnRNPs, 
may constitute a core machinery for the transport of mRNA granules in neurons. 
A wide variety of ribosomal proteins were also found to interact with hnRNP K (Table 4.1) 
(Mikula et al., 2006) demonstrating the prominent role of this protein in the translational control. 
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Accordingly, it was demonstrated that hnRNP K together with hnRNP E1/2 regulates the 
recruitment of 60S ribosomal subunits to form a competent 80S ribosome to initiate the translation 
of 15-lipoxygenase (LOX) mRNA in reticulocytes (Ostareck et al., 2001; Ostareck et al., 1997)  
The proteomic study that we performed to analyse the hnRNP K interactome showed several 
new binding partners, which remain to be validated. Some of those are synaptic-localized proteins 
with well established functions in plasticity-related events such as CaMKIIα [for a review see 
(Coultrap and Bayer, 2012)] and cytoskeleton regulators. These observations contribute to the 
growing evidence suggesting a role for hnRNP K in the regulation of cytoskeleton composition. 
hnRNP K directly interacts with the regulator of actin dynamics, N-WASP via its KI domain (Yoo et 
al., 2006). This study showed that hnRNP K negatively regulates N-WASP-induced cell spreading 
and filopodia formation in mouse fibroblasts (Yoo et al., 2006). Furthermore, it was recently 
demonstrated that hnRNP K interacts with Abelson-interacting protein 1 (Abi1) at postsynaptic 
sites in hippocampal neurons (Proepper et al., 2011). Abi1 is localized in dendritic spines and 
postsynaptic densities (PSDs) where it plays an important role in regulating cytoskeleton 
reorganization and synaptic maturation (Courtney et al., 2000). Accordingly, hnRNP K knockdown 
results in a significant increase in filopodia formation and decrease in the number of mature 
synapses, an effect that mimics the neuronal morphology in the absence of Abi1 (Proepper et al., 
2011). Furthermore, hnRNP K was shown to post-transcriptionally regulate multiple transcripts 
that collectively organize microfilaments, microtubules, and neuronal intermediate filaments to 
make the axon (Liu and Szaro, 2011). Altogether, our results highlight a possible major role of 
hnRNP K in the regulation of local mRNA metabolism and/or cytoskeleton regulation at the 
synapse. 
In the final set of experiments we provide direct evidence that synaptic activity regulates the 
mRNA content of hnRNP K-containing mRNPs in vivo. We found that the LTP paradigm that we 
used induces a massive increase in the total abundance of BDNF mRNA in total extracts of 
dentate gyrus homogenates and chelation of extracellular BDNF with TrkB-Fc reduced synaptic 
potentiation induced by high-frequency stimulation. These observations are in agreement with the 
key role that this neurotrophin plays in this form of synaptic plasticity (Minichiello, 2009). Several 
activity-inducing paradigms were shown to promote the release of endogenous BDNF (Kuczewski 
et al., 2009; Lessmann and Brigadski, 2009), including the response to high-frequency stimulation 
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(Aicardi et al., 2004). Furthermore, BDNF was shown to play an important role in the protein 
synthesis-dependent late phase of LTP induced by high-frequency stimulation in the 
hippocampus CA1 region (Chen et al., 1999; Kang and Schuman, 1996) and BDNF-induced 
synaptic potentiation has also been reported, both in vitro (Kang and Schuman, 1996) and in vivo 
(Messaoudi et al., 2002; Ying et al., 2002). Accordingly, BDNF is required for the maintenance of 
LTP in the CA1 region of the hippocampus (Figurov et al., 1996; Korte et al., 1998; Minichiello et 
al., 2002).  
Induction of LTP in the dentate gyrus in vivo also resulted in a significant increase in the total 
mRNA levels of GluN1, when determined 30 min after high-frequency stimulation. Importantly, 
under the same conditions there was a decrease in the levels of hnRNP K and GluN1 transcripts 
associated with hnRNP K, although the effect was not statistically significant in the latter case. 
These results are in agreement with the observations in hippocampal synaptoneuronsomes 
stimulated with BDNF. In contrast with these results, 2 h upon HFS all the hnRNP K-associated 
mRNAs are increased in the hnRNP K-containing complexes, although the effect is not 
statistically significant for the number of experiments performed. Given the role of TrkB signaling 
in the induction of this form of synaptic potentiation, and although our analysis was performed in 
total homogenates, it is tempting to speculate that BDNF may contribute to the regulation of 
hnRNP K and hnRNP K-bound mRNAs at the synapse at the early phase after high-frequency 
stimulation. The effect of BDNF may be mediated by increasing the delivery of hnRNP K into 
synapses, as we observed in cultured hippocampal neurons, and by inducing the release of 
hnRNP K-bound mRNAs from the mRNPs, as we observed in synaptoneurosomes. The observed 
increase in all hnRNP K-bound mRNAs 2 h post-HFS may be secondary to the initial increase in 
transcription activity and/or due to the desensitization of the signaling mechanisms that account 
for the initial decrease in the interaction of hnRNP K with the transcripts. Since stimulation of 
cultured hippocampal neurons provides a simple system to investigate the regulation of the 
interaction between hnRNP K and the associated transcripts, it will be interesting to determine 
whether long incubations (2-3 h) with BDNF also change the pattern of interaction of hnRNP K 
with the transcripts. Further analysis of dentate gyrus homogenates obtained after the TrkB-Fc 
infusion experiments should also elucidate about the role of BDNF in the HFS-induced regulation 
of hnRNP K-associated transcripts. 
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4.5. Conclusions 
In this work we demonstrate that synaptic activity and the neurotrophin BDNF regulate hnRNP 
K and hnRNP K-bound mRNAs in vitro and in vivo. We showed that hnRNP K partly colocalizes 
with Staufen1 in dendrites of hippocampal neurons further demonstrating a role for hnRNP K in 
the transport of dendritic-localized transcripts. In addition, hnRNP K is rapidly delivered into 
synapses in response to neuronal activation. Moreover, studies performed in hippocampal 
synaptoneurosomes showed that several hnRNP K-bound mRNAs, such as the transcripts for 
GluN1, GluA1 and BDNF, are released from hnRNP K-containing mRNPs in response to 
stimulation with BDNF. These results suggest a key role for hnRNP K in the local translation of 
several proteins that contribute to the late phase of LTP. Accordingly, we found that the hnRNP K 
and possibly the GluN1 mRNAs are dissociated from the hnRNP K-carrying mRNPs in the early 
phase of HFS-induced LTP in the medial perforant path-granule cells synapses, a phenomenon 
that is dependent on extracellular BDNF. Altogether, the evidence here reported suggests a 
fundamental role for hnRNP K in the regulation of neuronal function and is likely to play a role in 
BDNF-mediated plasticity events. 
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The present work has focused on two members of the hnRNP family of proteins and overall, 
we provide evidence indicating that hnRNPs, besides the well established functions in the 
nucleus, may also play a prominent role in the regulation of dendritic mRNA metabolism in the 
central nervous system. 
 
5.1. General conclusions and open questions 
5.1.1. Regulation of the activity-dependent accumulation of hnRNP A2/B1 in 
dendrites and synapses 
 
We found that the delivery of hnRNP A2/B1 into dendrites and synaptic sites is a regulated 
process since both synaptic activity and BDNF treatment increased hnRNP A2/B1 levels in 
dendrites and at the synapse in cultured hippocampal neurons. Importantly, we showed that 
synaptic activity induces the delivery of hnRNP A2/B1 into synaptic sites by a mechanism that 
depends on endogenous released BDNF. In contrast, the activity-dependent increase in dendritic 
hnRNP A2/B1 was not affected by the TrkB-Fc-mediated blocking of extracellular ligands of TrkB 
receptors, indicating that this effect does not require the actions of BDNF. Whether these effects 
depend on the redistribution of preexisting hnRNP A2/B1 or require new protein synthesis is 
unknown. To answer this question, additional experiments should be performed in the presence 
of inhibitors of translation to evaluate the relative contribution of protein synthesis to the observed 
effects. Furthermore, it will be of interest to dissect the mechanisms involved in the activity-
dependent changes in the distribution of this ribonucleoprotein. The use of pharmacological 
inhibitors of AMPA and NMDA receptors would allow evaluating the relative contribution of these 
receptors in the dendritic and synaptic accumulation of hnRNP A2/B1 following neuronal 
activation. Since BDNF mediates the activity-dependent increase of hnRNP A2/B1 in synaptic 
sites, it would be also important to dissect the signaling pathways (e.g. using pharmacological 
inhibitors) required for the BDNF-induced accumulation of hnRNP A2/B1 in dendrites and, in 
particular, at the synapse. 
The immunocytochemistry experiments also showed that hnRNP A2/B1 and Staufen1 are 
likely to be present, to some extent, in the same subset of dendritic mRNPs in cultured 
hippocampal neurons. Interestingly, we also found that Staufen1, in contrast with hnRNP A2/B1, 
Chapter 5 
132 
was present in synaptic polysomal fractions which, to our knowledge, provides the first evidence 
suggesting a role for Staufen1 in the translational control of synaptic-localized mRNAs. 
 
5.1.2. Regulation of hnRNP K distribution in neurons 
We observed that hnRNP K is present in dendritic processes and in synaptic sites under 
resting conditions in cultured hippocampal neurons. Furthermore, the hnRNP K distribution was 
found to be regulated by synaptic activity and by the neurotrophin BDNF. The results show that, 
as observed for hnRNP A2/B1, synaptic activity upregulates hnRNP K protein levels in dendrites 
and in synaptic sites. Interestingly, short-term stimulation with BDNF did not change dendritic 
levels of hnRNP K but induced the delivery of the protein to synapses. A sustained activation of 
TrkB receptors was required to increase hnRNP K in dendrites, suggesting that short or long 
incubations with BDNF result in distinct physiological responses. As previously mentioned for 
hnRNP A2/B1, it is currently unknown whether these changes in hnRNP K levels in dendrites and 
at the synapse result from the redistribution of pre-existing hnRNP K or instead require new 
hnRNP K synthesis. To test this hypothesis, experiments should be performed in the presence of 
protein synthesis inhibitors. Moreover, it will be of interest to investigate the mechanisms by which 
synaptic activity and BDNF differentially regulate hnRNP K distribution. This can be addressed 
using pharmacological inhibitors of AMPA and NMDA receptors to unravel if the activation of 
these receptors contributes to the delivery of hnRNP K into dendrites and synapses following 
neuronal activation. Furthermore, as previously shown for hnRNP A2/B1, we are currently 
investigating the role of endogenous released BDNF in the activity-dependent synaptic delivery of 
hnRNP K, using the scavenger of TrkB ligands TrkB-Fc. 
 
5.1.3. The nature of hnRNP A2/B1 and hnRNP K ribonucleoprotein complexes 
One of the major questions in the field is related to the nature and composition of the mRNPs 
involved in the transport of mRNA to distal dendritic domains. It is thought that the transport 
mRNPs may be in a close interplay with other types of RNA granules. This hypothesis was raised 
after the findings suggesting that neuronal mRNPs and P-bodies may share some structural 
features. For instance, some trans-acting proteins usually involved in mRNA transport, such as 
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FMRP and ZBP, were identified in P-bodies (Cougot et al., 2008). Furthermore, a recent study 
reported the activity-dependent accumulation of neuronal P-bodies (usually involved in mRNA 
degradation or storage) in synaptic sites with a concomitant release of mRNA (Oh et al., 2013). 
More interestingly, in contrast with previous findings (Zeitelhofer et al., 2008), it was suggested 
that Staufen1 may also belong to the group of proteins with roles in mRNA transport present in 
mammalian neuronal P-bodies (Oh et al., 2013). 
In this work we observed that both hnRNP A2/B1 and hnRNP K can, to some extent, localize 
in dendritic particles that also contain Staufen1. Since Staufen1 is a well known player in the 
dendritic-transport of mRNA, these findings per se indicate that both hnRNPs play a role in this 
process. This is well established for hnRNP A2/B1 but little evidence is available for hnRNP K. 
We have performed a proteomic study to identify hnRNP K-interacting proteins in adult rat 
hippocampus. The results suggested an interaction between hnRNP K and hnRNP A2/B1. 
However, we could not confirm this interaction by Western blot analysis of the hnRNP K 
immunoprecipitates. In the future it will be important to investigate whether these two hnRNPs are 
found in the same structures in dendrites of hippocampal neurons, and if hnRNP K and/or hnRNP 
A2/B1 are present in silent-foci that respond to synaptic stimulation. Experiments should be 
performed to analyse the colocalization between hnRNP A2/B1 and hnRNP K, or between both 
proteins and markers of P-bodies, in dendrites of cultured hippocampal neurons. In addition, the 
transfection of hnRNP K and/or hnRNP A2/B1 constructs into hippocampal neurons will allow 
performing live-cell imaging to evaluate whether synaptic activation or BDNF stimulation increase 
the motility of exogenous hnRNP K and/or hnRNP A2/B1. This approach will also provide a 
valuable tool to visualize and evaluate the kinetics of the activity-dependent delivery of these 
proteins into the synapse. Since the putative role of hnRNP K in the delivery of mRNAs into 
dendritic domains in neurons remains to be proved, it will be of interest to generate contructs 
lacking the KHs (KH1, KH2, and KH3) or the KI domains to investigate if the results obtained 
depend on the binding to mRNA or other proteins, respectively. 
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5.1.4. Regulation of dendritic and synaptic mRNA by hnRNP K 
The present work showed that hnRNP K associates with several transcripts with important 
roles in synaptic plasticity. More importantly, we showed that BDNF stimulation induces the 
release of these transcripts at the synapse. Since hnRNP K accumulates in dendrites and at the 
synapse upon synaptic activation, and likely also following BDNF stimulation, it will be of interest 
to perform in situ hybridization experiments targeting some of the hnRNP K-bound transcripts (for 
instance BDNF, GluA1 or GluN1), together with immunocytochemistry using an antibody against 
hnRNP K, to investigate the colocalization of the mRNAs with hnRNP K in dendrites of 
hippocampal neurons. This approach will allow evaluating if BDNF treatment or synaptic activity 
preferentially disrupts hnRNP K-mRNA interactions in synaptic processes. To evaluate whether 
hnRNP K is required for the dendritic transport and/or synaptic delivery of these transcripts 
experiments can be performed knocking down hnRNP K (e.g. using siRNAs or shRNAs) in 
hippocampal neurons followed by in situ hybridization to detect the selected hnRNP K-bound 
mRNAs. Quantification of the amount of mRNA in dendrites and at the synapse (e.g. 
colocalization with PSD95) would provide valuable information about the role of the protein in the 
dendritic transport and synaptic delivery of these transcripts. To test our working hypothesis, 
hnRNP K may also be overexpressed to determine if the expected increase in the dendritic- 
and/or synaptic-localized mRNAs occurs.  
It is important to note that, at the moment, it remains to be determined whether hnRNP K binds 
directly the hnRNP K-bound transcripts that we have identified. EMSA (electrophoretic mobility 
shift assay) experiments will further elucidate the nature of the interaction between hnRNP K and 
mRNAs. 
 
5.1.5. Does hnRNP K regulate the translation of the selected hnRNP K-bound 
mRNAs? 
 
hnRNPs are involved in several aspects of mRNA metabolism, including the translational 
control of transcripts (Han et al., 2010). We did not detect hnRNP A2/B1 in polysomal fractions 
obtained from synaptoneurosomes isolated from the rat brain, suggesting that hnRNP A2/B1 is 
not present in the functional units of protein synthesis at the synapse. These results suggest that 
hnRNP A2/B1 does not play a role in the translation control of synaptic-localized mRNAs. 
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Since hnRNP K has been shown to play a role in the regulation of translation (Bomsztyk et al., 
2004) and we observed that hnRNP K-bound mRNAs are released from hnRNP K-carrying 
complexes locally at the synapse in response to BDNF, it is tempting to speculate that hnRNP K 
may be controlling the translation of its associated mRNAs. First, it will be important to determine 
whether hnRNP K is present in synaptic polysomes. Additional studies can be performed to 
further evaluate the possible role of hnRNP K in translation regulation. For instance, hnRNP K 
knockdown experiments will allow investigating the role of the protein in the regulation of the total 
rate of translation in neurons (e.g. using a general luciferase reporter). This question may be 
addressed using a recently developed methodology with a metabolic labeling approach based on 
incorporation of noncanonical amino acids into proteins followed by chemoselective fluorescence 
tagging by means of ‘click chemistry’ (Dieterich et al., 2010). This method enables the observation 
of new proteins in both soma and dendrites and has already been used to demonstrate that 
BDNF induces the synthesis of new proteins in dendrites (Dieterich et al., 2010). This method 
would allow comparing translation in dendrites in the presence or in the absence of hnRNP K, and 
determining the effect of BDNF stimulation. However, this type of strategy does not allow 
distinguishing between hnRNP K specific targets. For that purpose it would be necessary to 
generate luciferase reporter constructs containing the sequences of specific hnRNP K-bound 
mRNAs and perform luciferase reporter assays. Since one of hnRNP K-bound mRNAs is BDNF, 
experiments may be performed to knockdown hnRNP K and transfect the d2EGFP-long 3’UTR 
BDNF construct into hippocampal neurons. This reporter harbors a membrane insertion tag for 
limiting diffusion of newly synthesized d2EGFP from the site of translation, and was recently used 
to evaluate the activity-dependent translation of BDNF in dendrites (Lau et al., 2010). Although 
this is very challenging from an experimental point of view, it may provide an insight into the role 
of hnRNP K in the activity-dependent dendritic translation of BDNF. It is important to note that, as 
previously mentioned, it is still not known if hnRNP K binds directly the BDNF mRNA and, despite 
the majority of translational control elements being localized in the 3’UTR, other regulatory 
elements may also be present in other regions. This may be tested using other BDNF constructs, 
containing distinct sequences (e.g. coding sequence). 
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5.1.6. Do the HFS-induced changes in hnRNP K-bound mRNAs require BDNF? 
In the last set of experiments we showed that hnRNP K-associated mRNAs are differentially 
regulated upon HFS-induced LTP in the dentate gyrus of live anesthetized rats, a model of 
synaptic potentiation that requires TrkB signaling. Given the almost lack of in vivo studies in 
dendritic mRNA metabolism research, this represents an important contribution to the field. 
We found that hnRNP K mRNA is released from hnRNP K-carrying ribonucleoprotein 
complexes in dentate gyrus homogenates 30 min after LTP-induction in vivo, but whether this 
dissociation is prompt by BDNF is at the moment unknown. Analysis of the dentate gyrus 
homogenates obtained from the animals injected with the TrkB-Fc chimera should allow 
addressing this question  
Interestingly, although the changes were not statistically significant, no clear differences were 
observed in the regulation pattern of hnRNP K-associated mRNAs 2 h post-HFS, where 
apparently all the tested hnRNP K-bound mRNAs were increased.  
An important question is related to the localization in the cell of the alterations in hnRNP K 
binding to mRNAs after induction of LTP. The use of synaptic fractions may provide an insight 
about the compartment where these changes occur, increasing the functional relevance of these 
findings, but the amount of tissue that can be obtained may constitute a limitation. 
 
5.1.7. hnRNP K-mediated regulation of synaptic function 
A recent study demonstrated that hnRNP K interacts with Abi1 in postsynaptic sites in 
hippocampal neurons (Proepper et al., 2011). Abi1 is an actin-cytoskeleton regulator protein 
enriched in dendritic spines. Accordingly, hnRNP K and Abi1 are required for normal spine 
morphology (Proepper et al., 2011). Our proteomic study suggested several new binding partners 
for hnRNP K in adult hippocampus. Among those were proteins with well established roles at the 
synapse and/or in the regulation of cytoskeleton, supporting the idea that hnRNP K may have 
other functions in neurons that might not dependent on its ability to bind mRNA. This is also in 
agreement with the versatile structure of hnRNP K. Additional immunoprecipitation studies are 
required to confirm the interaction between hnRNP K and other proteins suggested by our 
proteomic study. The functional relevance of these findings also deserves further investigation. 
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Knockdown of hnRNP K was shown to reduce the number of mature synapses in hippocampal 
neurons (Proepper et al., 2011) but whether this affects the number of functional synapses 
remains to be determined. This possibility may be evaluated by knocking down hnRNP K and 
evaluating the surface levels of GluA1 in hippocampal neurons. Complementary experiments may 
be performed using whole-cell patch clamp recordings of AMPA receptor-mediated miniature 
excitatory postsynaptic currents (mEPSCs), in the CA1 region of organotypic cultures subjected to 
lentiviral-mediated siRNA knockdown of hnRNP K. Similarly, it would be also possible and 
challenging to perform the lentiviral-mediated siRNA knockdown of hnRNP K in vivo in the 
dentate gyrus of rats. This would allow to test whether hnRNP K is required for the induction, 
persistence and/or maintenance of the HFS-induced form of synaptic potentiation in the perforant 
path-dentate gyrus synapse. 
 
Altogether, the findings reported in this thesis strongly support a scenario where both hnRNP 
A2/B1 and hnRNP K regulate mRNA metabolism in dendrites, which is likely to play a role in 
BDNF-mediated synaptic plasticity. 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 
References 
 

 141 
 
References 
Aakalu, G., Smith, W. B., Nguyen, N., Jiang, C., Schuman, E. M., 2001. Dynamic visualization of local 
protein synthesis in hippocampal neurons. Neuron 30, 489-502. 
 
Abdelmohsen, K., Hutchison, E. R., Lee, E. K., Kuwano, Y., Kim, M. M., Masuda, K., Srikantan, S., Subaran, 
S. S., Marasa, B. S., Mattson, M. P., Gorospe, M., 2010. miR-375 inhibits differentiation of neurites by 
lowering HuD levels. Mol Cell Biol 30, 4197-4210. 
 
Adachi, N., Kohara, K., Tsumoto, T., 2005. Difference in trafficking of brain-derived neurotrophic factor 
between axons and dendrites of cortical neurons, revealed by live-cell imaging. BMC Neurosci 6, 42. 
 
Adams, J. P., Dudek, S. M., 2005. Late-phase long-term potentiation: getting to the nucleus. Nat Rev 
Neurosci 6, 737-743. 
 
Aicardi, G., Argilli, E., Cappello, S., Santi, S., Riccio, M., Thoenen, H., Canossa, M., 2004. Induction of long-
term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-
derived neurotrophic factor. Proc Natl Acad Sci U S A 101, 15788-15792. 
 
Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., Timmusk, T., 2007. Mouse and rat BDNF gene structure and 
expression revisited. J Neurosci Res 85, 525-535. 
 
Ainger, K., Avossa, D., Diana, A. S., Barry, C., Barbarese, E., Carson, J. H., 1997. Transport and localization 
elements in myelin basic protein mRNA. J Cell Biol 138, 1077-1087. 
 
Alder, J., Thakker-Varia, S., Crozier, R. A., Shaheen, A., Plummer, M. R., Black, I. B., 2005. Early 
presynaptic and late postsynaptic components contribute independently to brain-derived neurotrophic factor-
induced synaptic plasticity. J Neurosci 25, 3080-3085. 
 
Alonso, M., Medina, J. H., Pozzo-Miller, L., 2004. ERK1/2 activation is necessary for BDNF to increase 
dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem 11, 172-178. 
 
Amaral, D., Lavenex, P., 2007. Hippocampal neuroanatomy. In: Andersen, P., Morris, R., Amaral, D., Bliss, 
T., O'Keefe, J., (Eds), The Hippocampus book. Oxford University Press, New York, pp. 37-114. 
 
Amaral, D. G., Scharfman, H. E., Lavenex, P., 2007. The dentate gyrus: fundamental neuroanatomical 
organization (dentate gyrus for dummies). Prog Brain Res 163, 3-22. 
 
Amaral, M. D., Pozzo-Miller, L., 2007. TRPC3 channels are necessary for brain-derived neurotrophic factor 
to activate a nonselective cationic current and to induce dendritic spine formation. J Neurosci 27, 5179-5189. 
 
An, J. J., Gharami, K., Liao, G. Y., Woo, N. H., Lau, A. G., Vanevski, F., Torre, E. R., Jones, K. R., Feng, Y., 
Lu, B., Xu, B., 2008. Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in 
hippocampal neurons. Cell 134, 175-187. 
 
Anderson, P., Kedersha, N., 2006. RNA granules. J Cell Biol 172, 803-808. 
 
Andreassi, C., Riccio, A., 2009. To localize or not to localize: mRNA fate is in 3'UTR ends. Trends Cell Biol 
19, 465-474. 
 
Aoki, C., Wu, K., Elste, A., Len, G., Lin, S., McAuliffe, G., Black, I. B., 2000. Localization of brain-derived 
neurotrophic factor and TrkB receptors to postsynaptic densities of adult rat cerebral cortex. J Neurosci Res 
59, 454-463. 
 
Atwal, J. K., Massie, B., Miller, F. D., Kaplan, D. R., 2000. The TrkB-Shc site signals neuronal survival and 
local axon growth via MEK and P13-kinase. Neuron 27, 265-277. 
 
Bagni, C., Mannucci, L., Dotti, C. G., Amaldi, F., 2000. Chemical stimulation of synaptosomes modulates 
alpha -Ca2+/calmodulin-dependent protein kinase II mRNA association to polysomes. J Neurosci 20, RC76. 
 
Baj, G., Leone, E., Chao, M. V., Tongiorgi, E., 2011. Spatial segregation of BDNF transcripts enables BDNF 
to differentially shape distinct dendritic compartments. Proc Natl Acad Sci U S A 108, 16813-16818. 
 
Bajenova, O., Stolper, E., Gapon, S., Sundina, N., Zimmer, R., Thomas, P., 2003. Surface expression of 
heterogeneous nuclear RNA binding protein M4 on Kupffer cell relates to its function as a carcinoembryonic 
antigen receptor. Exp Cell Res 291, 228-241. 
 
Balkowiec, A., Katz, D. M., 2002. Cellular mechanisms regulating activity-dependent release of native brain-
derived neurotrophic factor from hippocampal neurons. J Neurosci 22, 10399-10407. 
Chapter 6 
142 
 
Bannai, H., Fukatsu, K., Mizutani, A., Natsume, T., Iemura, S., Ikegami, T., Inoue, T., Mikoshiba, K., 2004. 
An RNA-interacting protein, SYNCRIP (heterogeneous nuclear ribonuclear protein Q1/NSAP1) is a 
component of mRNA granule transported with inositol 1,4,5-trisphosphate receptor type 1 mRNA in neuronal 
dendrites. J Biol Chem 279, 53427-53434. 
 
Barde, Y. A., Edgar, D., Thoenen, H., 1982. Purification of a new neurotrophic factor from mammalian brain. 
EMBO J 1, 549-553. 
 
Bassell, G. J., Warren, S. T., 2008. Fragile X syndrome: loss of local mRNA regulation alters synaptic 
development and function. Neuron 60, 201-214. 
 
Batish, M., van den Bogaard, P., Kramer, F. R., Tyagi, S., 2012. Neuronal mRNAs travel singly into 
dendrites. Proc Natl Acad Sci U S A 109, 4645-4650. 
 
Belelovsky, K., Elkobi, A., Kaphzan, H., Nairn, A. C., Rosenblum, K., 2005. A molecular switch for 
translational control in taste memory consolidation. Eur J Neurosci 22, 2560-2568. 
 
Benson, D. L., 1997. Dendritic compartmentation of NMDA receptor mRNA in cultured hippocampal neurons. 
Neuroreport 8, 823-828. 
 
Berentsen, B., 2009. microRNA-34a Function in Long-Term Potentiation in the Dentate Gyrus of the 
Anaesthetised Rat. Department of Biomedicine. University of Bergen, Bergen. 
 
Blichenberg, A., Rehbein, M., Muller, R., Garner, C. C., Richter, D., Kindler, S., 2001. Identification of a cis-
acting dendritic targeting element in the mRNA encoding the alpha subunit of Ca2+/calmodulin-dependent 
protein kinase II. Eur J Neurosci 13, 1881-1888. 
 
Bliss, T. V., Collingridge, G. L., 1993. A synaptic model of memory: long-term potentiation in the 
hippocampus. Nature 361, 31-39. 
 
Bliss, T. V., Lomo, T., 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the 
anaesthetized rabbit following stimulation of the perforant path. J Physiol 232, 331-356. 
 
Bockers, T. M., Segger-Junius, M., Iglauer, P., Bockmann, J., Gundelfinger, E. D., Kreutz, M. R., Richter, D., 
Kindler, S., Kreienkamp, H. J., 2004. Differential expression and dendritic transcript localization of Shank 
family members: identification of a dendritic targeting element in the 3' untranslated region of Shank1 mRNA. 
Mol Cell Neurosci 26, 182-190. 
 
Bomsztyk, K., Denisenko, O., Ostrowski, J., 2004. hnRNP K: one protein multiple processes. Bioessays 26, 
629-638. 
 
Bosch, M., Hayashi, Y., 2012. Structural plasticity of dendritic spines. Curr Opin Neurobiol 22, 383-388. 
 
Bourne, J. N., Harris, K. M., 2008. Balancing structure and function at hippocampal dendritic spines. Annu 
Rev Neurosci 31, 47-67. 
 
Bourne, J. N., Harris, K. M., 2011. Coordination of size and number of excitatory and inhibitory synapses 
results in a balanced structural plasticity along mature hippocampal CA1 dendrites during LTP. 
Hippocampus 21, 354-373. 
 
Bramham, C. R., Alme, M. N., Bittins, M., Kuipers, S. D., Nair, R. R., Pai, B., Panja, D., Schubert, M., Soule, 
J., Tiron, A., Wibrand, K., 2010. The Arc of synaptic memory. Exp Brain Res 200, 125-140. 
 
Bramham, C. R., Messaoudi, E., 2005. BDNF function in adult synaptic plasticity: the synaptic consolidation 
hypothesis. Prog Neurobiol 76, 99-125. 
 
Bramham, C. R., Wells, D. G., 2007. Dendritic mRNA: transport, translation and function. Nat Rev Neurosci 
8, 776-789. 
 
Brendel, C., Rehbein, M., Kreienkamp, H. J., Buck, F., Richter, D., Kindler, S., 2004. Characterization of 
Staufen 1 ribonucleoprotein complexes. Biochem J 384, 239-246. 
 
Cajigas, I. J., Tushev, G., Will, T. J., tom Dieck, S., Fuerst, N., Schuman, E. M., 2012. The local 
transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging. Neuron 74, 
453-466. 
 
 143 
 
References 
Caldeira, M. V., Melo, C. V., Pereira, D. B., Carvalho, R., Correia, S. S., Backos, D. S., Carvalho, A. L., 
Esteban, J. A., Duarte, C. B., 2007a. Brain-derived neurotrophic factor regulates the expression and synaptic 
delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal 
neurons. J Biol Chem 282, 12619-12628. 
 
Caldeira, M. V., Melo, C. V., Pereira, D. B., Carvalho, R. F., Carvalho, A. L., Duarte, C. B., 2007b. BDNF 
regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci 
35, 208-219. 
 
Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G. M., Carnemolla, B., Orecchia, P., Zardi, L., 
Righetti, P. G., 2004. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. 
Electrophoresis 25, 1327-1333. 
 
Cao, W., Razanau, A., Feng, D., Lobo, V. G., Xie, J., 2012. Control of alternative splicing by forskolin 
through hnRNP K during neuronal differentiation. Nucleic Acids Res 40, 8059-8071. 
 
Carson, J. H., Kwon, S., Barbarese, E., 1998. RNA trafficking in myelinating cells. Curr Opin Neurobiol 8, 
607-612. 
 
Carvalho, A. L., Caldeira, M. V., Santos, S. D., Duarte, C. B., 2008. Role of the brain-derived neurotrophic 
factor at glutamatergic synapses. Br J Pharmacol 153 Suppl 1, S310-324. 
 
Chao, M. V., 2003. Neurotrophins and their receptors: a convergence point for many signalling pathways. 
Nat Rev Neurosci 4, 299-309. 
 
Chekulaeva, M., Filipowicz, W., 2009. Mechanisms of miRNA-mediated post-transcriptional regulation in 
animal cells. Curr Opin Cell Biol 21, 452-460. 
 
Chen, G., Kolbeck, R., Barde, Y. A., Bonhoeffer, T., Kossel, A., 1999. Relative contribution of endogenous 
neurotrophins in hippocampal long-term potentiation. J Neurosci 19, 7983-7990. 
 
Chen, L. Y., Rex, C. S., Casale, M. S., Gall, C. M., Lynch, G., 2007. Changes in synaptic morphology 
accompany actin signaling during LTP. J Neurosci 27, 5363-5372. 
 
Chen, N., Schors, R. C. v., Smit, A. B., 2011. A 1D-PAGE/LC-ESI Linear Ion Trap Orbitrap MS Approach for 
the Analysis of Synapse Proteomes and Synaptic Protein Complexes. In: Li, K. W., (Ed), Neuroproteomics. 
Humana Press, pp. 159-167. 
 
Chiaruttini, C., Sonego, M., Baj, G., Simonato, M., Tongiorgi, E., 2008. BDNF mRNA splice variants display 
activity-dependent targeting to distinct hippocampal laminae. Mol Cell Neurosci 37, 11-19. 
 
Chiaruttini, C., Vicario, A., Li, Z., Baj, G., Braiuca, P., Wu, Y., Lee, F. S., Gardossi, L., Baraban, J. M., 
Tongiorgi, E., 2009. Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A 
(Val66Met) mutation. Proc Natl Acad Sci U S A 106, 16481-16486. 
 
Chotiner, J. K., Khorasani, H., Nairn, A. C., O'Dell, T. J., Watson, J. B., 2003. Adenylyl cyclase-dependent 
form of chemical long-term potentiation triggers translational regulation at the elongation step. Neuroscience 
116, 743-752. 
 
Cohen, M. S., Bas Orth, C., Kim, H. J., Jeon, N. L., Jaffrey, S. R., 2011. Neurotrophin-mediated dendrite-to-
nucleus signaling revealed by microfluidic compartmentalization of dendrites. Proc Natl Acad Sci U S A 108, 
11246-11251. 
 
Cohen, S., Levi-Montalcini, R., Hamburger, V., 1954. A Nerve Growth-Stimulating Factor Isolated from 
Sarcom as 37 and 180. Proc Natl Acad Sci U S A 40, 1014-1018. 
 
Comprido, D., 2011. Regulation of heterogeneous nuclear Ribonucleoprotein K (hnRNP K) by BDNF: 
changes in mRNA binding as determined by microarray analysis. University of Coimbra, Coimbra. 
 
Costa-Mattioli, M., Sossin, W. S., Klann, E., Sonenberg, N., 2009. Translational control of long-lasting 
synaptic plasticity and memory. Neuron 61, 10-26. 
 
Cougot, N., Bhattacharyya, S. N., Tapia-Arancibia, L., Bordonne, R., Filipowicz, W., Bertrand, E., Rage, F., 
2008. Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal 
activation. J Neurosci 28, 13793-13804. 
 
Chapter 6 
144 
Coultrap, S. J., Bayer, K. U., 2012. CaMKII regulation in information processing and storage. Trends 
Neurosci 35, 607-618. 
 
Courtney, K. D., Grove, M., Vandongen, H., Vandongen, A., LaMantia, A. S., Pendergast, A. M., 2000. 
Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous 
system. Mol Cell Neurosci 16, 244-257. 
 
Crowder, R. J., Freeman, R. S., 1998. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary 
and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 18, 2933-
2943. 
 
Cull-Candy, S., Kelly, L., Farrant, M., 2006. Regulation of Ca2+-permeable AMPA receptors: synaptic 
plasticity and beyond. Curr Opin Neurobiol 16, 288-297. 
 
Dajas-Bailador, F., Bonev, B., Garcez, P., Stanley, P., Guillemot, F., Papalopulu, N., 2012. microRNA-9 
regulates axon extension and branching by targeting Map1b in mouse cortical neurons. Nat Neurosci 15, 
697-699. 
 
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., 
Fak, J. J., Chi, S. W., Licatalosi, D. D., Richter, J. D., Darnell, R. B., 2011. FMRP stalls ribosomal 
translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261. 
 
Deng, W., Aimone, J. B., Gage, F. H., 2010. New neurons and new memories: how does adult hippocampal 
neurogenesis affect learning and memory? Nat Rev Neurosci 11, 339-350. 
 
Derkach, V. A., Oh, M. C., Guire, E. S., Soderling, T. R., 2007. Regulatory mechanisms of AMPA receptors 
in synaptic plasticity. Nat Rev Neurosci 8, 101-113. 
 
di Penta, A., Mercaldo, V., Florenzano, F., Munck, S., Ciotti, M. T., Zalfa, F., Mercanti, D., Molinari, M., 
Bagni, C., Achsel, T., 2009. Dendritic LSm1/CBP80-mRNPs mark the early steps of transport commitment 
and translational control. J Cell Biol 184, 423-435. 
 
Dictenberg, J. B., Swanger, S. A., Antar, L. N., Singer, R. H., Bassell, G. J., 2008. A direct role for FMRP in 
activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev 
Cell 14, 926-939. 
 
Dieni, S., Matsumoto, T., Dekkers, M., Rauskolb, S., Ionescu, M. S., Deogracias, R., Gundelfinger, E. D., 
Kojima, M., Nestel, S., Frotscher, M., Barde, Y. A., 2012. BDNF and its pro-peptide are stored in presynaptic 
dense core vesicles in brain neurons. J Cell Biol 196, 775-788. 
 
Dieterich, D. C., Hodas, J. J., Gouzer, G., Shadrin, I. Y., Ngo, J. T., Triller, A., Tirrell, D. A., Schuman, E. M., 
2010. In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons. Nat 
Neurosci 13, 897-905. 
 
Doyle, M., Kiebler, M. A., 2011. Mechanisms of dendritic mRNA transport and its role in synaptic tagging. 
EMBO J 30, 3540-3552. 
 
Drake, C. T., Milner, T. A., Patterson, S. L., 1999. Ultrastructural localization of full-length trkB 
immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic 
plasticity. J Neurosci 19, 8009-8026. 
 
Dreyfuss, G., Matunis, M. J., Pinol-Roma, S., Burd, C. G., 1993. hnRNP proteins and the biogenesis of 
mRNA. Annu Rev Biochem 62, 289-321. 
 
Dubnau, J., Chiang, A. S., Grady, L., Barditch, J., Gossweiler, S., McNeil, J., Smith, P., Buldoc, F., Scott, R., 
Certa, U., Broger, C., Tully, T., 2003. The staufen/pumilio pathway is involved in Drosophila long-term 
memory. Curr Biol 13, 286-296. 
 
Duchaine, T. F., Hemraj, I., Furic, L., Deitinghoff, A., Kiebler, M. A., DesGroseillers, L., 2002. Staufen2 
isoforms localize to the somatodendritic domain of neurons and interact with different organelles. J Cell Sci 
115, 3285-3295. 
 
Dugre-Brisson, S., Elvira, G., Boulay, K., Chatel-Chaix, L., Mouland, A. J., DesGroseillers, L., 2005. 
Interaction of Staufen1 with the 5' end of mRNA facilitates translation of these RNAs. Nucleic Acids Res 33, 
4797-4812. 
 
 145 
 
References 
Dziembowska, M., Milek, J., Janusz, A., Rejmak, E., Romanowska, E., Gorkiewicz, T., Tiron, A., Bramham, 
C. R., Kaczmarek, L., 2012. Activity-dependent local translation of matrix metalloproteinase-9. J Neurosci 32, 
14538-14547. 
 
Eberwine, J., Miyashiro, K., Kacharmina, J. E., Job, C., 2001. Local translation of classes of mRNAs that are 
targeted to neuronal dendrites. Proc Natl Acad Sci U S A 98, 7080-7085. 
 
Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C. F., Seeburg, D. P., Batterton, M. N., Tada, T., Dolan, B. 
M., Sharp, P. A., Sheng, M., 2010. Regulation of synaptic structure and function by FMRP-associated 
microRNAs miR-125b and miR-132. Neuron 65, 373-384. 
 
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, 
B., Goldman, D., Dean, M., Lu, B., Weinberger, D. R., 2003. The BDNF val66met polymorphism affects 
activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269. 
 
Eliscovich, C., Buxbaum, A. R., Katz, Z. B., Singer, R. H., 2013. mRNA on the move: the road to its 
biological destiny. J Biol Chem 288, 20361-20368. 
 
Elvira, G., Wasiak, S., Blandford, V., Tong, X. K., Serrano, A., Fan, X., del Rayo Sanchez-Carbente, M., 
Servant, F., Bell, A. W., Boismenu, D., Lacaille, J. C., McPherson, P. S., DesGroseillers, L., Sossin, W. S., 
2006. Characterization of an RNA granule from developing brain. Mol Cell Proteomics 5, 635-651. 
 
Eom, T., Antar, L. N., Singer, R. H., Bassell, G. J., 2003. Localization of a beta-actin messenger 
ribonucleoprotein complex with zipcode-binding protein modulates the density of dendritic filopodia and 
filopodial synapses. J Neurosci 23, 10433-10444. 
 
Expert-Bezancon, A., Le Caer, J. P., Marie, J., 2002. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is 
a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A 
from chicken beta-tropomyosin pre-mRNA. J Biol Chem 277, 16614-16623. 
 
Falley, K., Schutt, J., Iglauer, P., Menke, K., Maas, C., Kneussel, M., Kindler, S., Wouters, F. S., Richter, D., 
Kreienkamp, H. J., 2009. Shank1 mRNA: dendritic transport by kinesin and translational control by the 
5'untranslated region. Traffic 10, 844-857. 
 
Feliers, D., Lee, M. J., Ghosh-Choudhury, G., Bomsztyk, K., Kasinath, B. S., 2007. Heterogeneous nuclear 
ribonucleoprotein K contributes to angiotensin II stimulation of vascular endothelial growth factor mRNA 
translation. Am J Physiol Renal Physiol 293, F607-615. 
 
Fenn, S., Du, Z., Lee, J. K., Tjhen, R., Stroud, R. M., James, T. L., 2007. Crystal structure of the third KH 
domain of human poly(C)-binding protein-2 in complex with a C-rich strand of human telomeric DNA at 1.6 A 
resolution. Nucleic Acids Res 35, 2651-2660. 
 
Figurov, A., Pozzo-Miller, L. D., Olafsson, P., Wang, T., Lu, B., 1996. Regulation of synaptic responses to 
high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381, 706-709. 
 
Fiore, R., Khudayberdiev, S., Christensen, M., Siegel, G., Flavell, S. W., Kim, T. K., Greenberg, M. E., 
Schratt, G., 2009. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent 
dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J 28, 697-710. 
 
Fortin, D. A., Srivastava, T., Dwarakanath, D., Pierre, P., Nygaard, S., Derkach, V. A., Soderling, T. R., 2012. 
Brain-derived neurotrophic factor activation of CaM-kinase kinase via transient receptor potential canonical 
channels induces the translation and synaptic incorporation of GluA1-containing calcium-permeable AMPA 
receptors. J Neurosci 32, 8127-8137. 
 
Fukazawa, Y., Saitoh, Y., Ozawa, F., Ohta, Y., Mizuno, K., Inokuchi, K., 2003. Hippocampal LTP is 
accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP 
maintenance in vivo. Neuron 38, 447-460. 
 
Fukuda, T., Naiki, T., Saito, M., Irie, K., 2009. hnRNP K interacts with RNA binding motif protein 42 and 
functions in the maintenance of cellular ATP level during stress conditions. Genes Cells 14, 113-128. 
 
Fumagalli, S., Thomas, G., 2000. S6 phosphorylation and signal transduction. In: Sonenberg, N., Hershey, J. 
W. B., Mathews, M. B., (Eds), Translation Control of Gene Expression. Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, New York, pp. 695-718. 
 
Gao, J., Wang, W. Y., Mao, Y. W., Graff, J., Guan, J. S., Pan, L., Mak, G., Kim, D., Su, S. C., Tsai, L. H., 
2010. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466, 1105-1109. 
Chapter 6 
146 
 
Gao, Y., Tatavarty, V., Korza, G., Levin, M. K., Carson, J. H., 2008. Multiplexed dendritic targeting of alpha 
calcium calmodulin-dependent protein kinase II, neurogranin, and activity-regulated cytoskeleton-associated 
protein RNAs by the A2 pathway. Mol Biol Cell 19, 2311-2327. 
 
Gartner, A., Polnau, D. G., Staiger, V., Sciarretta, C., Minichiello, L., Thoenen, H., Bonhoeffer, T., Korte, M., 
2006. Hippocampal long-term potentiation is supported by presynaptic and postsynaptic tyrosine receptor 
kinase B-mediated phospholipase Cgamma signaling. J Neurosci 26, 3496-3504. 
 
Gartner, A., Staiger, V., 2002. Neurotrophin secretion from hippocampal neurons evoked by long-term-
potentiation-inducing electrical stimulation patterns. Proc Natl Acad Sci U S A 99, 6386-6391. 
 
Gazzaley, A. H., Benson, D. L., Huntley, G. W., Morrison, J. H., 1997. Differential subcellular regulation of 
NMDAR1 protein and mRNA in dendrites of dentate gyrus granule cells after perforant path transection. J 
Neurosci 17, 2006-2017. 
 
Gingras, A. C., Raught, B., Sonenberg, N., 2004. mTOR signaling to translation. Curr Top Microbiol Immunol 
279, 169-197. 
 
Giorgi, C., Moore, M. J., 2007. The nuclear nurture and cytoplasmic nature of localized mRNPs. Semin Cell 
Dev Biol 18, 186-193. 
 
Giorgi, C., Yeo, G. W., Stone, M. E., Katz, D. B., Burge, C., Turrigiano, G., Moore, M. J., 2007. The EJC 
factor eIF4AIII modulates synaptic strength and neuronal protein expression. Cell 130, 179-191. 
 
Glanzer, J., Miyashiro, K. Y., Sul, J. Y., Barrett, L., Belt, B., Haydon, P., Eberwine, J., 2005. RNA splicing 
capability of live neuronal dendrites. Proc Natl Acad Sci U S A 102, 16859-16864. 
 
Gomes, J. R., Costa, J. T., Melo, C. V., Felizzi, F., Monteiro, P., Pinto, M. J., Inacio, A. R., Wieloch, T., 
Almeida, R. D., Graos, M., Duarte, C. B., 2012. Excitotoxicity downregulates TrkB.FL signaling and 
upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons. J 
Neurosci 32, 4610-4622. 
 
Grishin, N. V., 2001. KH domain: one motif, two folds. Nucleic Acids Res 29, 638-643. 
 
Grosshans, D. R., Clayton, D. A., Coultrap, S. J., Browning, M. D., 2002. LTP leads to rapid surface 
expression of NMDA but not AMPA receptors in adult rat CA1. Nat Neurosci 5, 27-33. 
 
Gruart, A., Sciarretta, C., Valenzuela-Harrington, M., Delgado-Garcia, J. M., Minichiello, L., 2007. Mutation at 
the TrkB PLC{gamma}-docking site affects hippocampal LTP and associative learning in conscious mice. 
Learn Mem 14, 54-62. 
 
Gu, W., Pan, F., Zhang, H., Bassell, G. J., Singer, R. H., 2002. A predominantly nuclear protein affecting 
cytoplasmic localization of beta-actin mRNA in fibroblasts and neurons. J Cell Biol 156, 41-51. 
 
Guire, E. S., Oh, M. C., Soderling, T. R., Derkach, V. A., 2008. Recruitment of calcium-permeable AMPA 
receptors during synaptic potentiation is regulated by CaM-kinase I. J Neurosci 28, 6000-6009. 
 
Guzowski, J. F., Lyford, G. L., Stevenson, G. D., Houston, F. P., McGaugh, J. L., Worley, P. F., Barnes, C. 
A., 2000. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the 
maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 20, 3993-
4001. 
 
Ha, J., Lo, K. W., Myers, K. R., Carr, T. M., Humsi, M. K., Rasoul, B. A., Segal, R. A., Pfister, K. K., 2008. A 
neuron-specific cytoplasmic dynein isoform preferentially transports TrkB signaling endosomes. J Cell Biol 
181, 1027-1039. 
 
Habelhah, H., Shah, K., Huang, L., Ostareck-Lederer, A., Burlingame, A. L., Shokat, K. M., Hentze, M. W., 
Ronai, Z., 2001. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA 
translation. Nat Cell Biol 3, 325-330. 
 
Hadari, Y. R., Kouhara, H., Lax, I., Schlessinger, J., 1998. Binding of Shp2 tyrosine phosphatase to FRS2 is 
essential for fibroblast growth factor-induced PC12 cell differentiation. Mol Cell Biol 18, 3966-3973. 
 
Hamanoue, M., Middleton, G., Wyatt, S., Jaffray, E., Hay, R. T., Davies, A. M., 1999. p75-mediated NF-
kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor. 
Mol Cell Neurosci 14, 28-40. 
 147 
 
References 
 
Han, S. P., Tang, Y. H., Smith, R., 2010. Functional diversity of the hnRNPs: past, present and perspectives. 
Biochem J 430, 379-392. 
 
Hardingham, G. E., Fukunaga, Y., Bading, H., 2002. Extrasynaptic NMDARs oppose synaptic NMDARs by 
triggering CREB shut-off and cell death pathways. Nat Neurosci 5, 405-414. 
 
Hartmann, M., Heumann, R., Lessmann, V., 2001. Synaptic secretion of BDNF after high-frequency 
stimulation of glutamatergic synapses. EMBO J 20, 5887-5897. 
 
Havik, B., Rokke, H., Bardsen, K., Davanger, S., Bramham, C. R., 2003. Bursts of high-frequency stimulation 
trigger rapid delivery of pre-existing alpha-CaMKII mRNA to synapses: a mechanism in dendritic protein 
synthesis during long-term potentiation in adult awake rats. Eur J Neurosci 17, 2679-2689. 
 
He, X. L., Garcia, K. C., 2004. Structure of nerve growth factor complexed with the shared neurotrophin 
receptor p75. Science 304, 870-875. 
 
Hebb, D. O., 1949. The organization of behavior. Wiley, New York. 
 
Herb, A., Wisden, W., Catania, M. V., Marechal, D., Dresse, A., Seeburg, P. H., 1997. Prominent dendritic 
localization in forebrain neurons of a novel mRNA and its product, dendrin. Mol Cell Neurosci 8, 367-374. 
 
Herbert, T. P., Proud, C. G., 2007. Regulation of translation elongation and the cotranslational protein 
targeting pathway. In: Mathews, M. B., Sonenberg, N., Hershey, J. W. B., (Eds), Translational Control in 
Biology and Medicine. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 601-624. 
 
Hoek, K. S., Kidd, G. J., Carson, J. H., Smith, R., 1998. hnRNP A2 selectively binds the cytoplasmic 
transport sequence of myelin basic protein mRNA. Biochemistry 37, 7021-7029. 
 
Holgado-Madruga, M., Moscatello, D. K., Emlet, D. R., Dieterich, R., Wong, A. J., 1997. Grb2-associated 
binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth 
factor. Proc Natl Acad Sci U S A 94, 12419-12424. 
 
Huang, Y. S., Carson, J. H., Barbarese, E., Richter, J. D., 2003. Facilitation of dendritic mRNA transport by 
CPEB. Genes Dev 17, 638-653. 
 
Huang, Y. W., Ruiz, C. R., Eyler, E. C., Lin, K., Meffert, M. K., 2012. Dual regulation of miRNA biogenesis 
generates target specificity in neurotrophin-induced protein synthesis. Cell 148, 933-946. 
 
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., 
Amit, I., Rabani, M., Attardi, L. D., Regev, A., Lander, E. S., Jacks, T., Rinn, J. L., 2010. A large intergenic 
noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419. 
 
Huttelmaier, S., Zenklusen, D., Lederer, M., Dictenberg, J., Lorenz, M., Meng, X., Bassell, G. J., Condeelis, 
J., Singer, R. H., 2005. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of 
ZBP1. Nature 438, 512-515. 
 
Inamura, N., Nawa, H., Takei, N., 2005. Enhancement of translation elongation in neurons by brain-derived 
neurotrophic factor: implications for mammalian target of rapamycin signaling. J Neurochem 95, 1438-1445. 
 
Jeong, J. H., Nam, Y. J., Kim, S. Y., Kim, E. G., Jeong, J., Kim, H. K., 2007. The transport of Staufen2-
containing ribonucleoprotein complexes involves kinesin motor protein and is modulated by mitogen-
activated protein kinase pathway. J Neurochem 102, 2073-2084. 
 
Ji, Y., Lu, Y., Yang, F., Shen, W., Tang, T. T., Feng, L., Duan, S., Lu, B., 2010. Acute and gradual increases 
in BDNF concentration elicit distinct signaling and functions in neurons. Nat Neurosci 13, 302-309. 
 
Jourdi, H., Iwakura, Y., Narisawa-Saito, M., Ibaraki, K., Xiong, H., Watanabe, M., Hayashi, Y., Takei, N., 
Nawa, H., 2003. Brain-derived neurotrophic factor signal enhances and maintains the expression of AMPA 
receptor-associated PDZ proteins in developing cortical neurons. Dev Biol 263, 216-230. 
 
Jovanovic, J. N., Czernik, A. J., Fienberg, A. A., Greengard, P., Sihra, T. S., 2000. Synapsins as mediators 
of BDNF-enhanced neurotransmitter release. Nat Neurosci 3, 323-329. 
 
Jung, M. Y., Lorenz, L., Richter, J. D., 2006. Translational control by neuroguidin, a eukaryotic initiation 
factor 4E and CPEB binding protein. Mol Cell Biol 26, 4277-4287. 
 
Chapter 6 
148 
Kaech, S., Banker, G., 2006. Culturing hippocampal neurons. Nat Protoc 1, 2406-2415. 
 
Kanai, Y., Dohmae, N., Hirokawa, N., 2004. Kinesin transports RNA: isolation and characterization of an 
RNA-transporting granule. Neuron 43, 513-525. 
 
Kandel, E. R., 2001. The molecular biology of memory storage: a dialogue between genes and synapses. 
Science 294, 1030-1038. 
 
Kang, H., Schuman, E. M., 1996. A requirement for local protein synthesis in neurotrophin-induced 
hippocampal synaptic plasticity. Science 273, 1402-1406. 
 
Kang, H., Welcher, A. A., Shelton, D., Schuman, E. M., 1997. Neurotrophins and time: different roles for 
TrkB signaling in hippocampal long-term potentiation. Neuron 19, 653-664. 
 
Kanhema, T., Dagestad, G., Panja, D., Tiron, A., Messaoudi, E., Havik, B., Ying, S. W., Nairn, A. C., 
Sonenberg, N., Bramham, C. R., 2006. Dual regulation of translation initiation and peptide chain elongation 
during BDNF-induced LTP in vivo: evidence for compartment-specific translation control. J Neurochem 99, 
1328-1337. 
 
Kaplan, D. R., Miller, F. D., 2000. Neurotrophin signal transduction in the nervous system. Curr Opin 
Neurobiol 10, 381-391. 
 
Kasai, H., Fukuda, M., Watanabe, S., Hayashi-Takagi, A., Noguchi, J., 2010. Structural dynamics of dendritic 
spines in memory and cognition. Trends Neurosci 33, 121-129. 
 
Kawashima, H., Numakawa, T., Kumamaru, E., Adachi, N., Mizuno, H., Ninomiya, M., Kunugi, H., Hashido, 
K., 2010. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate 
receptors via the suppression of microRNA-132 expression. Neuroscience 165, 1301-1311. 
 
Kelleher, R. J., 3rd, Govindarajan, A., Jung, H. Y., Kang, H., Tonegawa, S., 2004. Translational control by 
MAPK signaling in long-term synaptic plasticity and memory. Cell 116, 467-479. 
 
Kessels, H. W., Malinow, R., 2009. Synaptic AMPA receptor plasticity and behavior. Neuron 61, 340-350. 
 
Kiebler, M. A., Bassell, G. J., 2006. Neuronal RNA granules: movers and makers. Neuron 51, 685-690. 
 
Kiebler, M. A., Hemraj, I., Verkade, P., Kohrmann, M., Fortes, P., Marion, R. M., Ortin, J., Dotti, C. G., 1999. 
The mammalian staufen protein localizes to the somatodendritic domain of cultured hippocampal neurons: 
implications for its involvement in mRNA transport. J Neurosci 19, 288-297. 
 
Kim, Y. K., Furic, L., Desgroseillers, L., Maquat, L. E., 2005. Mammalian Staufen1 recruits Upf1 to specific 
mRNA 3'UTRs so as to elicit mRNA decay. Cell 120, 195-208. 
 
Kislauskis, E. H., Zhu, X., Singer, R. H., 1994. Sequences responsible for intracellular localization of beta-
actin messenger RNA also affect cell phenotype. J Cell Biol 127, 441-451. 
 
Klein, M. E., Younts, T. J., Castillo, P. E., Jordan, B. A., 2013. RNA-binding protein Sam68 controls synapse 
number and local beta-actin mRNA metabolism in dendrites. Proc Natl Acad Sci U S A 110, 3125-3130. 
 
Knowles, R. B., Sabry, J. H., Martone, M. E., Deerinck, T. J., Ellisman, M. H., Bassell, G. J., Kosik, K. S., 
1996. Translocation of RNA granules in living neurons. J Neurosci 16, 7812-7820. 
 
Kobayashi, H., Yamamoto, S., Maruo, T., Murakami, F., 2005. Identification of a cis-acting element required 
for dendritic targeting of activity-regulated cytoskeleton-associated protein mRNA. Eur J Neurosci 22, 2977-
2984. 
 
Kohara, K., Kitamura, A., Morishima, M., Tsumoto, T., 2001. Activity-dependent transfer of brain-derived 
neurotrophic factor to postsynaptic neurons. Science 291, 2419-2423. 
 
Kohrmann, M., Luo, M., Kaether, C., DesGroseillers, L., Dotti, C. G., Kiebler, M. A., 1999. Microtubule-
dependent recruitment of Staufen-green fluorescent protein into large RNA-containing granules and 
subsequent dendritic transport in living hippocampal neurons. Mol Biol Cell 10, 2945-2953. 
 
Kondo, M., Takei, Y., Hirokawa, N., 2012. Motor protein KIF1A is essential for hippocampal synaptogenesis 
and learning enhancement in an enriched environment. Neuron 73, 743-757. 
 
 149 
 
References 
Konecna, A., Heraud, J. E., Schoderboeck, L., Raposo, A. A., Kiebler, M. A., 2009. What are the roles of 
microRNAs at the mammalian synapse? Neurosci Lett 466, 63-68. 
 
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., Bonhoeffer, T., 1995. Hippocampal long-term 
potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A 92, 8856-
8860. 
 
Korte, M., Kang, H., Bonhoeffer, T., Schuman, E., 1998. A role for BDNF in the late-phase of hippocampal 
long-term potentiation. Neuropharmacology 37, 553-559. 
 
Korte, M., Staiger, V., Griesbeck, O., Thoenen, H., Bonhoeffer, T., 1996. The involvement of brain-derived 
neurotrophic factor in hippocampal long-term potentiation revealed by gene targeting experiments. J Physiol 
Paris 90, 157-164. 
 
Kosturko, L. D., Maggipinto, M. J., Korza, G., Lee, J. W., Carson, J. H., Barbarese, E., 2006. Heterogeneous 
nuclear ribonucleoprotein (hnRNP) E1 binds to hnRNP A2 and inhibits translation of A2 response element 
mRNAs. Mol Biol Cell 17, 3521-3533. 
 
Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I., Schlessinger, J., 1997. A 
lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. 
Cell 89, 693-702. 
 
Kovalchuk, Y., Hanse, E., Kafitz, K. W., Konnerth, A., 2002. Postsynaptic Induction of BDNF-Mediated Long-
Term Potentiation. Science 295, 1729-1734. 
 
Krecic, A. M., Swanson, M. S., 1999. hnRNP complexes: composition, structure, and function. Curr Opin Cell 
Biol 11, 363-371. 
 
Krichevsky, A. M., Kosik, K. S., 2001. Neuronal RNA granules: a link between RNA localization and 
stimulation-dependent translation. Neuron 32, 683-696. 
 
Krucker, T., Siggins, G. R., Halpain, S., 2000. Dynamic actin filaments are required for stable long-term 
potentiation (LTP) in area CA1 of the hippocampus. Proc Natl Acad Sci U S A 97, 6856-6861. 
 
Kuczewski, N., Porcher, C., Lessmann, V., Medina, I., Gaiarsa, J. L., 2009. Activity-dependent dendritic 
release of BDNF and biological consequences. Mol Neurobiol 39, 37-49. 
 
Lau, A. G., Irier, H. A., Gu, J., Tian, D., Ku, L., Liu, G., Xia, M., Fritsch, B., Zheng, J. Q., Dingledine, R., Xu, 
B., Lu, B., Feng, Y., 2010. Distinct 3'UTRs differentially regulate activity-dependent translation of brain-
derived neurotrophic factor (BDNF). Proc Natl Acad Sci U S A 107, 15945-15950. 
 
Le Clainche, C., Carlier, M. F., 2008. Regulation of actin assembly associated with protrusion and adhesion 
in cell migration. Physiol Rev 88, 489-513. 
 
Le, M. T., Xie, H., Zhou, B., Chia, P. H., Rizk, P., Um, M., Udolph, G., Yang, H., Lim, B., Lodish, H. F., 2009. 
MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol 
29, 5290-5305. 
 
Leal, G., Comprido, D., Duarte, C. B., 2013. BDNF-induced local protein synthesis and synaptic plasticity. 
Neuropharmacology. 
 
Lebeau, G., Maher-Laporte, M., Topolnik, L., Laurent, C. E., Sossin, W., Desgroseillers, L., Lacaille, J. C., 
2008. Staufen1 regulation of protein synthesis-dependent long-term potentiation and synaptic function in 
hippocampal pyramidal cells. Mol Cell Biol 28, 2896-2907. 
 
Lebeau, G., Miller, L. C., Tartas, M., McAdam, R., Laplante, I., Badeaux, F., DesGroseillers, L., Sossin, W. 
S., Lacaille, J. C., 2011. Staufen 2 regulates mGluR long-term depression and Map1b mRNA distribution in 
hippocampal neurons. Learn Mem 18, 314-326. 
 
Lee, R., Kermani, P., Teng, K. K., Hempstead, B. L., 2001. Regulation of cell survival by secreted 
proneurotrophins. Science 294, 1945-1948. 
 
Lee, S. W., Lee, M. H., Park, J. H., Kang, S. H., Yoo, H. M., Ka, S. H., Oh, Y. M., Jeon, Y. J., Chung, C. H., 
2012. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage. 
EMBO J 31, 4441-4452. 
 
Chapter 6 
150 
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., 
Brockway, K. S., Byrnes, E. J., Chen, L., Chen, T. M., Chin, M. C., Chong, J., Crook, B. E., Czaplinska, A., 
Dang, C. N., Datta, S., Dee, N. R., Desaki, A. L.,et al., 2007. Genome-wide atlas of gene expression in the 
adult mouse brain. Nature 445, 168-176. 
 
Lessmann, V., Brigadski, T., 2009. Mechanisms, locations, and kinetics of synaptic BDNF secretion: an 
update. Neurosci Res 65, 11-22. 
 
Lessmann, V., Heumann, R., 1998. Modulation of unitary glutamatergic synapses by neurotrophin-4/5 or 
brain-derived neurotrophic factor in hippocampal microcultures: presynaptic enhancement depends on pre-
established paired-pulse facilitation. Neuroscience 86, 399-413. 
 
Levine, E. S., Crozier, R. A., Black, I. B., Plummer, M. R., 1998. Brain-derived neurotrophic factor modulates 
hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. Proc Natl Acad 
Sci U S A 95, 10235-10239. 
 
Levine, E. S., Kolb, J. E., 2000. Brain-derived neurotrophic factor increases activity of NR2B-containing N-
methyl-D-aspartate receptors in excised patches from hippocampal neurons. J Neurosci Res 62, 357-362. 
 
Lewin, G. R., Barde, Y. A., 1996. Physiology of the neurotrophins. Annu Rev Neurosci 19, 289-317. 
 
Li, Y. X., Zhang, Y., Lester, H. A., Schuman, E. M., Davidson, N., 1998. Enhancement of neurotransmitter 
release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. J Neurosci 18, 
10231-10240. 
 
Liao, L., Pilotte, J., Xu, T., Wong, C. C., Edelman, G. M., Vanderklish, P., Yates, J. R., 3rd, 2007. BDNF 
induces widespread changes in synaptic protein content and up-regulates components of the translation 
machinery: an analysis using high-throughput proteomics. J Proteome Res 6, 1059-1071. 
 
Lin, A. C., Holt, C. E., 2007. Local translation and directional steering in axons. EMBO J 26, 3729-3736. 
 
Lin, D. T., Makino, Y., Sharma, K., Hayashi, T., Neve, R., Takamiya, K., Huganir, R. L., 2009. Regulation of 
AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation. Nat Neurosci 12, 879-
887. 
 
Lin, S. Y., Wu, K., Levine, E. S., Mount, H. T., Suen, P. C., Black, I. B., 1998. BDNF acutely increases 
tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic 
densities. Brain Res Mol Brain Res 55, 20-27. 
 
Link, W., Konietzko, U., Kauselmann, G., Krug, M., Schwanke, B., Frey, U., Kuhl, D., 1995. Somatodendritic 
expression of an immediate early gene is regulated by synaptic activity. Proc Natl Acad Sci U S A 92, 5734-
5738. 
 
Linnarsson, S., Bjorklund, A., Ernfors, P., 1997. Learning deficit in BDNF mutant mice. Eur J Neurosci 9, 
2581-2587. 
 
Lisman, J., Yasuda, R., Raghavachari, S., 2012. Mechanisms of CaMKII action in long-term potentiation. Nat 
Rev Neurosci 13, 169-182. 
 
Liu, Y., Gervasi, C., Szaro, B. G., 2008. A crucial role for hnRNP K in axon development in Xenopus laevis. 
Development 135, 3125-3135. 
 
Liu, Y., Rohrschneider, L. R., 2002. The gift of Gab. FEBS Lett 515, 1-7. 
 
Liu, Y., Szaro, B. G., 2011. hnRNP K post-transcriptionally co-regulates multiple cytoskeletal genes needed 
for axonogenesis. Development 138, 3079-3090. 
 
Liu, Y., Yu, H., Deaton, S. K., Szaro, B. G., 2012. Heterogeneous nuclear ribonucleoprotein K, an RNA-
binding protein, is required for optic axon regeneration in Xenopus laevis. J Neurosci 32, 3563-3574. 
 
Lopez-Munoz, F., Boya, J., Alamo, C., 2006. Neuron theory, the cornerstone of neuroscience, on the 
centenary of the Nobel Prize award to Santiago Ramon y Cajal. Brain Res Bull 70, 391-405. 
 
Lu, Y., Christian, K., Lu, B., 2008. BDNF: a key regulator for protein synthesis-dependent LTP and long-term 
memory? Neurobiol Learn Mem 89, 312-323. 
 
 151 
 
References 
Lugli, G., Larson, J., Demars, M. P., Smalheiser, N. R., 2012. Primary microRNA precursor transcripts are 
localized at post-synaptic densities in adult mouse forebrain. J Neurochem 123, 459-466. 
 
Luo, L., 2000. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1, 173-180. 
 
Luo, M., Duchaine, T. F., DesGroseillers, L., 2002. Molecular mapping of the determinants involved in 
human Staufen-ribosome association. Biochem J 365, 817-824. 
 
Lyford, G. L., Yamagata, K., Kaufmann, W. E., Barnes, C. A., Sanders, L. K., Copeland, N. G., Gilbert, D. J., 
Jenkins, N. A., Lanahan, A. A., Worley, P. F., 1995. Arc, a growth factor and activity-regulated gene, 
encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433-445. 
 
Lynch, M., Chen, L., Ravitz, M. J., Mehtani, S., Korenblat, K., Pazin, M. J., Schmidt, E. V., 2005. hnRNP K 
binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its 
regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol 25, 6436-6453. 
 
Lynch, M. A., 2004. Long-term potentiation and memory. Physiol Rev 84, 87-136. 
 
Macchi, P., Kroening, S., Palacios, I. M., Baldassa, S., Grunewald, B., Ambrosino, C., Goetze, B., Lupas, A., 
St Johnston, D., Kiebler, M., 2003. Barentsz, a new component of the Staufen-containing ribonucleoprotein 
particles in mammalian cells, interacts with Staufen in an RNA-dependent manner. J Neurosci 23, 5778-
5788. 
 
Makkerh, J. P., Ceni, C., Auld, D. S., Vaillancourt, F., Dorval, G., Barker, P. A., 2005. p75 neurotrophin 
receptor reduces ligand-induced Trk receptor ubiquitination and delays Trk receptor internalization and 
degradation. EMBO Rep 6, 936-941. 
 
Malenka, R. C., 2003a. The long-term potential of LTP. Nat Rev Neurosci 4, 923-926. 
 
Malenka, R. C., 2003b. Synaptic plasticity and AMPA receptor trafficking. Ann N Y Acad Sci 1003, 1-11. 
 
Malenka, R. C., Bear, M. F., 2004. LTP and LTD: an embarrassment of riches. Neuron 44, 5-21. 
 
Malenka, R. C., Nicoll, R. A., 1993. NMDA-receptor-dependent synaptic plasticity: multiple forms and 
mechanisms. Trends Neurosci 16, 521-527. 
 
Malinow, R., Malenka, R. C., 2002. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25, 
103-126. 
 
Manadas, B., Santos, A. R., Szabadfi, K., Gomes, J. R., Garbis, S. D., Fountoulakis, M., Duarte, C. B., 2009. 
BDNF-induced changes in the expression of the translation machinery in hippocampal neurons: protein 
levels and dendritic mRNA. J Proteome Res 8, 4536-4552. 
 
Marin, P., Nastiuk, K. L., Daniel, N., Girault, J. A., Czernik, A. J., Glowinski, J., Nairn, A. C., Premont, J., 
1997. Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in 
neurons. J Neurosci 17, 3445-3454. 
 
Marion, R. M., Fortes, P., Beloso, A., Dotti, C., Ortin, J., 1999. A human sequence homologue of Staufen is 
an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum. 
Mol Cell Biol 19, 2212-2219. 
 
Martin, K. C., Ephrussi, A., 2009. mRNA localization: gene expression in the spatial dimension. Cell 136, 
719-730. 
 
Martin, K. J., Shpiro, N., Traynor, R., Elliott, M., Arthur, J. S., 2011. Comparison of the specificity of Trk 
inhibitors in recombinant and neuronal assays. Neuropharmacology 61, 148-155. 
 
Matsuda, N., Lu, H., Fukata, Y., Noritake, J., Gao, H., Mukherjee, S., Nemoto, T., Fukata, M., Poo, M. M., 
2009. Differential activity-dependent secretion of brain-derived neurotrophic factor from axon and dendrite. J 
Neurosci 29, 14185-14198. 
 
Matsumoto, T., Rauskolb, S., Polack, M., Klose, J., Kolbeck, R., Korte, M., Barde, Y. A., 2008. Biosynthesis 
and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat Neurosci 
11, 131-133. 
 
Chapter 6 
152 
Mayford, M., Baranes, D., Podsypanina, K., Kandel, E. R., 1996. The 3'-untranslated region of CaMKII alpha 
is a cis-acting signal for the localization and translation of mRNA in dendrites. Proc Natl Acad Sci U S A 93, 
13250-13255. 
 
Meakin, S. O., MacDonald, J. I., Gryz, E. A., Kubu, C. J., Verdi, J. M., 1999. The signaling adapter FRS-2 
competes with Shc for binding to the nerve growth factor receptor TrkA. A model for discriminating 
proliferation and differentiation. J Biol Chem 274, 9861-9870. 
 
Megias, M., Emri, Z., Freund, T. F., Gulyas, A. I., 2001. Total number and distribution of inhibitory and 
excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102, 527-540. 
 
Melo, C. V., Mele, M., Curcio, M., Comprido, D., Silva, C. G., Duarte, C. B., 2013. BDNF regulates the 
expression and distribution of vesicular glutamate transporters in cultured hippocampal neurons. PLoS One 
8, e53793. 
 
Messaoudi, E., Bardsen, K., Srebro, B., Bramham, C. R., 1998. Acute intrahippocampal infusion of BDNF 
induces lasting potentiation of synaptic transmission in the rat dentate gyrus. J Neurophysiol 79, 496-499. 
 
Messaoudi, E., Kanhema, T., Soule, J., Tiron, A., Dagyte, G., da Silva, B., Bramham, C. R., 2007. Sustained 
Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin 
polymerization in the dentate gyrus in vivo. J Neurosci 27, 10445-10455. 
 
Messaoudi, E., Ying, S. W., Kanhema, T., Croll, S. D., Bramham, C. R., 2002. Brain-derived neurotrophic 
factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 22, 7453-7461. 
 
Michael, W. M., Eder, P. S., Dreyfuss, G., 1997. The K nuclear shuttling domain: a novel signal for nuclear 
import and nuclear export in the hnRNP K protein. EMBO J 16, 3587-3598. 
 
Mikl, M., Vendra, G., Kiebler, M. A., 2011. Independent localization of MAP2, CaMKIIalpha and beta-actin 
RNAs in low copy numbers. EMBO Rep 12, 1077-1084. 
 
Mikula, M., Dzwonek, A., Karczmarski, J., Rubel, T., Dadlez, M., Wyrwicz, L. S., Bomsztyk, K., Ostrowski, J., 
2006. Landscape of the hnRNP K protein-protein interactome. Proteomics 6, 2395-2406. 
 
Mikula, M., Ostrowski, J., 2010. heterogenous nuclear ribonucleoprotein K. Transcription Factor 
Encyclopedia. 
 
Miller, S., Yasuda, M., Coats, J. K., Jones, Y., Martone, M. E., Mayford, M., 2002. Disruption of dendritic 
translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation. Neuron 36, 
507-519. 
 
Minichiello, L., 2009. TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 10, 850-860. 
 
Minichiello, L., Calella, A. M., Medina, D. L., Bonhoeffer, T., Klein, R., Korte, M., 2002. Mechanism of TrkB-
mediated hippocampal long-term potentiation. Neuron 36, 121-137. 
 
Minichiello, L., Korte, M., Wolfer, D., Kuhn, R., Unsicker, K., Cestari, V., Rossi-Arnaud, C., Lipp, H. P., 
Bonhoeffer, T., Klein, R., 1999. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 
24, 401-414. 
 
Mizuno, M., Yamada, K., He, J., Nakajima, A., Nabeshima, T., 2003. Involvement of BDNF receptor TrkB in 
spatial memory formation. Learn Mem 10, 108-115. 
 
Mizutani, A., Fukuda, M., Ibata, K., Shiraishi, Y., Mikoshiba, K., 2000. SYNCRIP, a cytoplasmic counterpart 
of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms. J Biol 
Chem 275, 9823-9831. 
 
Mori, Y., Imaizumi, K., Katayama, T., Yoneda, T., Tohyama, M., 2000. Two cis-acting elements in the 3' 
untranslated region of alpha-CaMKII regulate its dendritic targeting. Nat Neurosci 3, 1079-1084. 
 
Moumen, A., Magill, C., Dry, K. L., Jackson, S. P., 2013. ATM-dependent phosphorylation of heterogeneous 
nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage. Cell Cycle 
12, 698-704. 
 
Moumen, A., Masterson, P., O'Connor, M. J., Jackson, S. P., 2005. hnRNP K: an HDM2 target and 
transcriptional coactivator of p53 in response to DNA damage. Cell 123, 1065-1078. 
 
 153 
 
References 
Muddashetty, R. S., Kelic, S., Gross, C., Xu, M., Bassell, G. J., 2007. Dysregulated metabotropic glutamate 
receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a 
mouse model of fragile X syndrome. J Neurosci 27, 5338-5348. 
 
Muddashetty, R. S., Nalavadi, V. C., Gross, C., Yao, X., Xing, L., Laur, O., Warren, S. T., Bassell, G. J., 
2011. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR 
signaling. Mol Cell 42, 673-688. 
 
Munro, T. P., Magee, R. J., Kidd, G. J., Carson, J. H., Barbarese, E., Smith, L. M., Smith, R., 1999. 
Mutational analysis of a heterogeneous nuclear ribonucleoprotein A2 response element for RNA trafficking. J 
Biol Chem 274, 34389-34395. 
 
Muslimov, I. A., Iacoangeli, A., Brosius, J., Tiedge, H., 2006. Spatial codes in dendritic BC1 RNA. J Cell Biol 
175, 427-439. 
 
Muslimov, I. A., Patel, M. V., Rose, A., Tiedge, H., 2011. Spatial code recognition in neuronal RNA targeting: 
role of RNA-hnRNP A2 interactions. J Cell Biol 194, 441-457. 
 
Nairn, A. C., Palfrey, H. C., 1987. Identification of the major Mr 100,000 substrate for calmodulin-dependent 
protein kinase III in mammalian cells as elongation factor-2. J Biol Chem 262, 17299-17303. 
 
Nakata, H., Nakamura, S., 2007. Brain-derived neurotrophic factor regulates AMPA receptor trafficking to 
post-synaptic densities via IP3R and TRPC calcium signaling. FEBS Lett 581, 2047-2054. 
 
Napoli, I., Mercaldo, V., Boyl, P. P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Mohr, E., Massimi, 
M., Falconi, M., Witke, W., Costa-Mattioli, M., Sonenberg, N., Achsel, T., Bagni, C., 2008. The fragile X 
syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134, 1042-
1054. 
 
Narisawa-Saito, M., Carnahan, J., Araki, K., Yamaguchi, T., Nawa, H., 1999. Brain-derived neurotrophic 
factor regulates the expression of AMPA receptor proteins in neocortical neurons. Neuroscience 88, 1009-
1014. 
 
Ninan, I., Bath, K. G., Dagar, K., Perez-Castro, R., Plummer, M. R., Lee, F. S., Chao, M. V., 2010. The 
BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus. J 
Neurosci 30, 8866-8870. 
 
O'Connell, K. L., Stults, J. T., 1997. Identification of mouse liver proteins on two-dimensional electrophoresis 
gels by matrix-assisted laser desorption/ionization mass spectrometry of in situ enzymatic digests. 
Electrophoresis 18, 349-359. 
 
Oe, S., Yoneda, Y., 2010. Cytoplasmic polyadenylation element-like sequences are involved in dendritic 
targeting of BDNF mRNA in hippocampal neurons. FEBS Lett 584, 3424-3430. 
 
Oh, J. Y., Kwon, A., Jo, A., Kim, H., Goo, Y. S., Lee, J. A., Kim, H. K., 2013. Activity-dependent synaptic 
localization of processing bodies and their role in dendritic structural plasticity. J Cell Sci 126, 2114-2123. 
 
Okada, Y., Yamazaki, H., Sekine-Aizawa, Y., Hirokawa, N., 1995. The neuron-specific kinesin superfamily 
protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. 
Cell 81, 769-780. 
 
Oleynikov, Y., Singer, R. H., 2003. Real-time visualization of ZBP1 association with beta-actin mRNA during 
transcription and localization. Curr Biol 13, 199-207. 
 
Orefice, L. L., Waterhouse, E. G., Partridge, J. G., Lalchandani, R. R., Vicini, S., Xu, B., 2013. Distinct roles 
for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic 
spines. J Neurosci 33, 11618-11632. 
 
Ostareck-Lederer, A., Ostareck, D. H., Cans, C., Neubauer, G., Bomsztyk, K., Superti-Furga, G., Hentze, M. 
W., 2002. c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced 
mRNAs. Mol Cell Biol 22, 4535-4543. 
 
Ostareck, D. H., Ostareck-Lederer, A., Shatsky, I. N., Hentze, M. W., 2001. Lipoxygenase mRNA silencing in 
erythroid differentiation: The 3'UTR regulatory complex controls 60S ribosomal subunit joining. Cell 104, 
281-290. 
 
Chapter 6 
154 
Ostareck, D. H., Ostareck-Lederer, A., Wilm, M., Thiele, B. J., Mann, M., Hentze, M. W., 1997. mRNA 
silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 
3' end. Cell 89, 597-606. 
 
Ostrowski, J., Kawata, Y., Schullery, D. S., Denisenko, O. N., Bomsztyk, K., 2003. Transient recruitment of 
the hnRNP K protein to inducibly transcribed gene loci. Nucleic Acids Res 31, 3954-3962. 
 
Ostrowski, J., Schullery, D. S., Denisenko, O. N., Higaki, Y., Watts, J., Aebersold, R., Stempka, L., 
Gschwendt, M., Bomsztyk, K., 2000. Role of tyrosine phosphorylation in the regulation of the interaction of 
heterogenous nuclear ribonucleoprotein K protein with its protein and RNA partners. J Biol Chem 275, 3619-
3628. 
 
Ouyang, Y., Rosenstein, A., Kreiman, G., Schuman, E. M., Kennedy, M. B., 1999. Tetanic stimulation leads 
to increased accumulation of Ca(2+)/calmodulin-dependent protein kinase II via dendritic protein synthesis in 
hippocampal neurons. J Neurosci 19, 7823-7833. 
 
Pal, R., Agbas, A., Bao, X., Hui, D., Leary, C., Hunt, J., Naniwadekar, A., Michaelis, M. L., Kumar, K. N., 
Michaelis, E. K., 2003. Selective dendrite-targeting of mRNAs of NR1 splice variants without exon 5: 
identification of a cis-acting sequence and isolation of sequence-binding proteins. Brain Res 994, 1-18. 
 
Pan, F., Huttelmaier, S., Singer, R. H., Gu, W., 2007. ZBP2 facilitates binding of ZBP1 to beta-actin mRNA 
during transcription. Mol Cell Biol 27, 8340-8351. 
 
Pang, P. T., Teng, H. K., Zaitsev, E., Woo, N. T., Sakata, K., Zhen, S., Teng, K. K., Yung, W. H., 
Hempstead, B. L., Lu, B., 2004. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal 
plasticity. Science 306, 487-491. 
 
Panja, D., Dagyte, G., Bidinosti, M., Wibrand, K., Kristiansen, A. M., Sonenberg, N., Bramham, C. R., 2009. 
Novel translational control in Arc-dependent long term potentiation consolidation in vivo. J Biol Chem 284, 
31498-31511. 
 
Park, H., Poo, M. M., 2013. Neurotrophin regulation of neural circuit development and function. Nat Rev 
Neurosci 14, 7-23. 
 
Park, S., Park, J. M., Kim, S., Kim, J. A., Shepherd, J. D., Smith-Hicks, C. L., Chowdhury, S., Kaufmann, W., 
Kuhl, D., Ryazanov, A. G., Huganir, R. L., Linden, D. J., Worley, P. F., 2008. Elongation factor 2 and fragile 
X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 
59, 70-83. 
 
Pascual, M., Climent, E., Guerri, C., 2001. BDNF induces glutamate release in cerebrocortical nerve 
terminals and in cortical astrocytes. Neuroreport 12, 2673-2677. 
 
Patterson, S. L., Abel, T., Deuel, T. A., Martin, K. C., Rose, J. C., Kandel, E. R., 1996. Recombinant BDNF 
rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16, 
1137-1145. 
 
Pelisch, F., Pozzi, B., Risso, G., Munoz, M. J., Srebrow, A., 2012. DNA damage-induced heterogeneous 
nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J Biol Chem 287, 30789-
30799. 
 
Pereira, D. B., Rebola, N., Rodrigues, R. J., Cunha, R. A., Carvalho, A. P., Duarte, C. B., 2006. Trkb 
receptors modulation of glutamate release is limited to a subset of nerve terminals in the adult rat 
hippocampus. J Neurosci Res 83, 832-844. 
 
Perycz, M., Urbanska, A. S., Krawczyk, P. S., Parobczak, K., Jaworski, J., 2011. Zipcode binding protein 1 
regulates the development of dendritic arbors in hippocampal neurons. J Neurosci 31, 5271-5285. 
 
Pestova, T. V., Lorsch, J. R., Hellen, C. U. T., 2007. The mechanism of translation initiation in eukaryotes. In: 
Mathews, M. B., Sonenberg, N., Hershey, J. W. B., (Eds), Translational Control in Biology and Medicine. 
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 87-128. 
 
Pinol-Roma, S., Choi, Y. D., Matunis, M. J., Dreyfuss, G., 1988. Immunopurification of heterogeneous 
nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev 2, 215-227. 
 
Pinol-Roma, S., Dreyfuss, G., 1992. Shuttling of pre-mRNA binding proteins between nucleus and 
cytoplasm. Nature 355, 730-732. 
 
 155 
 
References 
Platenik, J., Kuramoto, N., Yoneda, Y., 2000. Molecular mechanisms associated with long-term consolidation 
of the NMDA signals. Life Sci 67, 335-364. 
 
Poon, M. M., Choi, S. H., Jamieson, C. A., Geschwind, D. H., Martin, K. C., 2006. Identification of process-
localized mRNAs from cultured rodent hippocampal neurons. J Neurosci 26, 13390-13399. 
 
Pozzo-Miller, L. D., Gottschalk, W., Zhang, L., McDermott, K., Du, J., Gopalakrishnan, R., Oho, C., Sheng, Z. 
H., Lu, B., 1999. Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein 
distribution in the hippocampus of BDNF knockout mice. J Neurosci 19, 4972-4983. 
 
Proepper, C., Steinestel, K., Schmeisser, M. J., Heinrich, J., Steinestel, J., Bockmann, J., Liebau, S., 
Boeckers, T. M., 2011. Heterogeneous nuclear ribonucleoprotein k interacts with Abi-1 at postsynaptic sites 
and modulates dendritic spine morphology. PLoS One 6, e27045. 
 
Pullman, J. M., Martin, T. E., 1983. Reconstitution of nucleoprotein complexes with mammalian 
heterogeneous nuclear ribonucleoprotein (hnRNP) core proteins. J Cell Biol 97, 99-111. 
 
Qian, X., Riccio, A., Zhang, Y., Ginty, D. D., 1998. Identification and characterization of novel substrates of 
Trk receptors in developing neurons. Neuron 21, 1017-1029. 
 
Racz, B., Weinberg, R. J., 2013. Microdomains in forebrain spines: an ultrastructural perspective. Mol 
Neurobiol 47, 77-89. 
 
Raju, C. S., Fukuda, N., Lopez-Iglesias, C., Goritz, C., Visa, N., Percipalle, P., 2011. In neurons, activity-
dependent association of dendritically transported mRNA transcripts with the transacting factor CBF-A is 
mediated by A2RE/RTS elements. Mol Biol Cell 22, 1864-1877. 
 
Rao, V. R., Finkbeiner, S., 2007. NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci 30, 
284-291. 
 
Rao, V. R., Pintchovski, S. A., Chin, J., Peebles, C. L., Mitra, S., Finkbeiner, S., 2006. AMPA receptors 
regulate transcription of the plasticity-related immediate-early gene Arc. Nat Neurosci 9, 887-895. 
 
Redondo, R. L., Morris, R. G., 2011. Making memories last: the synaptic tagging and capture hypothesis. 
Nat Rev Neurosci 12, 17-30. 
 
Rehbein, M., Wege, K., Buck, F., Schweizer, M., Richter, D., Kindler, S., 2002. Molecular characterization of 
MARTA1, a protein interacting with the dendritic targeting element of MAP2 mRNAs. J Neurochem 82, 1039-
1046. 
 
Reichardt, L. F., 2006. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361, 
1545-1564. 
 
Remenyi, J., Hunter, C. J., Cole, C., Ando, H., Impey, S., Monk, C. E., Martin, K. J., Barton, G. J., Hutvagner, 
G., Arthur, J. S., 2010. Regulation of the miR-212/132 locus by MSK1 and CREB in response to 
neurotrophins. Biochem J 428, 281-291. 
 
Rex, C. S., Lin, C. Y., Kramar, E. A., Chen, L. Y., Gall, C. M., Lynch, G., 2007. Brain-derived neurotrophic 
factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus. J Neurosci 27, 
3017-3029. 
 
Rhoads, R. E., 1999. Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 
274, 30337-30340. 
 
Richter, J. D., 2007. CPEB: a life in translation. Trends Biochem Sci 32, 279-285. 
 
Righi, M., Tongiorgi, E., Cattaneo, A., 2000. Brain-derived neurotrophic factor (BDNF) induces dendritic 
targeting of BDNF and tyrosine kinase B mRNAs in hippocampal neurons through a phosphatidylinositol-3 
kinase-dependent pathway. J Neurosci 20, 3165-3174. 
 
Rook, M. S., Lu, M., Kosik, K. S., 2000. CaMKIIalpha 3' untranslated region-directed mRNA translocation in 
living neurons: visualization by GFP linkage. J Neurosci 20, 6385-6393. 
 
Ross, A. F., Oleynikov, Y., Kislauskis, E. H., Taneja, K. L., Singer, R. H., 1997. Characterization of a beta-
actin mRNA zipcode-binding protein. Mol Cell Biol 17, 2158-2165. 
 
Chapter 6 
156 
Ryazanov, A. G., Rudkin, B. B., Spirin, A. S., 1991. Regulation of protein synthesis at the elongation stage. 
New insights into the control of gene expression in eukaryotes. FEBS Lett 285, 170-175. 
 
Ryazanov, A. G., Shestakova, E. A., Natapov, P. G., 1988. Phosphorylation of elongation factor 2 by EF-2 
kinase affects rate of translation. Nature 334, 170-173. 
 
Santos, A. R., Comprido, D., Duarte, C. B., 2010. Regulation of local translation at the synapse by BDNF. 
Prog Neurobiol 92, 505-516. 
 
Sanz-Clemente, A., Nicoll, R. A., Roche, K. W., 2013. Diversity in NMDA receptor composition: many 
regulators, many consequences. Neuroscientist 19, 62-75. 
 
Sasaki, Y., Welshhans, K., Wen, Z., Yao, J., Xu, M., Goshima, Y., Zheng, J. Q., Bassell, G. J., 2010. 
Phosphorylation of zipcode binding protein 1 is required for brain-derived neurotrophic factor signaling of 
local beta-actin synthesis and growth cone turning. J Neurosci 30, 9349-9358. 
 
Scannevin, R. H., Huganir, R. L., 2000. Postsynaptic organization and regulation of excitatory synapses. Nat 
Rev Neurosci 1, 133-141. 
 
Scheetz, A. J., Nairn, A. C., Constantine-Paton, M., 2000. NMDA receptor-mediated control of protein 
synthesis at developing synapses. Nat Neurosci 3, 211-216. 
 
Schinder, A. F., Berninger, B., Poo, M., 2000. Postsynaptic target specificity of neurotrophin-induced 
presynaptic potentiation. Neuron 25, 151-163. 
 
Schratt, G. M., Nigh, E. A., Chen, W. G., Hu, L., Greenberg, M. E., 2004. BDNF regulates the translation of a 
select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent 
pathway during neuronal development. J Neurosci 24, 7366-7377. 
 
Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., Greenberg, M. E., 2006. A 
brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289. 
 
Shan, J., Munro, T. P., Barbarese, E., Carson, J. H., Smith, R., 2003. A molecular mechanism for mRNA 
trafficking in neuronal dendrites. J Neurosci 23, 8859-8866. 
 
Shepherd, J. D., Huganir, R. L., 2007. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu 
Rev Cell Dev Biol 23, 613-643. 
 
Shiina, N., Shinkura, K., Tokunaga, M., 2005. A novel RNA-binding protein in neuronal RNA granules: 
regulatory machinery for local translation. J Neurosci 25, 4420-4434. 
 
Shiina, N., Yamaguchi, K., Tokunaga, M., 2010. RNG105 deficiency impairs the dendritic localization of 
mRNAs for Na+/K+ ATPase subunit isoforms and leads to the degeneration of neuronal networks. J 
Neurosci 30, 12816-12830. 
 
Simsek-Duran, F., Lonart, G., 2008. The role of RIM1alpha in BDNF-enhanced glutamate release. 
Neuropharmacology 55, 27-34. 
 
Skalweit, A., Doller, A., Huth, A., Kahne, T., Persson, P. B., Thiele, B. J., 2003. Posttranscriptional control of 
renin synthesis: identification of proteins interacting with renin mRNA 3'-untranslated region. Circ Res 92, 
419-427. 
 
Small, D. L., Murray, C. L., Mealing, G. A., Poulter, M. O., Buchan, A. M., Morley, P., 1998. Brain derived 
neurotrophic factor induction of N-methyl-D-aspartate receptor subunit NR2A expression in cultured rat 
cortical neurons. Neurosci Lett 252, 211-214. 
 
Stains, J. P., Lecanda, F., Towler, D. A., Civitelli, R., 2005. Heterogeneous nuclear ribonucleoprotein K 
represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter. Biochem J 385, 
613-623. 
 
Steward, O., Levy, W. B., 1982. Preferential localization of polyribosomes under the base of dendritic spines 
in granule cells of the dentate gyrus. J Neurosci 2, 284-291. 
 
Steward, O., Wallace, C. S., Lyford, G. L., Worley, P. F., 1998. Synaptic activation causes the mRNA for the 
IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 21, 741-751. 
 
 157 
 
References 
Steward, O., Worley, P. F., 2001. Selective targeting of newly synthesized Arc mRNA to active synapses 
requires NMDA receptor activation. Neuron 30, 227-240. 
 
Subramanian, M., Rage, F., Tabet, R., Flatter, E., Mandel, J. L., Moine, H., 2011. G-quadruplex RNA 
structure as a signal for neurite mRNA targeting. EMBO Rep 12, 697-704. 
 
Suen, P. C., Wu, K., Levine, E. S., Mount, H. T., Xu, J. L., Lin, S. Y., Black, I. B., 1997. Brain-derived 
neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor 
subunit 1. Proc Natl Acad Sci U S A 94, 8191-8195. 
 
Sutton, M. A., Schuman, E. M., 2006. Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127, 
49-58. 
 
Sweatt, J. D., 1999. Toward a molecular explanation for long-term potentiation. Learn Mem 6, 399-416. 
 
Takei, N., Inamura, N., Kawamura, M., Namba, H., Hara, K., Yonezawa, K., Nawa, H., 2004. Brain-derived 
neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation 
machinery and protein synthesis in neuronal dendrites. J Neurosci 24, 9760-9769. 
 
Takei, N., Kawamura, M., Hara, K., Yonezawa, K., Nawa, H., 2001. Brain-derived neurotrophic factor 
enhances neuronal translation by activating multiple initiation processes: comparison with the effects of 
insulin. J Biol Chem 276, 42818-42825. 
 
Takei, N., Kawamura, M., Ishizuka, Y., Kakiya, N., Inamura, N., Namba, H., Nawa, H., 2009. Brain-derived 
neurotrophic factor enhances the basal rate of protein synthesis by increasing active eukaryotic elongation 
factor 2 levels and promoting translation elongation in cortical neurons. J Biol Chem 284, 26340-26348. 
 
Tanaka, J., Horiike, Y., Matsuzaki, M., Miyazaki, T., Ellis-Davies, G. C., Kasai, H., 2008. Protein synthesis 
and neurotrophin-dependent structural plasticity of single dendritic spines. Science 319, 1683-1687. 
 
Tang, S. J., Meulemans, D., Vazquez, L., Colaco, N., Schuman, E., 2001. A role for a rat homolog of staufen 
in the transport of RNA to neuronal dendrites. Neuron 32, 463-475. 
 
Tang, S. J., Reis, G., Kang, H., Gingras, A. C., Sonenberg, N., Schuman, E. M., 2002. A rapamycin-sensitive 
signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci U S A 
99, 467-472. 
 
Tartaglia, N., Du, J., Tyler, W. J., Neale, E., Pozzo-Miller, L., Lu, B., 2001. Protein synthesis-dependent and -
independent regulation of hippocampal synapses by brain-derived neurotrophic factor. J Biol Chem 276, 
37585-37593. 
 
Taylor, D. J., Frank, J., Kinzy, T. G., 2007. Strucuture and function of the eukaryotic ribosome and elongation 
factors. In: Mathews, M. B., Sonenberg, N., Hershey, J. W. B., (Eds), Translational Control in Biology and 
Medicine. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 59-85. 
 
Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., Kermani, P., Torkin, R., Chen, Z. Y., 
Lee, F. S., Kraemer, R. T., Nykjaer, A., Hempstead, B. L., 2005. ProBDNF induces neuronal apoptosis via 
activation of a receptor complex of p75NTR and sortilin. J Neurosci 25, 5455-5463. 
 
Thakker-Varia, S., Alder, J., Crozier, R. A., Plummer, M. R., Black, I. B., 2001. Rab3A is required for brain-
derived neurotrophic factor-induced synaptic plasticity: transcriptional analysis at the population and single-
cell levels. J Neurosci 21, 6782-6790. 
 
Thoenen, H., 1991. The changing scene of neurotrophic factors. Trends Neurosci 14, 165-170. 
 
Thomas, K. L., Laroche, S., Errington, M. L., Bliss, T. V., Hunt, S. P., 1994. Spatial and temporal changes in 
signal transduction pathways during LTP. Neuron 13, 737-745. 
 
Thyagarajan, A., Szaro, B. G., 2008. Dynamic endogenous association of neurofilament mRNAs with K-
homology domain ribonucleoproteins in developing cerebral cortex. Brain Res 1189, 33-42. 
 
Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., Persson, H., 1993. Multiple 
promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475-489. 
 
Tiruchinapalli, D. M., Oleynikov, Y., Kelic, S., Shenoy, S. M., Hartley, A., Stanton, P. K., Singer, R. H., 
Bassell, G. J., 2003. Activity-dependent trafficking and dynamic localization of zipcode binding protein 1 and 
beta-actin mRNA in dendrites and spines of hippocampal neurons. J Neurosci 23, 3251-3261. 
Chapter 6 
158 
Tongiorgi, E., Righi, M., Cattaneo, A., 1997. Activity-dependent dendritic targeting of BDNF and TrkB 
mRNAs in hippocampal neurons. J Neurosci 17, 9492-9505. 
 
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., 
Yuan, H., Myers, S. J., Dingledine, R., 2010. Glutamate receptor ion channels: structure, regulation, and 
function. Pharmacol Rev 62, 405-496. 
 
Troca-Marin, J. A., Alves-Sampaio, A., Tejedor, F. J., Montesinos, M. L., 2010. Local translation of dendritic 
RhoA revealed by an improved synaptoneurosome preparation. Mol Cell Neurosci 43, 308-314. 
 
Tubing, F., Vendra, G., Mikl, M., Macchi, P., Thomas, S., Kiebler, M. A., 2010. Dendritically localized 
transcripts are sorted into distinct ribonucleoprotein particles that display fast directional motility along 
dendrites of hippocampal neurons. J Neurosci 30, 4160-4170. 
 
Tucker, R. P., Garner, C. C., Matus, A., 1989. In situ localization of microtubule-associated protein mRNA in 
the developing and adult rat brain. Neuron 2, 1245-1256. 
 
Tyler, W. J., Pozzo-Miller, L., 2003. Miniature synaptic transmission and BDNF modulate dendritic spine 
growth and form in rat CA1 neurones. J Physiol 553, 497-509. 
 
Tyler, W. J., Pozzo-Miller, L. D., 2001. BDNF enhances quantal neurotransmitter release and increases the 
number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci 21, 4249-
4258. 
 
Tyler, W. J., Zhang, X. L., Hartman, K., Winterer, J., Muller, W., Stanton, P. K., Pozzo-Miller, L., 2006. BDNF 
increases release probability and the size of a rapidly recycling vesicle pool within rat hippocampal excitatory 
synapses. J Physiol 574, 787-803. 
 
Udagawa, T., Swanger, S. A., Takeuchi, K., Kim, J. H., Nalavadi, V., Shin, J., Lorenz, L. J., Zukin, R. S., 
Bassell, G. J., Richter, J. D., 2012. Bidirectional control of mRNA translation and synaptic plasticity by the 
cytoplasmic polyadenylation complex. Mol Cell 47, 253-266. 
 
Verpelli, C., Piccoli, G., Zibetti, C., Zanchi, A., Gardoni, F., Huang, K., Brambilla, D., Di Luca, M., Battaglioli, 
E., Sala, C., 2010. Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent 
BDNF synthesis. J Neurosci 30, 5830-5842. 
 
Vessey, J. P., Schoderboeck, L., Gingl, E., Luzi, E., Riefler, J., Di Leva, F., Karra, D., Thomas, S., Kiebler, 
M. A., Macchi, P., 2010. Mammalian Pumilio 2 regulates dendrite morphogenesis and synaptic function. Proc 
Natl Acad Sci U S A 107, 3222-3227. 
 
Vo, N., Klein, M. E., Varlamova, O., Keller, D. M., Yamamoto, T., Goodman, R. H., Impey, S., 2005. A cAMP-
response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci 
U S A 102, 16426-16431. 
 
Waterhouse, E. G., Xu, B., 2009. New insights into the role of brain-derived neurotrophic factor in synaptic 
plasticity. Mol Cell Neurosci 42, 81-89. 
 
Watson, F. L., Heerssen, H. M., Bhattacharyya, A., Klesse, L., Lin, M. Z., Segal, R. A., 2001. Neurotrophins 
use the Erk5 pathway to mediate a retrograde survival response. Nat Neurosci 4, 981-988. 
 
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., 
Patel, B., Eberwine, J., Greenough, W. T., 1997. Fragile X mental retardation protein is translated near 
synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A 94, 5395-5400. 
 
West, A. E., Griffith, E. C., Greenberg, M. E., 2002. Regulation of transcription factors by neuronal activity. 
Nat Rev Neurosci 3, 921-931. 
 
White, R., Gonsior, C., Kramer-Albers, E. M., Stohr, N., Huttelmaier, S., Trotter, J., 2008. Activation of 
oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA 
granules. J Cell Biol 181, 579-586. 
 
Whitter, M. P., 2011. Connectivity of the Hippocampus. In: Cutsuridis, V., Graham, B., Cobb, S., Vida, I., 
(Eds), Hippocampal Microcircuits. Springer, New York, pp. 5-26. 
 
Wibrand, K., Messaoudi, E., Havik, B., Steenslid, V., Lovlie, R., Steen, V. M., Bramham, C. R., 2006. 
Identification of genes co-upregulated with Arc during BDNF-induced long-term potentiation in adult rat 
dentate gyrus in vivo. Eur J Neurosci 23, 1501-1511. 
 159 
 
References 
Woo, N. H., Teng, H. K., Siao, C. J., Chiaruttini, C., Pang, P. T., Milner, T. A., Hempstead, B. L., Lu, B., 
2005. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 8, 
1069-1077. 
 
Wright, J. H., Drueckes, P., Bartoe, J., Zhao, Z., Shen, S. H., Krebs, E. G., 1997. A role for the SHP-2 
tyrosine phosphatase in nerve growth-induced PC12 cell differentiation. Mol Biol Cell 8, 1575-1585. 
 
Wu, Y. C., Williamson, R., Li, Z., Vicario, A., Xu, J., Kasai, M., Chern, Y., Tongiorgi, E., Baraban, J. M., 2011. 
Dendritic trafficking of brain-derived neurotrophic factor mRNA: regulation by translin-dependent and -
independent mechanisms. J Neurochem 116, 1112-1121. 
 
Xie, W., Zhang, K., Cui, B., 2012. Functional characterization and axonal transport of quantum dot labeled 
BDNF. Integr. Biol. 8, 953-960. 
 
Xu, B., Gottschalk, W., Chow, A., Wilson, R. I., Schnell, E., Zang, K., Wang, D., Nicoll, R. A., Lu, B., 
Reichardt, L. F., 2000. The role of brain-derived neurotrophic factor receptors in the mature hippocampus: 
modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci 20, 6888-
6897. 
 
Yamada, M., Ohnishi, H., Sano, S., Nakatani, A., Ikeuchi, T., Hatanaka, H., 1997. Insulin receptor substrate 
(IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in 
response to brain-derived neurotrophic factor in cultured cerebral cortical neurons. J Biol Chem 272, 30334-
30339. 
 
Yamashita, T., Tucker, K. L., Barde, Y. A., 1999. Neurotrophin binding to the p75 receptor modulates Rho 
activity and axonal outgrowth. Neuron 24, 585-593. 
 
Yang, J., Siao, C. J., Nagappan, G., Marinic, T., Jing, D., McGrath, K., Chen, Z. Y., Mark, W., Tessarollo, L., 
Lee, F. S., Lu, B., Hempstead, B. L., 2009. Neuronal release of proBDNF. Nat Neurosci 12, 113-115. 
 
Yano, H., Ninan, I., Zhang, H., Milner, T. A., Arancio, O., Chao, M. V., 2006. BDNF-mediated 
neurotransmission relies upon a myosin VI motor complex. Nat Neurosci 9, 1009-1018. 
 
Yano, M., Okano, H. J., Okano, H., 2005. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K 
in neuronal differentiation through p21 mRNA post-transcriptional regulation. J Biol Chem 280, 12690-12699. 
 
Ye, H., Kuruvilla, R., Zweifel, L. S., Ginty, D. D., 2003. Evidence in support of signaling endosome-based 
retrograde survival of sympathetic neurons. Neuron 39, 57-68. 
 
Yin, Y., Edelman, G. M., Vanderklish, P. W., 2002. The brain-derived neurotrophic factor enhances synthesis 
of Arc in synaptoneurosomes. Proc Natl Acad Sci U S A 99, 2368-2373. 
 
Ying, S. W., Futter, M., Rosenblum, K., Webber, M. J., Hunt, S. P., Bliss, T. V., Bramham, C. R., 2002. 
Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for 
ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 22, 1532-1540. 
 
Yonekawa, Y., Harada, A., Okada, Y., Funakoshi, T., Kanai, Y., Takei, Y., Terada, S., Noda, T., Hirokawa, 
N., 1998. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-
deficient mice. J Cell Biol 141, 431-441. 
 
Yoo, Y., Wu, X., Egile, C., Li, R., Guan, J. L., 2006. Interaction of N-WASP with hnRNPK and its role in 
filopodia formation and cell spreading. J Biol Chem 281, 15352-15360. 
 
Yoon, Y., McKenna, M. C., Rollins, D. A., Song, M., Nuriel, T., Gross, S. S., Xu, G., Glatt, C. E., 2013. 
Anxiety-associated alternative polyadenylation of the serotonin transporter mRNA confers translational 
regulation by hnRNPK. Proc Natl Acad Sci U S A 110, 11624-11629. 
 
Zadran, S., Jourdi, H., Rostamiani, K., Qin, Q., Bi, X., Baudry, M., 2010. Brain-derived neurotrophic factor 
and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent 
phosphorylation. J Neurosci 30, 1086-1095. 
 
Zeitelhofer, M., Karra, D., Macchi, P., Tolino, M., Thomas, S., Schwarz, M., Kiebler, M., Dahm, R., 2008. 
Dynamic interaction between P-bodies and transport ribonucleoprotein particles in dendrites of mature 
hippocampal neurons. J Neurosci 28, 7555-7562. 
 
Zhang, G., Neubert, T. A., Jordan, B. A., 2012. RNA binding proteins accumulate at the postsynaptic density 
with synaptic activity. J Neurosci 32, 599-609. 
Chapter 6 
160 
Zhang, H. L., Eom, T., Oleynikov, Y., Shenoy, S. M., Liebelt, D. A., Dictenberg, J. B., Singer, R. H., Bassell, 
G. J., 2001. Neurotrophin-induced transport of a beta-actin mRNP complex increases beta-actin levels and 
stimulates growth cone motility. Neuron 31, 261-275. 
 
Zheng, F., Luo, Y., Wang, H., 2009. Regulation of brain-derived neurotrophic factor-mediated transcription of 
the immediate early gene Arc by intracellular calcium and calmodulin. J Neurosci Res 87, 380-392. 
 
Zhong, J., Zhang, T., Bloch, L. M., 2006. Dendritic mRNAs encode diversified functionalities in hippocampal 
pyramidal neurons. BMC Neurosci 7, 17. 
 
 
 
